<SEC-DOCUMENT>0001193125-24-096391.txt : 20240415
<SEC-HEADER>0001193125-24-096391.hdr.sgml : 20240415
<ACCEPTANCE-DATETIME>20240415172326
ACCESSION NUMBER:		0001193125-24-096391
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20240606
FILED AS OF DATE:		20240415
DATE AS OF CHANGE:		20240415

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Alaunos Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001107421
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				841475642
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33038
		FILM NUMBER:		24845521

	BUSINESS ADDRESS:	
		STREET 1:		2617 BISSONNET ST
		STREET 2:		SUITE 225
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77005
		BUSINESS PHONE:		(346) 355-4099

	MAIL ADDRESS:	
		STREET 1:		2617 BISSONNET ST
		STREET 2:		SUITE 225
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZIOPHARM ONCOLOGY INC
		DATE OF NAME CHANGE:	20050919

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EASYWEB INC
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>d778708dpre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<HTML><HEAD>
<TITLE>PRE 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, DC 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Rule <FONT STYLE="white-space:nowrap">14a-101)</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN PROXY STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&#8194;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant&#8194;&#9744; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B><B>&nbsp;</B> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant to &#167; <FONT STYLE="white-space:nowrap">240.14a-12</FONT>
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Alaunos Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified in Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
<FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2617 Bissonnet, Suite 225 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Houston, TX 77005 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF
ANNUAL MEETING OF STOCKHOLDERS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To be Held on June 6, 2024 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[&#9679;], 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the stockholders of Alaunos Therapeutics,
Inc.: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cordially invite you to the 2024 annual meeting of stockholders (the &#147;Annual Meeting&#148;) of Alaunos Therapeutics, Inc. (&#147;we,&#148;
&#147;Alaunos&#148; or the &#147;Company&#148;), which will be held virtually and exclusively online via live audio-only webcast, on June&nbsp;6, 2024, at 9:00 a.m. Eastern Time, for the following purposes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To elect each of the five nominees for director named in the accompanying proxy statement (the &#147;proxy
statement&#148;) to hold office until the 2025 annual meeting of stockholders and until his or her successor is duly elected and qualified or, if sooner, until his or her earlier death, resignation or removal (&#147;Proposal 1&#148;);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To ratify the selection of RSM US LLP as the independent registered public accounting firm of the Company for
its fiscal year ending December&nbsp;31, 2024 by the audit committee (the &#147;audit committee&#148;) of the board of directors of the Company (the &#147;Board&#148;) (&#147;Proposal 2&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To approve, on an advisory basis, the compensation of the Company&#146;s named executive officers as disclosed
in the proxy statement (&#147;Proposal 3&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To approve the amendment and restatement of the Company&#146;s second amended and restated certificate of
incorporation, as amended (our &#147;Charter&#148;), in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the Board, effect a reverse stock split with respect to the Company&#146;s issued and outstanding
common stock, par value $0.001 per share, including stock held by the Company as treasury shares, at a reverse stock split ratio of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-5</FONT></FONT> to <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15,</FONT></FONT> inclusive (&#147;Proposal 4&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To approve an amendment to the Company&#146;s Charter, in substantially the form attached to the proxy
statement as Annex B, to, at the discretion of the Board, increase the number of shares of common stock authorized for issuance thereunder from 34,666,667 shares to 50,000,000 shares (&#147;Proposal 5&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To approve a proposal to adjourn the Annual Meeting to a later date, if necessary or appropriate, to permit
further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal 4 and Proposal 5 (&#147;Proposal 6&#148;); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These items of business are more fully described in the proxy statement accompanying this notice. The proxy statement accompanying this
notice is being issued in connection with the solicitation by the Board of a proxy on the enclosed form of proxy card for use at the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You
will be able to attend and participate in the Annual Meeting online, submit your questions during the Annual Meeting and vote your shares electronically during the meeting by visiting www.virtualshareholdermeeting.com/TCRT2024. <B>Because the Annual
Meeting is being held electronically, you will not be able to attend the Annual Meeting in person.</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The record date for the Annual Meeting is April 9,
2024. Only stockholders of record at the close of business on that date may vote at the Annual Meeting or any adjournment or postponement thereof. To participate in and vote at the Annual Meeting, stockholders will need the unique <FONT
STYLE="white-space:nowrap">16-digit</FONT> control number (printed in the box marked by </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the arrow) in their Notice of Internet Availability of Proxy Materials or proxy card (if you requested a printed copy of the proxy materials). </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By Order of the Board of Directors,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Melinda Lackey</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Melinda Lackey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Legal and Administration; Secretary</I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Houston, Texas</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[&#9679;], 2024</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Your vote is very important. Whether or not you attend the Annual Meeting virtually, it is important that your shares
be represented. You may vote your proxy through the Internet, by telephone or, if you receive a paper proxy card by mail, by completing and returning the proxy card mailed to you. Voting instructions are provided in the Notice of Internet
Availability of Proxy Materials, or, if you receive a paper proxy card by mail, the instructions are printed on your proxy card and included in the proxy statement. If you participate virtually in the Annual Meeting, you may vote at that time, even
if you previously submitted your vote. Even if you plan to participate in the Annual Meeting, we urge you to vote as soon as possible over the internet, by telephone or by mail as described in the proxy statement. </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>Table of Contents </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_1">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND
VOTING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_2">PROPOSALS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_3">Proposal 1 Election of Directors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_4">Proposal 2 Ratification of Selection of Independent Registered Public Accounting
 Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_5">Proposal 3 Advisory Vote on Executive Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_6">Proposal 4 Approval of the Third Amended and Restated Certificate of Incorporation
 to Effect a Reverse Stock Split of Common Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_7">Proposal 5 Approval of the Certificate of Amendment to our Charter to Increase
 our Authorized Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_8">Proposal 6 Adjournment of Annual Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_9">STOCKHOLDER PROPOSALS FOR THE 2025 ANNUAL MEETING OF
STOCKHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_10">CURRENT DIRECTORS, DIRECTOR NOMINEES AND EXECUTIVE
OFFICERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_11">EXECUTIVE COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_12">Summary Compensation Table</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_13">Narrative to the Summary Compensation Table</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_14">Pay Versus Performance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_15">Role of our Compensation Committee, Management and Consultant</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_16">Outstanding Equity Awards at 2022 Fiscal <FONT STYLE="white-space:nowrap">Year-End
</FONT></A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_17">Stockholder Engagement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_18">INFORMATION REGARDING THE BOARD AND CORPORATE GOVERNANCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_19">Independence of the Board</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_20">Board Leadership Structure</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_21">Nasdaq Board Diversity Matrix</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_22">Director Attendance at Board and Stockholder Meetings</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_23">Board Committees</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_24">Director Nomination Process</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_25">Risk Management and Oversight</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_26">Stockholder Communications with Directors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_27">Code of Ethics and Business Conduct</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_28">Corporate Governance Guidelines</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_29">Whistleblower Policy</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_30">Corporate Governance Documents</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_31">Report of the Audit Committee</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_32">DIRECTOR COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_33"><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director
Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_34">Director Compensation Table</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_35">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION
PLANS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_36">LIMITATION OF LIABILITY AND INDEMNIFICATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_37">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_38">Related-Party Transaction Policy</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_39">Certain Related-Party Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_40">DELINQUENT SECTION 16(A) REPORTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_41">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_42">HOUSEHOLDING OF PROXY MATERIALS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_43">OTHER MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_44">Annex A &#150; Third Amended and Restated Certificate of Incorporation
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc778708_45">Annex B &#150; Certificate of Amendment to Second Amended and Restated Certificate
 of Incorporation </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">B-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Alaunos Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2617 Bissonnet, Suite 225, </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Houston, TX 77050 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY
STATEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held On June 6, 2024 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_1"></A>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who is soliciting my vote? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are providing you with
these proxy materials because the board of directors (the &#147;Board&#148;) of Alaunos Therapeutics, Inc. (&#147;we,&#148; &#147;Alaunos&#148; or the &#147;Company&#148;) is soliciting your proxy to vote at the 2024 annual meeting (the &#147;Annual
Meeting&#148;), including at any adjournments or postponements thereof. The Annual Meeting will be held on June 6, 2024 at 9:00 a.m., Eastern Time virtually and exclusively online via live audio-only webcast at
www.virtualshareholdermeeting.com/TCRT2024. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why did I receive a notice regarding the availability of proxy materials through the internet? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to rules adopted by the Securities and Exchange Commission (the &#147;SEC&#148;), we have elected to provide access to our proxy materials over the
internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials (the &#147;Notice&#148;) because the Board is soliciting your proxy to vote at the Annual Meeting, including at any adjournments or postponements thereof.
All stockholders will have the ability to access the proxy materials through the website referred to in the Notice or to request a printed set of the proxy materials. Instructions on how to access the proxy materials over the internet or to request
a printed set of the proxy materials may be found in the Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to mail the Notice on or about [&#9679;], 2024 to all stockholders of record
entitled to vote at the Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Will I receive any other proxy materials by mail? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may send you a proxy card, along with a second Notice, on or after [&#9679;], 2024. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I attend the Annual Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You cannot attend
the Annual Meeting physically. You can attend the Annual Meeting by visiting www.virtualshareholdermeeting.com/TCRT2024, where you will be able to listen to the Annual Meeting live, submit questions and vote online. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Annual Meeting will start at 9:00 a.m. Eastern Time on June 6, 2024. We encourage you to access the Annual Meeting prior to the start time to allow time
for online <FONT STYLE="white-space:nowrap">check-in.</FONT> We have worked to offer the same participation opportunities as would be provided at an <FONT STYLE="white-space:nowrap">in-person</FONT> meeting while further enhancing the online
experience available to all stockholders regardless of their location. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies. If you
experience technical difficulties during the Annual Meeting, you should call the technical support phone number provided when you log in to the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to enter the Annual Meeting virtually, you will need the unique <FONT STYLE="white-space:nowrap">16-digit</FONT> control number, which is included in
the Notice or on your proxy card if you are a stockholder of record of the shares, or included with your voting instruction card and voting instructions received from your broker, bank, trustee, or nominee if you are the beneficial owner of the
shares held in &#147;street name.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if I cannot virtually attend the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may vote your shares electronically before the meeting by internet, by proxy or by telephone as described below. You do not need to access the Annual
Meeting audio-only webcast to vote if you submitted your vote via proxy, by internet or by telephone in advance of the Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who can vote at
the Annual Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Only stockholders of record at the close of business on April 9, 2024 (the &#147;Record Date&#148;) will be entitled to vote at
the Annual Meeting. On the Record Date, there were 16,012,479 shares of common stock outstanding and entitled to vote. A list of such holders will be open to the examination of any stockholder for any purpose germane to the Annual Meeting at Alaunos
Therapeutics, Inc., 2617 Bissonnet, Suite 225, Houston, TX 77005 for a period of 10 days prior to the Annual Meeting. Please contact the Secretary of the Company to make arrangements to inspect the list. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stockholder of Record&#151;Shares Registered in Your Name:</I> If on April 9, 2024, your shares were registered directly in your name with our transfer
agent, Equiniti Trust Company (&#147;EQ&#148;), then you are a stockholder of record. As a stockholder of record, you may vote at the Annual Meeting virtually or vote by proxy prior to the Annual Meeting. Whether or not you plan to attend the Annual
Meeting, we urge you to vote by proxy through the internet, by telephone or using a proxy card that you may request as instructed below, to ensure your vote is counted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Beneficial Owner&#151;Shares Registered in the Name of a Broker or Bank:</I> If on April 9, 2024, your shares were not registered in your name, but instead
are held in an account at a brokerage firm, bank, dealer or similar organization, then you are the beneficial owner of shares held in &#147;street name&#148; and the Notice is being forwarded to you by that organization. The organization holding
your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker, bank or other agent regarding how to vote the shares in your account. You are
also invited to attend the Annual Meeting. Since you are not the stockholder of record, however, you may not vote your shares at the Annual Meeting even if you participate virtually unless you request and obtain a valid proxy from your broker, bank
or other agent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What am I voting on? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are six
matters scheduled for a vote: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To elect each of the five nominees for director named in this proxy statement (the &#147;proxy statement&#148;)
to hold office until the 2025 annual meeting of stockholders and until his or her successor is duly elected and qualified or, if sooner, until his or her earlier death, resignation or removal (&#147;Proposal 1&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To ratify the selection of RSM US LLP as the independent registered public accounting firm of the Company for
its fiscal year ending December&nbsp;31, 2024 by the audit committee (the &#147;audit committee&#148;) of the Board (&#147;Proposal 2&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To approve, on an advisory basis, the compensation of the Company&#146;s named executive officers as disclosed
in the proxy statement (&#147;Proposal 3&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To approve the amendment and restatement of the Company&#146;s second amended and restated certificate of
incorporation, as amended (our &#147;Charter&#148;), in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the Board, effect a reverse stock split with respect to the Company&#146;s issued and outstanding
common stock, par value $0.001 per share, including stock held by the Company as treasury shares, at a reverse stock split ratio of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-5</FONT></FONT> to <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15,</FONT></FONT> inclusive (&#147;Proposal 4&#148; or the &#147;Reverse Stock Split Proposal&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To approve an amendment to the Company&#146;s Charter, in substantially the form attached to the proxy
statement as Annex B, to, at the discretion of the Board, increase the number of shares of common stock </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
authorized for issuance thereunder from 34,666,667 shares to 50,000,000 shares (&#147;Proposal 5&#148; or the &#147;Authorized Stock Increase Proposal&#148;); and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To approve a proposal to adjourn the Annual Meeting to a later date, if necessary or appropriate, to permit
further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal 4 and Proposal 5 (&#147;Proposal 6&#148; or the &#147;Adjournment Proposal&#148;).
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How does the Board recommend that I vote? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board unanimously recommends that you: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Vote your shares &#147;FOR&#148; Proposal 1 </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Vote your shares &#147;FOR&#148; Proposal 2 </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Vote your shares &#147;FOR&#148; Proposal 3 </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Vote your shares &#147;FOR&#148; Proposal 4 </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Vote your shares &#147;FOR&#148; Proposal 5 </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Vote your shares &#147;FOR&#148; Proposal 6 </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if another matter is properly brought before the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the Annual
Meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I
vote? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to Proposal 1, you may vote &#147;For&#148; all the nominees to the Board, or you may &#147;Withhold&#148; your vote for any of the
nominees you specify. With respect to the other proposals, you may vote &#147;For&#148; or &#147;Against,&#148; or you may abstain from voting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
procedures for voting are fairly simple: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stockholder of Record&#151;Shares Registered in Your Name:</I> If you are a stockholder of record, you may
vote electronically over the internet before or during Annual Meeting, vote by proxy over the telephone, vote by proxy through the internet, or vote by proxy using a proxy card that you may request or that we may elect to deliver at a later time.
Whether or not you plan to attend the virtual Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the Annual Meeting virtually and vote electronically at the Annual Meeting even if you have already voted
by proxy. You may vote as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To vote through the internet before the Annual Meeting, go to www.proxyvote.com to complete an electronic proxy
card. You will be asked to provide the <FONT STYLE="white-space:nowrap">16-digit</FONT> control number from the Notice. Your vote must be received by 11:59 p.m. Eastern Time, on June&nbsp;5, 2024 to be counted. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To vote your shares electronically at the Annual Meeting, you will need to visit
www.virtualshareholdermeeting.com/TCRT2024 during the Annual Meeting while the polls are open and follow the instructions provided on the Notice or the proxy card. You will be asked to provide the control number from the notice and follow the
instructions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To vote over the telephone from a location in the United States, dial toll-free <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903,</FONT></FONT></FONT> using a touch-tone phone and follow the recorded instructions. You will be asked to provide the <FONT STYLE="white-space:nowrap">16-digit</FONT> control
number from the Notice. Your vote must be received by 11:59 p.m. Eastern Time, on June&nbsp;5, 2024 to be counted. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To vote using a proxy card, you may request a proxy card by following the instructions in the Notice. Once you
receive the proxy card, simply mark, sign, and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. If you return your signed proxy
card to us before the Annual Meeting, we will vote your shares as you direct. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Beneficial Owner&#151;Shares Registered in the Name of
a Broker or Bank:</I> If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a Notice containing voting instructions from that organization rather than from us. Simply follow the
voting instructions in the Notice to ensure that your vote is counted. To vote electronically at the Annual Meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow the instructions from your broker, bank or other agent
included with these proxy materials, or contact your broker, bank or other agent to request a proxy form. You can also visit www.proxyvote.com, call
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-454-8683,</FONT></FONT></FONT> or return the voting instruction form in the enclosed postage-paid envelope. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We provide Internet proxy voting to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your
proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies. </I></B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes do I have? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On each matter to be voted
upon, you have one vote for each share of our common stock you own as of the Record Date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If I am a stockholder of record and I do not vote, or if I
return a proxy card or otherwise vote without giving specific voting instructions, what happens? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a stockholder of record and do not vote by
completing your proxy card, by telephone, through the internet or by voting electronically at the Annual Meeting, your shares will not be voted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you
return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable, &#147;For&#148; the election of all five nominees for director, &#147;For&#148; the ratification of the selection by
the audit committee of RSM US LLP as our independent registered public accounting firm for our fiscal year ending December&nbsp;31, 2024, &#147;For&#148; the approval, on an advisory basis, of the compensation of our named executive officers as
disclosed in this proxy statement, &#147;For&#148; the approval of the Reverse Stock Split Proposal, &#147;For&#148; the Authorized Stock Increase Proposal, and &#147;For&#148; the Adjournment Proposal. If any other matter is properly presented at
the Annual Meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If I am a
beneficial owner of shares held in street name and I do not provide my broker or bank with voting instructions, what happens? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a beneficial
owner of shares held in street name and you do not instruct your broker, bank or other agent how to vote your shares, your broker, bank or other agent may still be able to vote your shares in its discretion on certain &#147;routine&#148; proposals.
Under the rules of the New York Stock Exchange (&#147;NYSE&#148;), brokers, banks and other securities intermediaries that are subject to NYSE rules may use their discretion to vote your &#147;uninstructed&#148; shares with respect to matters
considered to be &#147;routine&#148; under NYSE rules, but not with respect to <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> matters. Proposals 1 and 3 are considered to be
<FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> under NYSE rules, meaning that your broker, bank or other agent may not vote your shares on those proposals in the absence of your voting instructions. However, Proposal 2, the Reverse
Stock Split Proposal, the Authorized Stock Increase Proposal and the Adjournment Proposal are considered to be &#147;routine&#148; matters under NYSE rules, meaning that if you do not return voting instructions to your broker, bank or other agent by
its deadline, your shares may be voted by your broker, bank or other agent in its discretion on Proposal 2, the Reverse Stock Split Proposal, the Authorized </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stock Increase Proposal and the Adjournment Proposal. Accordingly, if you own shares through a nominee, such as a broker, bank or other agent, please be sure to instruct your nominee how to vote
to ensure that your vote is counted on all of the proposals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If you are a beneficial owner of shares held in street name, in order to ensure your
shares are voted in the way you would prefer, you must provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent. </I></B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What does it mean if I receive more than one Notice? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If
you receive more than one Notice, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on each Notice to ensure that all of your shares are voted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Can I change my vote after submitting my proxy? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stockholder of Record: Shares Registered in Your Name </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are the record holder of your shares, you may revoke your proxy
in any one of the following ways: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You may submit another properly completed proxy card with a later date (which automatically revokes the earlier
proxy). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You may grant a subsequent proxy by telephone or through the internet. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You may send a timely written notice that you are revoking your proxy to our Secretary at our principal executive
offices at 2617 Bissonnet, Suite 225, Houston, TX 77005. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You may attend the Annual Meeting virtually and vote electronically. Simply attending the Annual Meeting
virtually will not, by itself, revoke your proxy. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even if you plan to attend the Annual Meeting virtually, we recommend that you
also submit your proxy or voting instructions or vote by telephone or through the Internet so that your vote will be counted if you later decide not to attend the Annual Meeting. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your most current proxy card, telephone proxy or internet proxy is the one that is counted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Beneficial Owner: Shares Registered in the Name of Broker, Bank or Other Agent </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If your shares are held by your broker, bank or other agent as a nominee, you should follow the instructions provided by such broker, bank or other agent. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How are votes counted? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Votes will be counted by the
inspector of election appointed for the Annual Meeting, who will separately count, for the proposal to elect directors (Proposal 1), votes &#147;For,&#148; &#147;Withhold,&#148; for all except and broker
<FONT STYLE="white-space:nowrap">non-votes;</FONT> and with respect to all other proposals, votes &#147;For&#148; and &#147;Against,&#148; abstentions and, if applicable, broker <FONT STYLE="white-space:nowrap">non-votes.</FONT> Abstentions will
have the same effect as &#147;Against&#148; votes on Proposal 2, Proposal 3, the Authorized Stock Increase Proposal and the Adjournment Proposal, and will have no effect on Proposal 1, Proposal&nbsp;4 or Proposal&nbsp;5. Broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> on Proposals 1 and 3 will have no effect and will not be counted towards the vote total for either of those proposals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What are &#147;broker <FONT STYLE="white-space:nowrap">non-votes&#148;?</FONT></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed above, when a beneficial owner of shares held in street name does not give voting instructions to his or her broker, bank or other agent holding
his or her shares as to how to vote on matters deemed to be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">&#147;non-routine,&#148;</FONT> under the NYSE rules, the broker, bank or agent cannot vote the shares. These <FONT STYLE="white-space:nowrap">un-voted</FONT>
shares are counted as &#147;broker <FONT STYLE="white-space:nowrap">non-votes.&#148;</FONT> Proposals 1 and 3 are considered to be <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> under the NYSE rules and therefore we expect broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> to exist in connection with those proposals. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on those proposals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>As a reminder, if you are a beneficial owner of shares held in street name, in order to ensure your shares are voted in the way you would prefer, you
must provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent. </I></B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes are needed to approve each proposal? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following table summarizes the minimum vote needed to approve each proposal and the effect of abstentions and broker <FONT STYLE="white-space:nowrap">non-votes.</FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposal</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposal Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vote Required for Approval</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Effect of</B><br><B>Abstentions</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Effect of</B><br><B>Broker</B><br><B><FONT STYLE="white-space:nowrap">Non-Votes</FONT></B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Election of directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Directors will be elected by a plurality of the votes cast by the holders of shares present or represented by proxy and entitled to vote on the election of directors. The five nominees receiving the most &#147;For&#148; votes will
be elected as directors.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">No<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">No effect</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ratification of the selection of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2024</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#147;For&#148; votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Against</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Not<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Applicable&nbsp;(1)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approval, on an advisory basis, of the compensation of our named executive officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#147;For&#148; votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Against</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">No effect</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Reverse Stock Split</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The votes cast &#147;For&#148; the amendment exceed the votes cast against the amendment.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">No<BR>effect</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Not<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Applicable (1)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Authorized Stock Increase</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The votes cast &#147;For&#148; the amendment exceed the votes cast against the amendment.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">No<BR>effect</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Not<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Applicable (1)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Adjournment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#147;For&#148; votes from the holders of a majority of the shares present in person or represented by proxy.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Against</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Not<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Applicable (1)</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Under NYSE rules, this proposal is considered to be a &#147;routine&#148; matter. Accordingly, if you hold your
shares in street name and do not provide voting instructions to your broker, bank or agent that holds your shares, your broker, bank or other such agent has discretionary authority to vote your shares on this proposal. Any failure by a broker, bank
or other agent to vote a share over which it exercises discretion will have the same effect as a vote against the proposal. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What is the quorum requirement? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders holding at least a majority in voting power of the
outstanding shares entitled to vote are deemed present at the Annual Meeting in person or represented by proxy. On the Record Date, there were 16,012,479 shares outstanding and entitled to vote. Thus, the holders of 8,006,240 shares must be deemed
present in person or represented by proxy at the Annual Meeting to have a quorum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your shares will be counted towards the quorum only if you submit a
valid proxy (or one is submitted on your behalf by your broker, bank or agent) or if you vote electronically at the Annual Meeting. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will be counted towards the quorum
requirement. If there is no quorum, the holders of a majority of shares deemed present at the Annual Meeting in person or represented by proxy may adjourn the Annual Meeting to another date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who will serve as inspector of elections? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A
representative of Broadridge Financial Solutions (&#147;Broadridge&#148;) will serve as inspector of elections and Broadridge will tabulate votes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How
can I find out the results of the voting at the Annual Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Preliminary voting results will be announced at the Annual Meeting. In addition, final
voting results will be published in a current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a
Form <FONT STYLE="white-space:nowrap">8-K</FONT> within four business days after the Annual Meeting, we intend to file a Form <FONT STYLE="white-space:nowrap">8-K</FONT> to publish preliminary results and, within four business days after the final
results are known to us, file an additional Form <FONT STYLE="white-space:nowrap">8-K</FONT> to publish the final results. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if I have questions
for the Company&#146;s transfer agent? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please contact EQ, at the phone number or address listed below, if you are a registered stockholder and have
questions concerning stock certificates, transfers or ownership or other matters pertaining to your stock account. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">800-937-5449</FONT></FONT> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 Wall Street, Floor 23 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10005 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">What if I want to request a
paper or email copy of these documents? </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you want to receive a paper or <FONT STYLE="white-space:nowrap">e-mail</FONT> copy of these documents, you
must request one. There is no charge for requesting a copy. Please choose one of the following methods to make your request:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">BY INTERNET:&nbsp;www.proxyvote.com</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">BY TELEPHONE:
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-579-1639</FONT></FONT></FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">BY <FONT STYLE="white-space:nowrap">E-MAIL*:&nbsp;sendmaterial@proxyvote.com</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">* If requesting materials by <FONT STYLE="white-space:nowrap">e-mail,</FONT> please send a blank <FONT STYLE="white-space:nowrap">e-mail</FONT> with the
information that is printed in the box marked by the arrow&nbsp;XXXX XXXX XXXX XXXX (located on the following page) in the subject line. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Proxy
Statement contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are all statements contained in this Proxy Statement that are not historical fact, and in some
cases can be identified by terms such as: &#147;anticipate,&#148; &#147;believe,&#148; &#147;estimate,&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;expect,&#148; &#147;forecast,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;project,&#148; &#147;target,&#148; &#147;potential,&#148; &#147;will&#148; and other words
and terms of similar meaning.&nbsp;These statements are based on management&#146;s current beliefs and assumptions and on information currently available to management. These statements involve risks, uncertainties and other factors that may cause
actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in such forward-looking
statements are reasonable, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Any forward-looking statements in this Proxy
Statement reflect our current views with respect to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, level of activity, performance or
achievements to be materially different from any future results, level of activity, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results, levels of activity or performance of
achievements to differ materially from current expectations include, among other things, those described under Part I, Item 1A, &#147;Risk Factors&#148; and elsewhere in the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the
fiscal year ended December&nbsp;31, 2023. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by law, we assume no obligation to update or revise these forward-looking statements for
any reason, even if new information becomes available in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_2"></A>PROPOSALS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_3"></A>Proposal 1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Election of Directors </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board presently
has five directors: Robert J. Hofmeister, Ph.D., Dale Curtis Hogue, Jr.; Robert W. Postma; Jaime Vieser; and Holger Weis. Each of Dr.&nbsp;Hofmeister Mr.&nbsp;Postma, Mr.&nbsp;Vieser and Mr.&nbsp;Weis was previously elected by the stockholders.
Mr.&nbsp;Hogue was appointed as a member of our Board effective December&nbsp;29, 2023 in connection with the termination of Mr.&nbsp;Kevin Boyle, Sr. and resignation of Ms.&nbsp;Mary Thistle. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;28, 2024, our Board nominated all of our existing directors for election at the Annual Meeting. If elected, each of our proposed nominees has
consented to serve as one of our directors, to hold office until our next annual meeting of stockholders and until his successor has been duly elected and qualified, or, if sooner, until his earlier death, resignation or removal. Proxies cannot be
voted for a greater number of persons than the number of nominees named in the proxy statement. If any director nominee should withdraw or otherwise become unavailable to serve, the proxies which would have otherwise been voted for that director
nominee may be voted for a substitute director nominee selected by our Board. We are not aware of any reason that a nominee will be unable or unwilling to serve as a director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth each nominee to be elected at the Annual Meeting, the year each nominee was first elected as a director, the position(s)
currently held by each nominee with us and the year each nominee&#146;s term will expire, if such nominee is elected at the Annual Meeting. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name of Nominee</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position(s) with</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>the Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;First&nbsp;Became&nbsp;a<BR>Director</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Proposed&nbsp;Term<BR>Will Expire</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert J. Hofmeister</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Curtis Hogue, Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Interim&nbsp;Chief&nbsp;Executive&nbsp;Officer&nbsp;and&nbsp;Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert W. Postma</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jaime Vieser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holger Weis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director - Chair</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under our director resignation policy, any nominee in an uncontested election who does not receive a majority of the votes
cast (i.e. receives a greater number of votes &#147;withheld&#148; from his or her election than votes &#147;for&#148; in such election) shall submit his or her offer of resignation for consideration by the corporate governance and nominating
committee of the Board (the &#147;corporate governance and nominating committee&#148;). The corporate governance and nominating committee shall consider all of the relevant facts and circumstances and recommend to the Board the action to be taken
with respect to such offer of resignation, and the Board will then act on such recommendation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our corporate governance and nominating committee seeks to
assemble a Board that, as a whole, possesses the appropriate balance of professional and industry knowledge, financial expertise and management experience necessary to oversee and direct our business. The corporate governance and nominating
committee maintains a goal of recruiting members who complement and strengthen the skills of other members and who also exhibit integrity, collegiality, sound business judgment and other qualities that the corporate governance and nominating
committee views as critical to effective functioning of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of the director nominees are related by blood, marriage or adoption to any of our
other director nominees or executive officers. Certain of our directors were previously selected or nominated for election as a director, pursuant to a settlement agreement, dated February&nbsp;4, 2021 (the &#147;WaterMill Settlement
Agreement&#148;), with WaterMill Asset Management Corp. and Robert W. Postma (collectively, the &#147;WaterMill Parties&#148;). The WaterMill Settlement Agreement is no longer in effect and none of the directors originally nominated pursuant to its
terms were nominated pursuant to the agreement for this meeting. Pursuant to the WaterMill Settlement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement, we increased the size of our Board from eight to nine directors (and which has subsequently been reduced to seven as directors have left the Board) and appointed Mr.&nbsp;Postma to
fill the newly created directorship. Under the WaterMill Settlement Agreement, we agreed that until the earlier of (i)&nbsp;January&nbsp;1, 2022 and (ii)&nbsp;thirty (30) calendar days prior to the nomination deadline for our 2022 annual meeting of
stockholders, we would nominate each of Messrs. Postma, Vieser and Weis for election at any stockholder meeting at which directors are to be elected and would recommend, support and solicit proxies for the election of each of Messrs. Postma, Vieser
and Weis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Hogue, our Interim Chief Executive Officer and a director, was appointed as a <FONT STYLE="white-space:nowrap">non-employee</FONT>
director in December 2023, prior to his appointment as interim Chief Executive Officer in January 2024. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors are elected by a plurality of the votes of the holders of shares deemed present in person or represented by proxy and entitled to vote on the
election of directors. Accordingly, if a quorum is present, the five nominees receiving the highest number of &#147;FOR&#148; votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the
election of the five nominees named above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>The Board recommends that you vote &#147;FOR&#148; the election of each named nominee.
</I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_4"></A>Proposal 2 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ratification of Selection of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audit committee of the Board has selected RSM US LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31,
2024. RSM US LLP has audited our financial statements since 2010. A representative of RSM US LLP is expected to virtually attend the Annual Meeting. He or she will have an opportunity to make a statement if he or she so desires and will be available
to respond to appropriate questions from stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are not required by statute or our bylaws or other governing documents to obtain stockholder
ratification of the appointment of RSM US LLP as our independent registered public accounting firm. The audit committee has submitted the selection of RSM US LLP to the stockholders for ratification as a matter of good corporate practice. If the
stockholders do not ratify the appointment, the audit committee may reconsider its selection. Notwithstanding the proposed ratification of the selection of RSM US LLP by the stockholders, the audit committee, in its discretion, may direct the
appointment of a new independent registered public accounting firm at any time during the year without notice to, or the consent of, the stockholders, if the audit committee determines that such a change would be in our best interest and the best
interest of our stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Principal Accountant Fees and Services </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents the aggregate fees billed by RSM US LLP for the years ended December&nbsp;31, 2023 and 2022. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP><B>Fee Category</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">308,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">543,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">308,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">543,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents fees billed for professional services provided to us in connection with the annual audit of our
financial statements and the review of our quarterly condensed financial statements, as well as audit services that are normally provided by an independent registered public accounting firm in connection with statutory and regulatory filings or
engagements for those fiscal years, such as statutory audits, administrative fees <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">and&nbsp;out-of-pocket&nbsp;costs.</FONT></FONT> For 2023, there were no fees associated with
registration statements, comfort letters and consents, and for 2022, fees of $224,175 are associated with registration statements, comfort letters and consents. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than as discussed above, we did not incur any fees of RSM US LLP for audit-related, tax or other services in 2023 or 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All fees described above were <FONT STYLE="white-space:nowrap">pre-approved</FONT> by the audit committee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Pre-Approval</FONT> Policy and Procedures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audit committee has adopted a policy and procedures for the <FONT STYLE="white-space:nowrap">pre-approval</FONT> of audit and <FONT
STYLE="white-space:nowrap">non-audit</FONT> services rendered by our independent registered public accounting firm, RSM US LLP. The policy generally authorizes <FONT STYLE="white-space:nowrap">pre-approval</FONT> by the audit committee of specified
services in the defined categories of audit services, audit-related services and tax services up to specified amounts. <FONT STYLE="white-space:nowrap">Pre-approval</FONT> may also be given as part of the audit committee&#146;s approval of the scope
of the engagement of the independent registered public accounting firm or on an individual, explicit, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis before the independent registered public
accounting firm is engaged to provide each service. The <FONT STYLE="white-space:nowrap">pre-approval</FONT> of services may be delegated to one or more of the audit committee&#146;s members, but the decision must be reported to the full audit
committee at its next scheduled meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of the holders of a majority of the shares deemed present in person or represented by proxy and entitled to vote thereon at the annual
meeting will be required to ratify the selection of RSM US LLP. Abstentions will be counted toward the vote total for Proposal 2 and will have the same effect as &#147;AGAINST&#148; votes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>The Board recommends that you vote &#147;FOR&#148; the ratification of the selection of RSM US LLP as our independent registered public
accounting firm for our fiscal year ending December&nbsp;31, 2024. </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_5"></A>Proposal 3 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Advisory Vote on Executive Compensation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Dodd-Frank Wall Street Reform and Consumer Protection Act and Section&nbsp;14A of the Securities Exchange Act of 1934, as amended (the
&#147;Exchange Act&#148;), our stockholders are entitled to vote to approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement in accordance with the SEC&#146;s rules. At the 2023 annual
meeting of stockholders, our stockholders indicated their preference that we solicit a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory vote on the compensation of the named executive officers, commonly referred to as a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay</FONT></FONT> vote,&#148; every year. The Board has adopted a policy that is consistent with that preference indicated by our stockholders. Accordingly, this year we are
again asking the stockholders to approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the
philosophy, policies and practices described in this proxy statement. The compensation of our named executive officers is disclosed in the section titled &#147;<I>Executive Compensation</I>&#148; below, including the tabular and narrative
disclosures set forth in such section under the same heading. We believe that our compensation policies and decisions are focused on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> principles and
strongly aligned with our stockholders&#146; interests. Compensation of our named executive officers is designed to enable us to attract and retain talented and experienced executives, whose knowledge, skills and performance are critical to our
success, and motivate these executive officers to achieve our business objectives and to lead us in a competitive environment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are asking our
stockholders to indicate their support for the compensation of our named executive officers as described in this proxy statement by casting a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory vote &#147;FOR&#148; the following resolution:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>&#147;RESOLVED, that the stockholders hereby approve the compensation of the &#147;named executive officers&#148; of Alaunos Therapeutics, Inc., as
disclosed in the section titled &#147;Executive Compensation&#148; in the proxy statement for the Alaunos Therapeutics, Inc. 2024 Annual Meeting of stockholders pursuant to the compensation disclosure rules of the SEC, including the compensation
tables and narrative discussion.&#148; </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of the holders of a majority of the shares deemed present in person or represented by proxy and entitled to vote at the Annual Meeting
will be required to approve, on an advisory basis, the compensation of our named executive officers as described herein. Because the vote is advisory, it will not be binding on us, the Board or the Board&#146;s compensation committee (the
&#147;compensation committee&#148;). Nevertheless, the views expressed by our stockholders, whether through this vote or otherwise, are important to us and, accordingly, the Board and our compensation committee intend to consider the results of this
vote in making determinations in the future regarding executive compensation arrangements. Abstentions will be counted toward the vote total for Proposal 3 and will have the same effect as &#147;AGAINST&#148; votes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>The Board recommends that you vote &#147;FOR&#148; the proposal to approve the compensation of our named executive officers, as described
in this proxy statement. </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_6"></A>Proposal 4 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Approval of the Third Amended and Restated Certificate of Incorporation to Effect a Reverse Stock Split of Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;28, 2024, our Board unanimously
approved and recommended that our stockholders approve the amendment and restatement of our Charter to, at the discretion of the Board, effect a reverse stock split with respect to the Company&#146;s issued and outstanding common stock, par value
$0.001 per share, including stock held by the Company as treasury shares, at any reverse stock split ratio within a range of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-5</FONT></FONT> to <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-for-15,</FONT></FONT> inclusive, and a proportionate decrease in the number of our total authorized capital stock and common stock, as further described below. As further described below, we are seeking approval of this
Reverse Stock Split Proposal primarily to provide our Board with the authority to effect a reverse stock split only if needed to maintain our listing on the Nasdaq Capital Market (&#147;Nasdaq&#148;). Our Board has accordingly determined that it is
advisable and in the best interest of the Company and its stockholders for this Reverse Stock Split Proposal to be approved so that the Board has the necessary flexibility if, as we remain subject to continued monitoring by the appellate board of
Nasdaq following our successful compliance with the Minimum Price Standard in February 2024 for 12 months from the date of notification of compliance or February&nbsp;16, 2025 (the &#147;Compliance Period&#148;), we again fall below the Minimum
Price Standard during the Compliance Period, and the Board makes the determination that a reverse stock split provides us the best chance to regain compliance and avoid delisting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A reverse stock split, if implemented, would be at any ratio approved by our stockholders in this proposal within the range described above and would apply
equally to all outstanding shares of our common stock. Accordingly, each stockholder would hold the same percentage of common stock outstanding immediately following a reverse stock split as that stockholder held immediately prior to a reverse stock
split, except for adjustments that may result from the treatment of fractional shares as described below. In addition, a reverse stock split would result in a proportionate reduction in the number of shares of common stock authorized under the
Charter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approval of this proposal would permit, but not require, our Board to effect a reverse stock split by any ratio between <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-5</FONT></FONT> to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15,</FONT></FONT> inclusive, with the exact ratio to be selected at a whole number within
this range as determined by our Board in its sole discretion, provided that any reverse stock split is implemented within one year after the conclusion of the Annual Meeting. As described in more detail below, we are currently in compliance with the
Minimum Price Standard. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon receiving stockholder approval of a reverse stock split, the Board will have the authority, but not the obligation, to
elect, in its sole discretion, without further action on the part of our stockholders and as it determines to be in our and our stockholders&#146; best interests, to effect a reverse stock split and, if so, to select the reverse stock split ratio
from within the approved range of ratios described above, each ratio within such range having been approved by our stockholders. We believe that enabling our Board to select the ratio from within the stated range will provide us with the flexibility
to implement a reverse stock split in a manner designed to maximize the anticipated benefits for our stockholders. In determining the ratio following the receipt of stockholder approval, our Board may consider, among other factors, the following:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the historical trading price and trading volume of our common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of outstanding shares of our common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the then-prevailing trading price and trading volume of our common stock and the anticipated impact of a reverse
stock split on the trading market for our common stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the continued listing requirements of Nasdaq, including the requirement that, subject to limited exceptions,
listed companies maintain a minimum bid price of at least $1.00; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of authorized but unissued shares of our common stock that would result from a reverse stock split,
and potential uses of those additional authorized but unissued shares; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the anticipated impact of a particular ratio on our ability to reduce administrative and transactional costs; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prevailing general market and economic conditions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Reverse Stock Split Proposal is approved by the stockholders and the Board determines to implement a reverse stock split, we will file an amended and
restated Charter (the &#147;Third Amended and Restated Charter&#148;), with the Delaware Secretary of State. The material changes in the proposed Third Amended and Restated Charter are described in this proposal. This description is qualified in its
entirety by reference to the complete text of the Third Amended and Restated Charter, which is attached as Annex A to this proxy statement and incorporated into this proposal by reference. You are strongly encouraged to read the actual text of the
Third Amended and Restated Charter. The proposed Third Amended and Restated Charter is subject to revision for such changes as may be required by the Delaware General Corporation Law and any other changes consistent with this proposal that we may
deem necessary or appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Reverse Stock Split Proposal is approved by the stockholders and a reverse stock split is implemented by our
Board, no less than 5 and no more than 15 shares of existing common stock, as determined by our Board, will be combined into one share of common stock. Holders will receive, in lieu of any fractional share, an amount in cash (without interest) equal
to such fraction multiplied by the closing sales price of our common stock as reported on Nasdaq on the trading day immediately preceding the effective date of the Third Amended and Restated Charter. The Third Amended and Restated Charter, if
adopted, will include only the reverse stock split ratio determined by our Board to be in the best interest of the Company and its stockholders and all of the other ratios approved by our stockholders within the proposed range will be abandoned.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Reverse Stock Split Proposal is approved and the Board elects to implement a reverse stock split, the number of outstanding shares of our common
stock would be reduced in proportion to the ratio of the reverse stock split chosen by our Board. If a reverse stock split is implemented, the number of authorized shares of our common stock would decrease by the same proportion as the number of
shares of common stock that are outstanding at the time of the reverse stock split. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board reserves the right to elect not to effect a reverse stock
split, including any or all reverse stock split ratios within the proposed range, if it determines, in its sole discretion, that implementing a reverse stock split is not in the best interest of the Company and its stockholders. If our Board does
not implement a reverse stock split on or prior to the one year anniversary of the conclusion of the Annual Meeting, stockholder approval would again be required prior to implementing any future reverse stock split. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Background and Reasons for a Reverse Stock Split </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As
further described below, we and our Board are seeking approval for the Reverse Stock Split Proposal primarily to provide our Board with authority to effect a reverse stock split if needed to maintain our listing on Nasdaq. However, we cannot provide
assurance that a reverse stock split would achieve its intended or desired benefits, and we strongly encourage you to review the discussion below in the section titled &#147;<I>Risks and Potential Disadvantages Associated with a Reverse Stock
Split</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Nasdaq Minimum Price Standard&nbsp;&amp; Low Priced Stocks Rule </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nasdaq Listing Rule 5450(a)(1) requires that companies listed on the Nasdaq maintain a minimum closing bid price of at least $1.00 per share (the &#147;Minimum
Price Standard&#148;). Companies are considered out of compliance with the Minimum Price Standard if the Nasdaq closing bid price is below $1.00 per share for 30 consecutive business days. Under Nasdaq Listing Rule 5810(c)(3)(A), once out of
compliance with the Minimum Price Standard, a company has 180 calendar days to regain compliance by meeting the Minimum Price Standard. On November&nbsp;8, 2023, we were notified that our shares had traded below $0.10 for ten consecutive days in
violation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Nasdaq Listing Rule 5810(c)(3)(A)(iii) or the &#147;Low Priced Stocks Rule.&#148; We appealed this determination pursuant to the instructions provided by Nasdaq to the Hearings Panel or the
&#147;Panel.&#148; On February&nbsp;16, 2024, we were notified by the Panel that, following a 15 to 1 reverse stock split, our shares had traded above $1.00 for 10 consecutive days and we were now in compliance. However, we are also advised that in
application of Listing Rule 5815(d)(4)(B), we are subject to a Mandatory Panel Monitor for a period of one year from February&nbsp;16, 2024 or the Compliance Period. If, within that <FONT STYLE="white-space:nowrap">one-year</FONT> monitoring period,
we are determined to again be out of compliance with the Minimum Price Standard, we cannot provide Nasdaq with a plan of compliance with respect to that deficiency nor will Nasdaq be able to grant additional time for us to regain compliance with
respect to that deficiency. We will also not be afforded an applicable cure or compliance period pursuant to Rule 5810(c)(3). Instead, as with the Low Priced Stocks Rule, we will immediately be delisted but will again have an opportunity to request
a new hearing with the initial Panel or a newly convened Hearings Panel if the initial Panel is unavailable. We will be able to respond/present to the Hearings Panel as provided by Listing Rule 5815(d)(4)(C). At this time, the Board would likely
want to undergo a reverse stock split in order to ensure that our shares trade at a compliant price to prevent delisting. The Minimum Price Standard will be met if our common stock has a minimum closing bid price of at least $1.00 per share for a
minimum of 10 consecutive business days within the time frame allowed by the Panel to gain compliance.&#8195; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the date of this proxy statement, we
are in compliance with the Minimum Price Standard. The equity markets have experienced and continue to experience substantial volatility due to, among other factors, the wars in Ukraine and Israel, dramatic interest rate increases, and high levels
of inflation. On April&nbsp;9, 2024, the reported closing price of our common stock was $1.73 per share. Accordingly, there is a significant risk that we may fall below the Minimum Price Standard during the Compliance Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The primary purpose of a reverse stock split would be to achieve an increase in the per share market price of our common stock as necessary to meet the
Minimum Price Standard. A delisting of our common stock would materially and adversely affect a stockholder&#146;s ability to dispose of, or to obtain accurate quotations as to the market value of, our common stock. Furthermore, any delisting may
cause our common stock to be subject to &#147;penny stock&#148; regulations promulgated by the SEC. Under such regulations, broker-dealers are required to, among other things, comply with disclosure and special suitability determinations prior to
the sale of shares of common stock. If our common stock becomes subject to these regulations, the market price of our common stock and the liquidity thereof would be materially and adversely affected. Absent other factors, we believe that reducing
the number of outstanding shares of our common stock is a potentially effective means to increase the per share market price of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If our
shares of common stock are delisted from Nasdaq, we believe that our shares of common stock would likely be eligible to be quoted <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> on an inter-dealer
electronic quotation and trading system operated by OTC Markets Group. These markets are generally considered not to be as efficient as, and not as broad as, Nasdaq. Selling our shares of common stock on these markets could be more difficult because
smaller quantities of shares would likely be bought and sold, and transactions could be delayed. In addition, in the event our shares of common stock are delisted, broker-dealers would have certain regulatory burdens imposed upon them with respect
to our common stock, which may discourage broker-dealers from effecting transactions in our common stock, further limiting the liquidity of our common stock. These factors could result in lower prices and larger spreads in the bid and ask prices for
our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A delisting from Nasdaq and continued or further declines in our share price could also greatly impair our ability to raise additional
necessary capital through equity or debt financing, or to use our shares for business development or other corporate initiatives, and could significantly increase the ownership dilution to stockholders caused by our issuing equity in financing or
other transactions. Without the ability to raise additional capital, our ability to carry on our business and advance the development of our product candidates would be significantly impaired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board believes that the proposed reverse stock split would be a potentially effective means for us to obtain and/or maintain compliance with the Minimum
Price Standard and to avoid, or at least defer, the consequences of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
our common stock being delisted from Nasdaq by producing the immediate effect of increasing the bid price of our common stock. <B>Our Board currently intends to effect a reverse stock split only
if, in its sole discretion, it deems it to be a necessary step to gain compliance with the Minimum Price Standard, if needed during the Compliance Period.</B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>General Investment Considerations </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, we
believe that a reverse stock split could make our common stock more attractive to a broader range of institutional and other investors, as we have been advised that the current market price of our common stock may affect its acceptability to certain
institutional investors and other members of the investing public. In particular, many brokerage houses and institutional investors have internal policies and practices that may prohibit them from investing in
<FONT STYLE="white-space:nowrap">low-priced</FONT> stocks or discourage individual brokers from recommending <FONT STYLE="white-space:nowrap">low-priced</FONT> stocks to their customers. Moreover, because brokers&#146; commissions on <FONT
STYLE="white-space:nowrap">low-priced</FONT> stocks generally represent a relatively high percentage of the stock price, transaction costs would represent a higher percentage of total share value, which could result in decreased trading volume and
increased volatility in the trading price of our common stock. We believe that a reverse stock split could make our common stock a more attractive and cost-effective investment for many investors, which could enhance the liquidity of our common
stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks and Potential Disadvantages Associated with a Reverse Stock Split </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board believes that a reverse stock split is a potentially effective means to increase the per share market price of our common stock and thus enable us to
regain compliance with the Minimum Price Standard, if we fail below the Minimum Price Standard during the Compliance Period. However, there are a number of risks and potential disadvantages associated with a reverse stock split, including the
following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Board cannot predict the effect of a reverse stock split upon the market price for shares of our common
stock, and the success of similar reverse stock splits for companies in like circumstances has varied. Some investors may have a negative view of a reverse stock split. Recently, the market price of our common stock has declined substantially, and
the equity markets have experienced and continue to experience substantial volatility due to, among other factors, the wars in Ukraine and Israel, dramatic interest rate increases, and high levels of inflation. The principal purpose of a reverse
stock split would be to increase the trading price of our common stock to meet the Minimum Price Standard. However, the effect of a reverse stock split on the market price of our common stock cannot be predicted with any certainty, and we cannot
assure you that a reverse stock split will accomplish this objective for any meaningful period of time, or at all. Even if a reverse stock split has a positive effect on the market price for shares of our common stock, performance of our business
and financial results, general economic conditions and the market perception of our business, and other adverse factors which may not be in our control could lead to a decrease in the price of our common stock following a reverse stock split.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Although the Board believes that a higher stock price may help generate the interest of new investors, the
reverse stock split may not result in a <FONT STYLE="white-space:nowrap">per-share</FONT> price that will successfully attract certain types of investors and such resulting share price may not satisfy the investing guidelines of institutional
investors or investment funds. Further, other factors, such as our financial results, market conditions and the market perception of our business, may adversely affect the interest of new investors in the shares of our common stock. As a result, the
trading liquidity of the shares of our common stock may not improve as a result of a reverse stock split and there can be no assurance that a reverse stock split, if completed, will result in the intended benefits described above.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Even if a reverse stock split does result in an increased market price per share of our common stock, the market
price per share following a reverse stock split may not increase in proportion to the reduction of the number of shares of our common stock outstanding before the implementation of a reverse stock split. Accordingly, even with an increased market
price per share, the total market capitalization of shares of our common stock after a reverse stock split could be lower than the total market capitalization before a reverse stock split. Also, even if there is an initial increase in the market
price per share of our common stock after a </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
reverse stock split, the market price many not remain at that level due to factors described in this proposal or other factors, including the risks described in our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023, as updated in reports we subsequently file with the SEC. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If a reverse stock split is implemented and the market price of shares of our common stock then declines, the
percentage decline may be greater than would occur in the absence of a reverse stock split due to decreased liquidity in the market for our common stock. If the market price of shares of our common stock declines after a reverse stock split, the
percentage decline as an absolute number and as a percentage of our overall market capitalization may be greater than would occur in the absence of a reverse stock split. Accordingly, the total market capitalization of our common stock following a
reverse stock split could be lower than the total market capitalization before a reverse stock split. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Procedures for and Effects of
Implementing a Reverse Stock Split </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Procedures </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A
reverse stock split would become effective upon the filing of the Third Amended and Restated Charter with the Secretary of State of the State of Delaware. The exact timing of the filing of the Third Amended and Restated Charter, if it is filed,
would be determined by our Board based on its evaluation as to when such action would be in the best interest of the Company and its stockholders. In addition, our Board reserves the right, notwithstanding stockholder approval and without further
action by the stockholders, to elect not to proceed with a reverse stock split if, at any time prior to filing the Third Amended and Restated Charter, our Board determines in its sole discretion that it is not in our best interest and the best
interest of our stockholders to proceed with a reverse stock split. If the Third Amended and Restated Charter has not been filed with the Secretary of State of the State of Delaware on or prior to the one year anniversary of the conclusion of the
Annual Meeting, our Board will abandon the reverse stock split or seek stockholder reauthorization of a reverse stock split. Following are descriptions of how a reverse stock split would be implemented for beneficial holders, registered book entry
holders, and certificated holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Beneficial Holders</I>. Upon the implementation of a reverse stock split, we intend to treat shares held by
stockholders through a broker, bank or other agent in the same manner as registered stockholders whose shares are registered in their names. Brokers, banks and other agents would be instructed to effect a reverse stock split for their beneficial
holders holding our common stock in street name. However, these brokers, banks and other agents may have different procedures than registered stockholders for processing a reverse stock split. Stockholders who hold shares of our common stock with a
broker, bank or other agent and who have any questions in this regard are strongly encouraged to contact their brokers, banks or other agents for more information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Registered &#147;Book Entry&#148; Holders</I>. Certain of our registered holders of common stock may hold some or all of their shares electronically in
book-entry form with EQ. These stockholders do not have stock certificates evidencing their ownership of the common stock. They are, however, provided with a statement reflecting the number of shares registered in their accounts. If a reverse stock
split is implemented, stockholders who hold shares electronically in book-entry form with EQ would not need to take action (the exchange will be automatic) to receive whole shares of post-reverse split common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certificated Holders</I>. If a reverse stock split is implemented, stockholders holding shares of our common stock in certificated form would be sent a
letter of transmittal by EQ following the reverse stock split. The letter of transmittal would contain instructions on how a stockholder should surrender their certificate(s) representing shares of our common stock (the &#147;Old Certificates&#148;)
to EQ in exchange for certificates representing the appropriate number of whole shares of post-reverse split common stock (the &#147;New Certificates&#148;). No New Certificates would be issued to a stockholder until such stockholder delivered all
Old Certificates, together with a properly completed and executed letter of transmittal, to EQ. No stockholder would be required to pay a transfer or other fee to exchange their Old Certificates. Stockholders would then receive one or more New
Certificate(s) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
representing the number of whole shares of common stock they are entitled to as a result of a reverse stock split, subject to the treatment of fractional shares described below. Until
surrendered, we would deem outstanding Old Certificates held by stockholders to be cancelled and only to represent the number of whole shares of post-reverse split common stock to which these stockholders are entitled and the right to receive cash
in lieu of any fractional shares as described below. Any Old Certificates submitted for exchange, whether because of a sale, transfer or other disposition of stock, would automatically be exchanged for New Certificates. If an Old Certificate has a
restrictive legend on it, the New Certificate would be issued with the same restrictive legends that are on the Old Certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a reverse stock split
is implemented, we expect that EQ would act as the exchange agent for purposes of implementing the exchange of stock certificates. No service charges would be payable by holders of shares of common stock in connection with the exchange of
certificates. We would bear all of such expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>STOCKHOLDERS SHOULD <U>NOT</U> DESTROY ANY STOCK CERTIFICATES. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>STOCKHOLDERS SHOULD <U>NOT</U> SUBMIT STOCK CERTIFICATES FOR EXCHANGE UNLESS AND UNTIL REQUESTED TO DO SO, AND THEN STOCK CERTIFICATES SHOULD BE SUBMITTED
ONLY IN THE MANNER INSTRUCTED. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>STOCK CERTIFICATES SHOULD <U>NOT</U> BE SUBMITTED DIRECTLY TO THE COMPANY. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Outstanding Shares of Common Stock </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depending on the
ratio for a reverse stock split determined by our Board, a minimum of 5 and a maximum of 15 shares of existing common stock would be combined into one new share of common stock. Based on 16,012,479 shares of common stock issued and outstanding as of
the Record Date, immediately following a reverse stock split we would have approximately 3,202,496 shares of common stock issued and outstanding (without giving effect to the treatment of fractional shares) if the ratio for a reverse stock split is <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-5,</FONT></FONT> and 1,067,499 shares of common stock issued and outstanding (without giving effect to the treatment of fractional shares) if the ratio for a reverse stock split is <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15.</FONT></FONT> Any other ratio selected within such range would result in a number of shares of common stock issued and outstanding following the reverse stock split between
approximately 2,668,747 and 1,143,749 shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The actual number of shares issued after giving effect to a reverse stock split, if implemented, would
depend on the reverse stock split ratio that is ultimately selected by our Board. A reverse stock split would affect all holders of our common stock uniformly and would not affect any stockholder&#146;s percentage ownership interest in the Company,
except that, as described below in the section titled &#147;<I>Fractional Shares</I>,&#148; stockholders of record otherwise entitled to a fractional share, as a result of a reverse stock split, would instead receive an amount in cash. In addition,
a reverse stock split would not affect any stockholder&#146;s proportionate voting power, except for adjustments that may result from the treatment of fractional shares as described below. A reverse stock split may result in some stockholders owning
&#147;odd lots&#148; of less than 100 shares of common stock. Odd lot shares may be more difficult to sell, and brokerage commissions and other costs of transactions in odd lots are generally somewhat higher than the costs of transactions in
&#147;round lots&#148; of even multiples of 100 shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Authorized Shares of Common Stock </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A reverse stock split would result in a proportionate reduction in the number of authorized shares of our common stock under the Charter at the time a reverse
stock split is effected. A reverse stock split would not have any effect on the number of authorized shares of preferred stock, which would remain at 30,000,000 shares of preferred stock, par value $0.001. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For clarity, if the Authorized Stock Increase Proposal described below is approved by our stockholders and implemented by our Board, in its discretion,
through the filing of a certificate of amendment to our Charter prior </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to the implementation of the reverse stock split, the reverse stock split would have the effect of reducing the increased number of authorized shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the effective time of a reverse stock split, any authorized shares of our common stock, if and when issued, would be part of our existing class of
our common stock and would have the same rights and privileges as the shares of our common stock currently outstanding. Our stockholders do not, as such, have preemptive rights or preferential rights to purchase additional shares of our common stock
that we may issue. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Fractional Shares </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We would not
issue fractional shares in connection with a reverse stock split. Therefore, we would not issue certificates representing fractional shares resulting from the reverse stock split because the stockholder owns a number of shares of our common stock
not evenly divisible by the ratio. Stockholders would receive, in lieu of any fractional share, an amount in cash (without interest) equal to such fraction multiplied by the closing sales price of our common stock as reported on Nasdaq on the
trading day immediately preceding the effective date of the Third Amended and Restated Charter. The ownership of a fractional share interest following a reverse stock split would not give the holder any voting, dividend or other rights, except to
receive payment as described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If our Board elects to implement the proposed reverse stock split, stockholders owning, prior to the reverse stock
split, less than the number of whole shares of common stock that will be combined into one share of common stock in the reverse stock split would no longer be stockholders. The exact number by which the number of holders of our common stock would be
reduced will depend on the specific reverse stock split ratio adopted by the Board and the number of stockholders that hold less than that ratio as of the effective date of the reverse stock split. As of the Record Date, there were approximately 282
holders of record of our common stock, of which 61 held fewer than 15&nbsp;shares of common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Effects on Equity Compensation Plans and Awards,
Convertible Securities and Warrants </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a reverse stock split is implemented, proportionate adjustments would generally be required to be made with
regard to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the per share exercise price of, and the number of shares issuable upon exercise of, outstanding stock options
issued under our equity compensation plans; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of shares deliverable upon vesting and settlement of outstanding restricted stock and restricted stock
unit awards; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of shares reserved for issuance under our equity compensation plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the per share conversion price, and the number of shares issuable upon conversion of, outstanding convertible
securities entitling the holders to purchase or convert into, or otherwise acquire shares of our common stock; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the strike price and the number of shares issuable upon exercise of warrants entitling the holders to receive
shares of our common stock. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the case of options, convertible securities or other rights to acquire shares of our common stock, these
adjustments would result in approximately the same aggregate price required under such options, convertible securities or other rights upon exercise, conversion, or settlement, and approximately the same value of shares of common stock being
delivered upon such exercise, conversion, or settlement, immediately following a reverse stock split as was the case immediately preceding such reverse stock split. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the case of our outstanding warrants, the number of shares issuable under the warrants will be proportionately decreased and the exercise price of each
warrant proportionately increased. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of shares of common stock issuable upon exercise or vesting of outstanding equity awards, options
and warrants and the exercise or purchase price related thereto, if any, would be equitably adjusted in accordance with the terms of our 2012 Equity Incentive Plan and our 2020 Equity Incentive Plan, as applicable, or such stock option grants or
warrants, as the case may be, which may include rounding the number of shares of common stock issuable down to the nearest whole share or the payment of cash for fractional shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exchange Act Registration; Nasdaq Listing; CUSIP </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
common stock is currently registered under Section&nbsp;12(b) of the Exchange Act, and we are subject to periodic reporting and other requirements of the Exchange Act. The implementation of a reverse stock split would not affect the registration of
our common stock under the Exchange Act or our reporting or other requirements under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are currently listed on the Nasdaq Capital
Market under the trading symbol &#147;TCRT.&#148; If our common stock remains listed on the Nasdaq Capital Market up to the time of a reverse stock split, then immediately following the reverse stock split our common stock would continue to be
listed on the Nasdaq Capital Market under the &#147;TCRT&#148; symbol, although it is likely that Nasdaq would add the letter &#147;D&#148; to the end of the trading symbol for a period of 20 trading days after the effective date of the reverse
stock split to indicate that the reverse stock split had occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following a reverse stock split, our common stock would have a new Committee on
Uniform Securities Identification Procedures (&#147;CUSIP&#148;) number, which is a number used to identify our equity securities, and stock certificates with the older CUSIP number will need to be exchanged for stock certificates with the new CUSIP
number by following the procedures described above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Accounting Matters </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The filing of the Third Amended and Restated Charter and implementation of a reverse stock split would not affect the par value of our common stock per share,
which will remain $0.001. As a result, the stated capital attributable to common stock and the additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital account on our balance sheet would not change due to a reverse stock split. However,
the stated capital attributable specifically to our common stock would be reduced proportionally depending on the reverse stock split ratio, and the additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital account would be credited with
the amount by which the stated capital would be reduced. Also, if a reverse stock split is implemented, reported per share net income or loss would be higher because there will be fewer shares of our common stock outstanding. We do not anticipate
that any other accounting consequences would arise as a result of a reverse stock split. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Appraisal Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our stockholders are not entitled to dissenters&#146; or appraisal rights under the Delaware General Corporation Law with respect to any of the proposals being
voted on at the Annual Meeting and described in this proxy statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Federal Income Tax Consequences of a Reverse Stock Split </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following describes certain material U.S. federal income tax considerations of a reverse stock split expected to apply generally to U.S. Holders (as
defined below) of our common stock. This description is based upon current provisions of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), existing Treasury Regulations under the Code and current administrative rulings and court
decisions, all of which are subject to change or different interpretation. Any change, which may or may not be retroactive, could alter the tax consequences to us or our stockholders as described in this section. No ruling from the U.S. Internal
Revenue Service has been or will be requested in connection with a reverse stock split. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No attempt has been made to comment on all U.S. federal income
tax consequences of a reverse stock split that may be relevant to particular U.S. Holders, including holders: (i)&nbsp;that are subject to special tax rules such as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
dealers, brokers and traders in securities, mutual funds, regulated investment companies, real estate investment trusts, insurance companies, banks or other financial institutions or <FONT
STYLE="white-space:nowrap">tax-exempt</FONT> entities; (ii)&nbsp;that hold their shares as a hedge or as part of a hedging, straddle, &#147;conversion transaction,&#148; &#147;synthetic security,&#148; integrated investment or any risk reduction
strategy; (iii)&nbsp;that are partnerships, S corporations, or other pass-through entities or investors in such pass-through entities; or (iv)&nbsp;that do not hold their shares as capital assets for U.S. federal income tax purposes (generally,
property held for investment within the meaning of Section&nbsp;1221 of the Code). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the following discussion does not address the tax
consequences of a reverse stock split under state, local and foreign tax laws. The discussion assumes that for U.S. federal income tax purposes, a reverse stock split will not be integrated, or otherwise treated as part of a unified transaction,
with any other transaction. Furthermore, the following discussion does not address the tax consequences of transactions effectuated before, after or at the same time as a reverse stock split, whether or not they are in connection with a reverse
stock split. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a &#147;U.S. Holder&#148; means a beneficial owner of our common stock that is: (i)&nbsp;an individual who
is a citizen or resident of the U.S.; (ii) a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized in the U.S. or under the laws of the U.S. or any subdivision thereof; (iii)&nbsp;an estate
the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source; or (iv)&nbsp;a trust (other than a grantor trust) if (A)&nbsp;a court within the U.S. is able to exercise primary supervision over the
administration of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust or (B)&nbsp;it has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HOLDERS OF OUR COMMON STOCK ARE ADVISED TO CONSULT THEIR OWN TAX ADVISORS REGARDING THE U.S. FEDERAL INCOME TAX CONSEQUENCES OF A REVERSE STOCK SPLIT
IN LIGHT OF THEIR PERSONAL CIRCUMSTANCES AND THE CONSEQUENCES OF A REVERSE STOCK SPLIT UNDER OTHER FEDERAL, STATE, LOCAL AND FOREIGN TAX LAWS. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based
on the assumptions above, a reverse stock split will be treated as a <FONT STYLE="white-space:nowrap">tax-free</FONT> recapitalization for U.S. federal income tax purposes. Accordingly, if a reverse stock split is adopted: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A U.S. Holder that receives a reduced number of shares of our common stock pursuant to such reverse stock split
will not recognize any gain or loss, except with respect to the amount of cash (if any) received in respect of a fractional share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A U.S. Holder&#146;s aggregate tax basis in such holder&#146;s shares of common stock received in such reverse
stock split will equal the aggregate tax basis of such stockholder&#146;s shares of common stock held immediately before such reverse stock split, but not including the aggregate tax basis of shares surrendered in exchange for cash received in
respect of a fractional share (if any); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A U.S. Holder&#146;s holding period of shares of our common stock received in such reverse stock split will
include the holding period of the <FONT STYLE="white-space:nowrap">pre-reverse</FONT> stock split shares exchanged therefor; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A U.S. Holder that receives cash in lieu of a fractional share of common stock generally will recognize gain or
loss equal to the difference (if any) between the amount of cash received and the U.S. Holder&#146;s tax basis in the shares of common stock surrendered therefor. Such capital gain or loss generally will be long-term capital gain or loss if the U.S.
Holder&#146;s holding period for the common stock surrendered in the reverse stock split exceeds one year at the effective time of the reverse stock split. Long-term capital gains of <FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S. Holders
are generally subject to preferential tax rates. There are limitations on the deductibility of capital losses under the Code. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For
purposes of determining the tax basis and holding period of shares of our common stock received in a reverse stock split, U.S. Holders that acquired different blocks of shares our common stock at different times for different prices must calculate
their basis and holding periods separately for each identifiable block of such stock exchanged in the reverse stock split. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain of our stockholders may be required to attach a statement to their tax returns for the year in which
a reverse stock split is consummated that contains the information listed in applicable Treasury Regulations. All of our stockholders are advised to consult their own tax advisors with respect to the applicable reporting requirements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Affirmative votes &#147;For&#148; the
amendment must exceed the votes cast against the amendment for approval of this proposal. Abstentions will have no effect on the vote required for approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The approval of this proposal is not conditioned on the approval or disapproval of Authorized Stock Increase Proposal. However, should both this proposal and
the Authorized Stock Increase Proposal be approved by our stockholders, the Board would, in its discretion, choose which proposal(s) to implement, subject to its discretion to determine that neither proposal is in the best interest of the Company or
its stockholders. In the event that this proposal is approved by the stockholders and the Authorized Stock Increase Proposal is not, the Board currently intends to nonetheless implement this proposal if, in its sole discretion, it deems it to be a
necessary step to regain compliance with the Minimum Price Standard, should we fail to comply with the Standard during the Compliance Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>The Board recommends that you vote &#147;FOR&#148; the proposal to approve the Third Amended and Restated Charter to effect a reverse
stock split, at our Board&#146;s discretion. </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_7"></A>Proposal 5 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Approval of the Certificate of Amendment to our Charter to Increase our Authorized Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;28, 2024, our Board unanimously
approved and recommended that our stockholders approve an amendment to our Charter to, at the discretion of the Board, increase the authorized shares of our common stock from 34,666,667 shares of common stock to 50,000,000 shares of common stock
within one year after the conclusion of the Annual Meeting, representing an increase of approximately 44%. The number of shares of preferred stock authorized for issuance will remain the same, at 30,000,000 shares of preferred stock, and will not be
impacted by the increase in the authorized shares of capital stock or common stock, if approved by our stockholders. As of the Record Date, there were 16,012,479 shares of common stock issued and outstanding, no shares of common stock held as
treasury stock, no shares of preferred stock issued or outstanding and 3,220,730 shares of our common stock reserved for issuance in connection with the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the exercise of outstanding warrants to purchase 1,452,399 shares of common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the exercise and/or vesting of outstanding awards in the aggregate amount of 297,531 shares of common stock under
our 2012 Equity Incentive Plan and our 2020 Equity Incentive Plan; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the granting of future awards in the aggregate amount of 1,470,800 shares of common stock under our 2020 Equity
Incentive Plan. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the Record Date, 15,433,458 authorized shares of common stock remained available for future issuance.
Accordingly, our Board unanimously determined it was advisable and in the best interest of the stockholders and the Company to amend our Charter to increase the number of authorized shares of common stock (the &#147;Share Increase&#148;) and
directed that it be submitted for approval by the stockholders at the Annual Meeting in light of the time and expense that would otherwise be required to convene a special meeting for consideration of the proposed amendment at a later time. The form
of the proposed Share Increase amendment is attached to this Proxy Statement as Annex B. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amendment would increase the number of shares of common
stock the Company is authorized to issue by 15,333,333 shares of common stock, or approximately 44%. Thus, if this proposal is approved by our stockholders, our total authorized capital stock would increase from 34,666,667 to 50,000,000, with the
number of authorized shares of our preferred stock remaining unchanged at 30,000,000. The additional shares of common stock proposed to be authorized under this proposal would have rights identical to our currently outstanding shares of common
stock. This description is qualified in its entirety by reference to the complete text of the certificate of amendment to our Charter, which is attached as Annex B to this proxy statement and incorporated into this proposal by reference. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reasons for Increasing the Number of Authorized Shares of Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board believes that the increase in our authorized shares of common stock will provide us with the ability to support our future anticipated growth and
would provide us with greater flexibility to consider and respond to future business opportunities and needs as they arise, including equity financings. The availability of additional shares of common stock would permit us to undertake certain of
the foregoing actions without the delay and expense associate with holding a special meeting of our stockholders to obtain stockholder approval each time such an opportunity arises. Unless and until we can generate sufficient revenues, we expect to
finance our cash needs in whole or in part through equity offerings. If the authorization of the Share Increase is postponed until the foregoing specific needs arise, the delay and expense incident to obtaining stockholder approval at that time
could impair our ability to meet our objectives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Possible Effects of Increasing the Number of Authorized Shares of Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except for the conversion or exercise of outstanding convertible or exercisable securities (which conversion or exercise would be at the option of the
respective holders), we currently have no plans, proposals, arrangements, or understandings to issue any authorized but unissued shares of our common stock. However, these additional authorized shares could be used in the future for various purposes
without further stockholder approval, except as such approval may be required in particular cases by our organizational documents, applicable law or the rules of any stock exchange or other system on which our securities may then be listed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, authorized but unissued shares of common stock may enable our Board to render more difficult or to discourage an attempt to
obtain control of the Company. One of the consequences of such an action would be to protect the continuity of or entrench our management. This may adversely affect the market price of our common stock. If, in the due exercise of its fiduciary
obligations, for example, our Board were to determine that a takeover proposal were not in the best interest of the Company, such shares could be issued by the Board without stockholder approval in one or more private placements or other
transactions that might prevent or render more difficult or make more costly the completion of any attempted takeover transactions by diluting voting or other rights of the proposed acquirer or insurgent stockholder group, by creating a substantial
voting block in institutional or other hands that might support the position of the incumbent Board, by effecting an acquisition that might complicate or preclude the takeover, or otherwise. We have no current intention to issue shares for
anti-takeover purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Failure to approve this Authorized Stock Increase Proposal could have adverse results for, and effects on, the Company. Without a
reasonable amount of authorized shares available to us for issuance, we may not have the ability to raise additional capital, establish strategic relationships with other companies or expand our business or product lines through acquisition. In
addition, if we effect a reverse stock split as described in Proposal 4, we will have a more limited number of authorized shares available for issuance which could further exacerbate the problems described above. Furthermore, our future success
depends upon our ability to attract, retain and motivate highly-skilled scientific, commercial and managerial employees, and if this proposal is not approved by our stockholders, the lack of sufficient unissued and unreserved authorized shares of
common stock to provide future equity incentive opportunities could adversely impact our ability to achieve these goals. Furthermore, given the decline in the price of our common stock, we may need additional shares of authorized common stock to
satisfy our capital needs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Effectiveness of Amendment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Share Increase, if approved by our stockholders, would become effective upon the filing and effectiveness of the certificate of amendment, the form of
which is attached hereto as Annex B, with the Secretary of State of the State of Delaware. Such filing would take place only in the event the Board determines, following approval by our stockholders, that it remains in the best interest of the
Company and its stockholders to effect the Share Increase. The exact timing of the filing of the amendment to effect the Share Increase, however, will be determined by our Board based on its evaluation as to when such action will be the most
advantageous to the Company and our stockholders; provided, however, that the Share Increase amendment must be effective within one year after the conclusion of the Annual Meeting. In addition, our Board reserves the right, notwithstanding
stockholder approval and without further action by the stockholders, to elect not to proceed with the Share Increase amendment if, at any time prior to the filing of the Share Increase amendment with the Secretary of State of the State of Delaware,
our Board, in its sole discretion, determines that it is no longer in our Company&#146;s best interest or the best interest of our stockholders to proceed with the Share Increase. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Bifurcation of Proposals 4 and 5 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The approval of this
proposal is not conditioned on the approval of the Reverse Stock Split Proposal. To the extent that only one of either of these proposals is approved by our stockholders, only the amendment to our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Charter to affect the proposal that was approved by our stockholders may be filed with the Secretary of State of the State of Delaware. To the extent that both the Authorized Stock Increase
Proposal and Reverse Stock Split Proposal are approved by our stockholders, the amendment to our Charter to effect the Share Increase is expected, subject the Board&#146;s discretion, to be filed in advance of the Third Amended and Restated Charter.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding approval of these proposals by our stockholders, our Board has reserved its right to abandon, at any time, either or both of the proposed
amendments if, in its sole discretion, it determines doing so is in the best interest of the Company and our stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required for Approval
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Affirmative votes &#147;For&#148; the amendment must exceed the votes cast against the amendment for approval of this proposal. Abstentions will have
no effect on the outcome of the vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The approval of this proposal is not conditioned on the approval or disapproval of Reverse Stock Split Proposal.
However, should both this proposal and the Reverse Stock Split Proposal be approved by our stockholders, the Board would, in its discretion, choose which proposal(s) to implement, subject to its discretion to determine that neither proposal is in
the best interest of the Company or its stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>The Board recommends that you vote &#147;FOR&#148; the proposal to approve the
amendment to implement the Share Increase, at our Board&#146;s discretion. </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_8"></A>Proposal 6 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Adjournment of Annual Meeting </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are
asking you to vote to approve one or more adjournments of the Annual Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to approve either the Reverse Stock Split Proposal or the
Authorized Stock Increase Proposal at the time of the Annual Meeting or if we do not have a quorum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If our stockholders approve this Adjournment
Proposal, we could adjourn the Annual Meeting and any reconvened session of the Annual Meeting and use the additional time to solicit additional proxies, including proxies from stockholders that have previously returned properly executed proxies
voting against the approval of the Reverse Stock Split Proposal or the Authorized Stock Increase Proposal. Among other things, approval of the Adjournment Proposal could mean that, even if we had received proxies representing a sufficient number of
votes against the approval of the Reverse Stock Split Proposal or the Authorized Stock Increase Proposal such that the proposal to approve any such proposal would be defeated, we could adjourn the Annual Meeting without a vote on the approval of
such proposal and seek to convince the holders of those shares to change their votes to votes in favor of approval of such proposal. Additionally, we may seek to adjourn the Annual Meeting if a quorum is not present. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board believes that it is in the best interest of the Company and our stockholders to be able to adjourn the Annual Meeting to a later date or dates if
necessary or appropriate for the purpose of soliciting additional proxies in respect of the approval of the Reverse Stock Split Proposal or the Authorized Stock Increase Proposal if there are insufficient votes to approve either or both at the time
of the Annual Meeting or in the absence of a quorum. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of the holders of a majority of the shares of common stock present in person or represented by proxy and entitled to vote at the Annual
Meeting is required for approval of the Adjournment Proposal. Abstentions will be counted toward the vote total for Proposal 6 and will have the same effect as &#147;AGAINST&#148; votes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>The Board recommends that you vote &#147;FOR&#148; approval of the adjournment of the Annual Meeting, if necessary, to solicit additional
proxies if there are insufficient votes at the time of the Annual Meeting to approve either the Reverse Stock Split Proposal or the Authorized Stock Increase Proposal. </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_9"></A>STOCKHOLDER PROPOSALS FOR THE 2025 ANNUAL MEETING OF
STOCKHOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For a proposal to be considered for inclusion in our proxy materials for presentation at the 2025 annual meeting of stockholders
pursuant to Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> under the Exchange Act, the proposal must be received by our Secretary at our principal executive offices at 2617 Bissonnet, Suite 225, Houston, TX 77005, by no later than [&#149;],
2024, unless the date of 2025 annual meeting of stockholders is changed by more than 30 days from the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of this year&#146;s annual meeting, in which case the deadline will be a reasonable
time before we begin to distribute the proxy materials for the 2025 annual meeting of stockholders. Due to the complexity of the respective rights of the stockholders and us in this area, any stockholder desiring to propose such an action is advised
to consult with his or her legal counsel with respect to such rights. We suggest that any such proposal be submitted to us by certified mail, return receipt requested. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rule <FONT STYLE="white-space:nowrap">14a-4</FONT> under the Exchange Act governs our use of our discretionary proxy voting authority with respect to a
stockholder proposal that the stockholder has not sought to include in our proxy statement. Rule <FONT STYLE="white-space:nowrap">14a-4</FONT> provides that if a proponent of a proposal fails to notify us at least 45 days prior to the <FONT
STYLE="white-space:nowrap">one-year</FONT> anniversary of the day of mailing of the prior year&#146;s proxy statement, management proxyholders will be allowed to use their discretionary voting authority as to whether the proposal is raised at the
annual meeting, without any discussion of the matter. If a stockholder wishes to bring a matter before the stockholders at the 2025 annual meeting of stockholders but does not notify us before [&#9679;], 2025 (or a reasonable time before we begin to
distribute the proxy materials for the 2025 annual meeting of stockholders if the date of the 2025 annual meeting of stockholders is changed by more than 30 days from the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of this
year&#146;s annual meeting), for all proxies we receive, the management proxyholders will have discretionary authority to vote on the matter, including discretionary authority to vote in opposition to the stockholder&#146;s proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recommendations for candidates to be considered for election to the Board at the 2025 annual meeting of stockholders may be submitted to the corporate
governance and nominating committee by our stockholders. In order to make such a recommendation, a stockholder must submit the recommendation in writing to the Chairperson of the corporate governance and nominating committee, in care of our
Secretary at our principal executive offices at 2617 Bissonnet, Suite 225, Houston, TX 77005, at least 120 days prior to the mailing date of the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the previous year&#146;s annual meeting
proxy statement. To enable the corporate governance and nominating committee to evaluate the candidate&#146;s qualifications, stockholder recommendations must include the following information: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The name and address of the nominating stockholder and of the director candidate; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A representation that the nominating stockholder is a holder of record of ours entitled to vote at the current
year&#146;s annual meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A description of any arrangements or understandings between the nominating stockholder and the director candidate
or candidates being recommended pursuant to which the nomination or nominations are to be made by the stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A resume detailing the educational, professional and other information necessary to determine if the nominee is
qualified to become a director of ours; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Such other information regarding each nominee proposed by such stockholder as would have been required to be
included in a proxy statement filed pursuant to the proxy rules of the SEC had each nominee been nominated by the Board; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The consent of each nominee to serve as a director of ours if so elected. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_10"></A>CURRENT DIRECTORS, DIRECTOR NOMINEES AND EXECUTIVE OFFICERS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Board </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set forth below are the names and
certain information about each of our directors as of April&nbsp;9, 2024. The information presented includes each director&#146;s age, principal occupation and business experience for the past five years and the names of other public companies of
which he or she has served as a director during the past five years. In addition, the table contains information about the specific and particular experience, qualifications, attributes or skills of each current director and each nominee for
director at the Annual Meeting that led the corporate governance and nominating committee to believe that such current director was appropriate for nomination at a previous annual meeting of stockholders or otherwise and, in the case of each nominee
for director at the Annual Meeting, that such nominee should serve on the Board following election at the Annual Meeting. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Positions and Offices Held</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Director</B><br><B>Since</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Curtis Hogue, Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Interim Chief Executive Officer and Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert J. Hofmeister, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert W. Postma</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jaime Vieser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holger Weis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dale&nbsp;Curtis&nbsp;Hogue,&nbsp;Jr.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><I>Director</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Hogue was appointed our interim Chief Executive Officer in January 2024 and a member of our Board in December 2023.
Mr.&nbsp;Hogue has worked for over 20 years in various roles on both the <FONT STYLE="white-space:nowrap">buy-</FONT> and sell-side covering biotechnology and pharmaceutical equities. Most recently, he founded Dune Lake Capital, a family office
focused on the healthcare industry. Mr.&nbsp;Hogue spent almost 8 years as a senior analyst at Discovery Capital Management where he covered global healthcare stocks including US therapeutics, Japanese pharmaceuticals and European pharma&nbsp;&amp;
biotech. Early in his career, he worked as a research scientist and as a patent examiner at the US Patent&nbsp;&amp; Trademark Office. Mr.&nbsp;Hogue holds an MBA from Duke University, an MS in Biotechnology from the Johns Hopkins University and a
BS in Physics form James Madison University.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Our Board believes that
Mr.&nbsp;Hogue&#146;s management and industry experience, as well as his financial expertise, qualify him to serve on our Board.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Robert J. Hofmeister,<BR>Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Dr.&nbsp;Hofmeister was appointed to our Board in March 2023. Dr.&nbsp;Hofmeister has over 25 years of scientific leadership and a successful track record of drug discovery and early development. Since January 2024, he holds the
CSO position at Myeloid Therapeutics, where he develops RNA immunotherapeutics and genome editing technologies. Prior to his current positions, he was the CSO at Resonance Medicine using their proprietary protease evolution platform to revolutionize
the treatment of multiple diseases. In this role, he drove the development and indication strategy that leverages their novel protease therapeutics. He joined TCR2 Therapeutics in 2015 as the company&#146;s first employee, serving as SVP, R&amp;D
before promotion to his most recent role of Chief Scientific Officer. There, he was instrumental in building and leading the R&amp;D function and driving the development of their proprietary
TRuC<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> <FONT STYLE="white-space:nowrap">-T</FONT> cell platform from concept to first cleared IND <FONT STYLE="white-space:nowrap">(TC-210</FONT> program). As part of senior leadership, he
successfully contributed to taking the company public and securing multi-million dollar rounds of fundraising. Previously, Dr.&nbsp;Hofmeister held various roles at EMD Serono where he was involved in the development of now approved Bavencio
(avelumab) and building the company&#146;s immuno-oncology platform. He started his biotech career at Micromet AG, now Amgen Research Munich, where he helped shape the development of Blincyto (blinatumomab), the first
<FONT STYLE="white-space:nowrap">FDA-approved</FONT> bispecific antibody for the treatment of refractory ALL.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Hofmeister received his Ph.D. from the University of
Regensburg in Germany, where he studied the signaling of the cytokine <FONT STYLE="white-space:nowrap">interleukin-1.</FONT> He continued to work in the cytokine field as a postdoctoral fellow at the National Cancer Institute.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Our Board believes that Dr.&nbsp;Hofmeister&#146;s management and industry experience,
as well as his financial expertise, qualify him to serve on our Board.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert W. Postma<BR></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><I>Director</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Postma has served as a member of our Board since February 2021. Mr.&nbsp;Postma has also served as the president of WaterMill
Asset Management Corp. (&#147;WaterMill&#148;), a company which he founded in July 1999. WaterMill actively trades in municipal bonds and equities, using the funds of Mr.&nbsp;Postma. Mr.&nbsp;Postma has over 44 years of trading experience and
received a B.A. in Business and Economics from Lafayette College.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Our Board believes
that Mr.&nbsp;Postma&#146;s management and trading experience allows Mr.&nbsp;Postma to provide financial guidance to us and qualifies him to serve on our Board.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jaime Vieser<BR></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><I>Director</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Vieser has served as a member of our Board since December 2020. Mr.&nbsp;Vieser currently manages Brushwood LLC, a private
investment firm. From 2010-2017, he was a Managing Partner and <FONT STYLE="white-space:nowrap">co-principal</FONT> of Castle Hill Asset Management LLC, a $2.7&nbsp;billion asset manager and hedge fund focusing on high yield and distressed debt.
Prior to founding Castle Hill, Mr.&nbsp;Vieser was responsible for Deutsche Bank&#146;s High Yield Sales and Trading Group in London from 1998 to 2008. Mr.&nbsp;Vieser originally joined Bankers Trust in New York in 1994 and worked in the Investment
Banking/Leveraged Finance division. Mr.&nbsp;Vieser graduated from the University of Michigan with a degree in Economics and from the Cox School of Business at Southern Methodist University with a Master&#146;s in Business Administration.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Our Board believes that Mr.&nbsp;Vieser&#146;s financial expertise and investment
experience allows Mr.&nbsp;Vieser to provide business guidance to us and qualifies him to serve on the Board.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holger&nbsp;Weis<BR></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Weis has served as a member of our Board since December 2020. Mr.&nbsp;Weis continues to serve as the principal of Weis Advisors,
Inc., a company that provides consulting services to life science companies, since founding the company in April 2018. Prior to that, he served in a number of roles at DemeRx, Inc., a clinical stage pharmaceutical company developing <FONT
STYLE="white-space:nowrap">non-addictive</FONT> treatments for drug addiction, including serving as Chief Operating Officer and Chief Financial Officer from December 2011 to July 2017, and also as President from September 2014 to July 2017, and as a
Consultant from July 2017 to April 2018. Earlier in his career, Mr.&nbsp;Weis served as the Chief Financial Officer of EnSA Holdings, LLC, a company that focuses on environmentally sustainable agriculture techniques and technologies for the
production of rice, from August 2010 to November 2011. From 2006 to 2010, he served as the Vice President&nbsp;&amp; Chief Financial Officer, Secretary and Treasurer of NovaVision, Inc., a therapeutic and diagnostic vision restoration company. Prior
to that, he served as the Chief Financial Officer&nbsp;&amp; Treasurer of GMP Companies, Inc., a company that develops and commercializes pharmaceutical, medical device and diagnostic technologies, from 2000 to 2005. Mr.&nbsp;Weis served as a Senior
Manager at Ernst&nbsp;&amp; Young, a multinational professional services company, from 1986 to 2000. Mr.&nbsp;Weis has <FONT STYLE="white-space:nowrap">co-authored</FONT> a number of scientific papers and presentations and is an inventor on a number
of patents and patent applications. Mr.&nbsp;Weis also serves on the board of directors of Jupiter NeuroSciences, Inc. Mr.&nbsp;Weis received a Bachelor of Business Administration in Accounting from the University of Georgia and is a Certified
Public Accountant.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Our Board believes that Mr.&nbsp;Weis&#146;s management and
industry experience, as well as his financial expertise, qualify him to serve on the Board.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Agreement to Appoint Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Postma, Mr.&nbsp;Vieser and Mr.&nbsp;Weis were all nominated for election as directors at our last annual meeting pursuant to the WaterMill Settlement
Agreement. See &#147;<I>Proposal 1&#151;Election of Directors</I>&#148; for more information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Executive Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information concerning our executive officers as of April&nbsp;9, 2024. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position(s)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Curtis Hogue, Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Interim Chief Executive Officer and Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ferdinand Groenewald</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vice President, Finance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Melinda Lackey</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Legal&nbsp;&amp; Administration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dale&nbsp;Curtis&nbsp;Hogue,&nbsp;Jr.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><I>Interim Chief Executive Officer and Director</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Mr.&nbsp;Hogue&#146;s biography is included above under the section titled &#147;Our Board.&#148;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ferdinand Groenewald</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Vice President</I>,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><I>Finance</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Mr.&nbsp;Groenewald was appointed to be our Vice President, Finance in February 2024. Since July 2022, Mr.&nbsp;Groenewald, age 39, has served in several capacities at the CFO Squad, which provides outsourced accounting and
consulting services. From January&nbsp;2, 2022 to July&nbsp;31, 2022, Mr.&nbsp;Groenewald had served as the Chief Accounting Officer of Muscle Maker, Inc., a Nasdaq-listed company. From September 2018 to January&nbsp;2, 2022, Mr.&nbsp;Groenewald
served as the Chief Financial Officer of Muscle Maker, Inc. From January&nbsp;25, 2018 through May&nbsp;29, 2018, Mr.&nbsp;Groenewald served as the Vice President of Finance, Principal Financial Officer and Principal Accounting Officer of Muscle
Maker, Inc., Muscle Maker Development, LLC and Muscle Maker Corp., LLC. In addition, from October 2017 through May&nbsp;29, 2018, he served as the controller of Muscle Maker, Inc. Mr.&nbsp;Groenewald is a certified public accountant with significant
experience in finance and accounting. From July 2018 through August 2018, he served as senior financial reporting accountant of Wrinkle Gardner&nbsp;&amp; Company, a full-service tax, accounting and business consulting firm. From February 2017 to
October 2017, Mr.&nbsp;Groenewald served as Senior Financial Accounting Consultant at Pharos Advisors, Inc. serving a broad range of industries. From November 2013 to February 2017, he served as a Senior Staff Accountant at Financial Consulting
Strategies, LLC, where he provided a broad range of accounting, financial reporting, and <FONT STYLE="white-space:nowrap">pre-auditing</FONT> services to various industries. From August 2015 to December 2015, Mr.&nbsp;Groenewald served as a
Financial Reporting Analyst at Valley National Bank. Mr.&nbsp;Groenewald holds a Bachelor of Science in accounting from the University of South Africa. Mr.&nbsp;Groenewald has served as a member of the Board of Directors of (i)&nbsp;HeartCore
Enterprises, Inc., a company listed on the Nasdaq Capital Market, since January&nbsp;24, 2022; (ii) SYLA Technologies Co., Ltd., a publicly reporting company that is listed on the Nasdaq Capital Market, since December&nbsp;1, 2022; and
(iii)&nbsp;Sushi Ginza Onodera, Inc., a company that has publicly filed a registration statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> in connection with its initial public offering, since July&nbsp;1, 2023.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Melinda Lackey,<BR></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><I>Legal&nbsp;&amp;
Administration</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Ms.&nbsp;Lackey joined as our Senior Vice President, Legal&nbsp;&amp; Administration in November 2021. She previously served as Counsel for Hogan Lovells from August 2021 until November 2021, where she supported life sciences
companies at all stages with a focus on licensing and intellectual property. Ms.&nbsp;Lackey previously served as legal counsel Kuur Therapeutics, Inc. (and after its acquisition by Athenex, Inc., Athenex) from June 2018 until August 2021. Before
industry, Ms.&nbsp;Lackey practiced law for 10 years focusing on intellectual property strategy and patent litigation from March 2008 until</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">June 2018. Ms.&nbsp;Lackey has a J.D. from University of Houston Law Center (2007)&nbsp;and graduated from Texas Tech Health Sciences Center with an M.S. in medical microbiology and immunology (2003), focusing on molecular
biology and immunology and a B.S. in Microbiology from Texas Tech University (1998).</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of our directors, director nominees or executive officers. None of our executive
officers is related by blood, marriage or adoption to any of our directors, director nominees or other executive officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_11"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_12"></A>Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding compensation awarded to or earned by our named executive officers. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name of Principal Position</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock</B><br><B>Awards</B><br><B>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Awards</B><br><B>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other</B><br><B>Compensation</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin S. Boyle, Sr. (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">617,836</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">689,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">409,529</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,716,946</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">270,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">904,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,818</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,792,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Drew Deniger (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">317,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47,888</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">264,035</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">629,680</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>VP, Research and Development</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">345,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">481,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,640</TD>
<TD NOWRAP VALIGN="bottom">(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">949,113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Melinda Lackey (8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">312,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76,620</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">313,033</TD>
<TD NOWRAP VALIGN="bottom">(9)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">701,737</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>SVP, Legal&nbsp;&amp; Administration</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">325,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">130,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">291,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,850</TD>
<TD NOWRAP VALIGN="bottom">(10)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">764,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These amounts have been calculated in accordance with ASC Topic 718. Pursuant to SEC rules, the amounts shown
exclude the impact of estimated forfeitures related to service-based vesting conditions. For a discussion of the assumptions relating to our valuations of these restricted stock awards and stock options, please see Note 3 to the financial statements
included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023. These amounts reflect our accounting expense for these restricted stock awards and stock options and do not correspond to
the actual value that may be recognized by our named executive officer. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Boyle was terminated on December&nbsp;22, 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Of such amount, $331,989 represents a <FONT STYLE="white-space:nowrap">one-time</FONT> separation payment that
was January of 2024, $56,171 paid for unused vacation time upon separation, $1,585 represents the dollar value of group term life insurance premiums we paid for the benefit of Mr.&nbsp;Boyle during 2023 and the remaining amount represents the amount
we contributed to Mr.&nbsp;Boyle&#146;s 401(k) plan account pursuant to our matching program. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Of such amount, $518 represents the dollar value of group term life insurance premiums we paid for the benefit
of Mr.&nbsp;Boyle during 2022, and the remaining amount represents the amount we contributed to Mr.&nbsp;Boyle&#146;s 401(k) plan account pursuant to our matching program. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Deniger was terminated on November&nbsp;15, 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Of such amount, $45,623 represent a <FONT STYLE="white-space:nowrap">one-time</FONT> retention bonus, $182,500
represents a separation payment, $16,846 paid for unused vacation time upon separation, $331 represents the dollar value of group term life insurance premiums we paid for the benefit of Dr.&nbsp;Deniger during 2023, and the remaining amount
represents the amount we contributed to Dr.&nbsp;Deniger&#146;s 401(k) plan account pursuant to our matching program. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Of such amount, $340 represents the dollar value of group term life insurance premiums we paid for the benefit
of Dr.&nbsp;Deniger during 2022, and the remaining amount represents the amount we contributed to Dr.&nbsp;Deniger&#146;s 401(k) plan account pursuant to our matching program. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ms.&nbsp;Lackey was terminated on November&nbsp;15, 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Of such amount, $44,998 represents a <FONT STYLE="white-space:nowrap">one-time</FONT> retention bonus, $193,846
represents a <FONT STYLE="white-space:nowrap">one-time</FONT> separation payment, $489 represents the dollar value of group term life insurance premiums we paid for the benefit of Ms.&nbsp;Lackey during 2023, $60,000 pursuant to a consulting
agreement post separation and the remaining amount represents the amount we contributed to Ms.&nbsp;Lackey&#146;s 401(k) plan account pursuant to our matching program. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Of such amount, $475 represents the dollar value of group term life insurance premiums we paid for the benefit
of Ms.&nbsp;Lackey during 2022, and the remaining amount represents the amount we contributed to Ms.&nbsp;Lackey&#146;s 401(k) plan account pursuant to our matching program. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_13"></A>Narrative to the Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We use base salaries to recognize the experience, skills, knowledge and responsibilities required of all our employees, including our named executive officers.
Base salaries are reviewed annually, typically in connection with our annual performance review process, and adjusted from time to time to realign salaries with market levels after taking into account individual responsibilities, performance and
experience. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023 Base<BR>Salary ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022 Base<BR>Salary ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent<BR>Increase<BR>(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin S. Boyle, Sr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Executive Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">635,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Drew Deniger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>VP, Research and Development</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">365,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">346,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Melinda Lackey</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>SVP, Legal and Administration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">360,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">325,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Annual Bonus </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2023, we
established formal bonus plan objectives, including accruing additional patients in our clinical trial, filing IND amendment with newly discovered TCRs through our hunTR program and improved manufacturing processes, and raising additional capital.
2023 bonuses to our named executive officers were paid out between 75% and 100% of target based on the compensation committee&#146;s assessment of each individual&#146;s performance. Our employment arrangements with our named executive officers
provide that the executive may be eligible to earn an annual performance bonus of up to a target percentage of the executive&#146;s base salary, as described further below under the section titled &#147;<I>Employment and Change in Control
Agreements</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Equity Compensation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
compensation committee believes that long-term equity incentive compensation is a critical component of our executive compensation program that links the interests of our executive officers with those of our stockholders. In 2023 and 2022,
equity-based awards for our executive officers were granted in the form of stock options. Stock options align executives&#146; realizable compensation with the creation of stockholder value and serve as an effective long-term incentive vehicle to
retain talent and incentivize performance. Executives only realize value from options if our stock price increases following the grant date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock
options granted to our executive officers vest over four years, with 1/16th of the options vesting each quarter. <I> </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We provide certain additional benefits to executive officers that are generally available to all employees, including medical, dental, vision and life
insurance coverage, as well as 401(k) matching contributions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Employment and Change in Control Agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We had the following employment agreements in place with our named executive officers. On January&nbsp;20, 2024, the Board appointed Dale Curtis Hogue, Jr. as
Interim Chief Executive Officer of the Company. On January&nbsp;21, 2024, the Company entered into an employment agreement with Mr.&nbsp;Hogue, under which he will receive an annual base salary of $250,000. In addition, Mr.&nbsp;Hogue was awarded
40,000 shares of common stock of the Company with an exercise price of $1.80. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Employment Agreement with Kevin S. Boyle, Sr. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Boyle served as our Chief Executive Officer from August 2021 pursuant to an employment agreement entered into in August 2021 until December&nbsp;22,
2023. Mr.&nbsp;Boyle had an <FONT STYLE="white-space:nowrap">at-will</FONT> employment relationship with us. Mr.&nbsp;Boyle&#146;s employment agreement required us to take all steps necessary to elect Mr.&nbsp;Boyle to our Board in connection with
his hiring. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Base Salary.</I> Mr.&nbsp;Boyle&#146;s annual base salary in 2023 was $635,000. Under his employment
agreement, Mr.&nbsp;Boyle&#146;s annual base salary was subject to review by the Board or the compensation committee at least annually. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Annual
Performance Bonus; <FONT STYLE="white-space:nowrap">Sign-on</FONT> Bonus.</I> Under his employment agreement, Mr.&nbsp;Boyle was eligible to receive an annual bonus based on his performance as determined by the Board or the compensation committee.
The target amount of the annual performance bonus was 60% of his base salary, with the actual amount to be received determined by the Board or the compensation committee. Mr.&nbsp;Boyle also received a
<FONT STYLE="white-space:nowrap">one-time</FONT> <FONT STYLE="white-space:nowrap">sign-on</FONT> bonus of $50,000 in 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Equity Incentive
Grants.</I> Mr.&nbsp;Boyle was eligible to receive equity awards as determined by the Board in its sole discretion.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-competition</FONT> and <FONT STYLE="white-space:nowrap">Non-solicitation.</FONT></I> Mr.&nbsp;Boyle entered into an
invention, <FONT STYLE="white-space:nowrap">non-disclosure</FONT> and <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement, which provides that he will not compete with us or solicit our clients or customers for a year after the
termination or cessation of his employment with us, and further provides that he will not solicit our employees for one year after the termination or cessation of his employment with us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Boyle Separation and Consulting Agreement. </I>On December&nbsp;22, 2023, we entered into a Separation and Release Agreement, effective December&nbsp;22,
2023, with Kevin S. Boyle, Sr. (the &#147;Boyle Separation Agreement&#148;), the Company&#146;s Chief Executive Officer, in connection with Mr.&nbsp;Boyle&#146;s termination. Pursuant to the terms of his employment agreement, upon his termination
Mr.&nbsp;Boyle was deemed to automatically resign from our Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Boyle Separation Agreement superseded in full all of the terms of
Mr.&nbsp;Boyle&#146;s employment agreement. Pursuant to the terms of the Separation Agreement, and subject to customary conditions, we agreed to pay Mr.&nbsp;Boyle a <FONT STYLE="white-space:nowrap">one-time</FONT> separation payment in an amount
equal to six months of Mr.&nbsp;Boyle&#146;s base salary and the cost of six months of COBRA premiums for Mr.&nbsp;Boyle, or approximately $331,990 less all applicable income and payroll taxes, deductions and withholdings. Mr.&nbsp;Boyle has agreed
to make himself reasonably available to us to provide information related to his transition. The Separation Agreement also provides for a customary mutual release of all claims by us and Mr.&nbsp;Boyle against one another. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also entered into a consulting agreement (the &#147;Boyle Consulting Agreement&#148;), effective January&nbsp;1, 2024, with Mr.&nbsp;Boyle pursuant to
which he will continue providing strategic and advisory services to us. The Boyle Consulting Agreement will continue for a period of six months. The Boyle Consulting Agreement provides for compensation at a fixed rate of $15,000 per month and
reimbursement for any usual and customary expenses incurred by Mr.&nbsp;Boyle in connection with performing services pursuant to the Boyle Consulting Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Employment Agreement with Drew Deniger, Ph.D. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Deniger served as our Vice President of Research and Development since October&nbsp;14, 2021, prior which Dr.&nbsp;Deniger served as our Vice
President, Immunology from 2019 pursuant to an offer letter agreement executed October&nbsp;31, 2018 until November&nbsp;15, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Base
salary.</I><I></I>&nbsp;Dr.&nbsp;Deniger&#146;s base salary in 2023 was $365,000. Dr.&nbsp;Deniger&#146;s annual base salary was subject to review by the Board or the compensation committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Equity Incentive Grants.</I>&nbsp;Dr.&nbsp;Deniger was also eligible to receive equity awards as determined by the Board in its sole discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Annual Performance Bonus;</I><I></I><I><FONT STYLE="white-space:nowrap">&nbsp;Sign-on</FONT></I><I></I><I>&nbsp;Bonus</I>. Pursuant to his offer letter
agreement, Dr.&nbsp;Deniger was eligible to receive an annual bonus based on his performance as determined by the Board or compensation committee. The target amount of the annual performance bonus is 30% of his base salary, with the actual amount to
be received determined by the Board or the compensation committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-competition</FONT></I><I></I><I>&nbsp;and</I><I></I><I><FONT
STYLE="white-space:nowrap">&nbsp;Non-solicitation.</FONT></I>&nbsp;Dr.&nbsp;Deniger entered into an invention, non-disclosure and non-competition agreement, which provides that he will not engage in the business of developing or selling oncology
products related to DNA-based biotherapeutic products, will not solicit our clients or customers for a year after the termination or cessation of his employment with us, and further provides that he will not solicit our employees for two years after
the termination or cessation of his employment with us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The Deniger Separation Agreement.</I><B><I> </I></B>As previously reported, on
November&nbsp;10, 2023, we terminated the employment of Dr.&nbsp;Deniger, &#147;Without Cause&#148; (as defined in his respective employment agreements) and, per his retention agreement, not because he failed to perform his duties at an
&#147;Acceptable Level&#148; (as defined therein), effective November&nbsp;15, 2023. In connection with their termination, we paid $45,623 to Dr.&nbsp;Deniger pursuant to his retention letter agreement, dated September&nbsp;1, 2023. Pursuant to the
terms of the separation and release agreement between us and Dr.&nbsp;Deniger (the &#147;Deniger Separation Agreement&#148;), Dr.&nbsp;Deniger has agreed to remain reasonably available to the Company, and to reasonably cooperate and assist us, in
connection with (i)&nbsp;any investigations, litigation or other proceedings in which he was involved while an employee and (ii)&nbsp;our consideration of strategic alternatives relating to its scientific assets. Subject to customary conditions, we
paid Dr.&nbsp;Deniger a <FONT STYLE="white-space:nowrap">one-time</FONT> separation payment in an amount equal to $182,500, less all applicable income and payroll taxes, deductions and withholdings. The Deniger Separation Agreement also provides for
a customary release of all claims against us by Dr.&nbsp;Deniger. The Deniger Separation Agreement superseded in full the terms of Dr.&nbsp;Deniger&#146;s employment and severance agreements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Employment Agreement with Melinda Lackey </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Lackey
served as our Senior Vice President, Legal since November 2021 pursuant to an employment agreement entered into in November 2021 until November&nbsp;15, 2023. The initial term of Ms.&nbsp;Lackey&#146;s employment agreement would have expired on the
second anniversary of the effective date. The term of Ms.&nbsp;Lackey&#146;s employment agreement would have automatically been extended for an additional 12 month period, and successive 12 month periods thereafter, unless at least 90 days prior to
the ensuring expiration date the we or Ms.&nbsp;Lackey gave written notice that we do not or she does not, as applicable, wish to extend the agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Base Salary.</I> Ms.&nbsp;Lackey&#146;s base salary in 2023 was $360,000. Under her employment agreement, Ms.&nbsp;Lackey&#146;s annual base salary was
subject to review by the Board or the compensation committee at least annually. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Annual Performance Bonus;
<FONT STYLE="white-space:nowrap">Sign-on</FONT> Bonus.</I> Under her employment agreement, Ms.&nbsp;Lackey was eligible to receive an annual bonus based on her performance as determined by the Board or the compensation committee. The target amount
of the annual performance bonus was 40% of her base salary, with the actual amount to be received determined by the Board or the compensation committee. Ms.&nbsp;Lackey also received a <FONT STYLE="white-space:nowrap">one-time</FONT> <FONT
STYLE="white-space:nowrap">sign-on</FONT> bonus of $30,000 in 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Equity Incentive Grants.</I> In connection with Ms.&nbsp;Lackey&#146;s hiring and
pursuant to her employment agreement, the Board granted to Ms.&nbsp;Lackey an option to purchase 370,000 shares of our common stock, which option has an exercise price of $1.22 per share. Ms.&nbsp;Lackey was also eligible to receive equity awards as
determined by the Board in its sole discretion. In addition, in the event of a &#147;change of control,&#148; all remaining unvested options would have become immediately exercisable in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-competition</FONT> and <FONT STYLE="white-space:nowrap">Non-solicitation.</FONT></I> Ms.&nbsp;Lackey entered into an
invention and <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement, which provides that she will not solicit our clients or customers for a year after the termination or cessation of her employment with us, and further provides that she
will not solicit our employees for one year after the termination or cessation of her employment with us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Lackey Separation</I><I></I><I>&nbsp;&amp;
Consulting Agreement</I><B><I>. </I></B>As previously reported, on November&nbsp;10, 2023, we terminated the employment of Ms.&nbsp;Lackey, Senior Vice President, Legal and Administration, &#147;Without Cause&#148; (as defined in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
her respective employment agreements) and, per her respective retention agreements, not because she failed to perform their duties at an &#147;Acceptable Level&#148; (as defined therein),
effective November&nbsp;15, 2023. In connection with their termination, we paid $44,998 to Ms.&nbsp;Lackey pursuant to her retention letter agreement, dated August&nbsp;14, 2023. Pursuant to the terms of the separation and release agreement between
us and Ms.&nbsp;Lackey (the &#147;Lackey Separation Agreement&#148;), Ms.&nbsp;Lackey agreed to remain reasonably available to the Company, and to reasonably cooperate and assist us, in connection with any investigations, litigation or other
proceedings in which she was involved while an employee. Subject to customary conditions, we paid Ms.&nbsp;Lackey a <FONT STYLE="white-space:nowrap">one-time</FONT> separation payment in an amount equal to $180,000, less all applicable income and
payroll taxes, deductions and withholdings. The Lackey Separation Agreement also provides for a customary release of all claims against us by Ms.&nbsp;Lackey. The Lackey Separation Agreement supersedes in full all terms of the Ms.&nbsp;Lackey&#146;s
employment agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also entered into a consulting agreement (the &#147;Lackey Consulting Agreement&#148;), effective November&nbsp;16, 2023, with
Ms.&nbsp;Lackey pursuant to which Ms.&nbsp;Lackey will continue providing legal services to us, including assisting in its ongoing exploration of strategic alternatives. The Lackey Consulting Agreement will continue indefinitely until terminated by
the Company or Ms.&nbsp;Lackey upon 30 days prior written notice. The Lackey Consulting Agreement provides for compensation at a fixed rate of $400 per hour and reimbursement by the Company for any usual and customary expenses incurred by
Ms.&nbsp;Lackey in connection with performing services pursuant to the Lackey Consulting Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_15"></A>Role of our
Compensation Committee, Management and Consultant </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Compensation Committee </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our compensation committee is responsible for reviewing, evaluating, approving, administering and interpreting our executive compensation and benefits
policies, programs and plans, including our equity compensation plans. In particular, with respect to the compensation of our named executive officers, our compensation committee is responsible for reviewing and recommending to the outside,
independent and <FONT STYLE="white-space:nowrap">non-employee</FONT> members of the Board the compensation levels and performance goals relevant to the compensation of these officers, and for evaluating the officers&#146; performance in light of
those goals and objectives. The outside, independent and <FONT STYLE="white-space:nowrap">non-employee</FONT> members of the Board approved the compensation committee&#146;s recommendations for the 2023 compensation of our named executive officers.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Management </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our human resources, finance and legal
departments work with our Chief Executive Officer (the &#147;Management Team&#148;) to design and develop new executive compensation programs, to recommend changes to existing compensation programs, to recommend financial and other performance
targets to be achieved under those programs, to prepare analyses of financial data, to prepare peer group data comparisons and to prepare other briefing materials for consideration by the compensation committee and ultimately, to implement the
decisions of the compensation committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Management Team recommends to the compensation committee for its discussion and ultimately, approval,
proposed corporate performance and strategic goals and their relative weighting for the upcoming fiscal year, and provides input on the level of attainment of the prior year&#146;s strategic goals, for purposes of determining awards under the annual
performance bonus plan for all our executives, including the Chief Executive Officer. For executives other than the Chief Executive Officer, the compensation committee will consider the individual performance of the executives, as assessed by the
Chief Executive Officer, and the compensation recommendations submitted to the compensation committee by the Chief Executive Officer. Our Chief Executive Officer and other members of management generally attend our compensation committee meetings
for a portion of the meeting. No executive officer was present for or voted in the compensation committee or the Board&#146;s final determinations regarding the amount of any component of his or her own 2023 compensation package. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Consultant </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2020, our compensation committee engaged Frederic W. Cook&nbsp;&amp; Co. (&#147;FW Cook&#148;) as its independent compensation consultant. FW Cook
provided independent market findings to the compensation committee and has provided advice to the compensation committee as to employee director compensation, Chief Executive Officer compensation and
<FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation in 2022 and 2023. FW Cook was determined to be free of conflicts of interest and able to operate as an independent compensation advisor. As part of its duties, FW Cook
provided the compensation committee with the following services: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">completed a competitive analysis of our 2022 and 2023 executive compensation programs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prepared a competitive analysis of the Board&#146;s compensation program, including observations and
recommendations; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prepared a competitive analysis of the Board&#146;s compensation program, including observations and
recommendations. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have engaged a new consultant for the 2024 fiscal year. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Trading Policy &#150; Hedging and Certain Transactions </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have a policy that prohibits our executive officers, directors and other members of management from engaging in short sales, transactions in put or call
options, pledging transactions, hedging transactions or other inherently speculative transactions with respect to our stock. Any violation of these policies may result in disciplinary action, including dismissal for cause. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_16"></A>Outstanding Equity Awards at 2023 Fiscal <FONT STYLE="white-space:nowrap">Year-End</FONT></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding option awards and restricted stock awards held as of December&nbsp;31, 2023 by our named executive
officers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of Securities Underlying</B><br><B>Unexercised Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Exercise&nbsp;Price</B><br><B>($/Sh)(1)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Expiration</B><br><B>Date</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares&nbsp;or&nbsp;Units&nbsp;of&nbsp;Stock&nbsp;That<BR>Have Not Vested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercisable&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unexercisable&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market&nbsp;Value<BR>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin S. Boyle, Sr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">98,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8/29/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3/29/2032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Melinda Lackey</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,792</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/9/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,083</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/14/2032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3/15/1933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Drew Deniger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/23/2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/30/2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1/3/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3/3/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/28/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,083</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/14/2032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3/15/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each stock option was granted with an exercise price equal to the fair market value of our common stock on the
grant date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Market values are calculated based on the closing market price of our common stock as reported on the Nasdaq
Capital Select Market on December&nbsp;31, 2023, which was $1.05 per share. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Vesting stopped upon separation date of December&nbsp;22, 2023. The former employee has 90 days to exercise
exercisable shares or they will be forfeited. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Vesting stopped upon separation date of November&nbsp;10, 2023. The former employee has 90 days to exercise
exercisable shares or they will be forfeited. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Vesting stopped upon separation date of November&nbsp;10, 2023. The former employee has 90 days to exercise
exercisable shares or they will be forfeited. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_17"></A>Stockholder Engagement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2023, our stockholder engagement included participation in investor conferences as well as individual investor meetings with stockholders and prospective
stockholders. Conversations spanned topics including, but not limited to, clinical development plans and corporate strategy. We also engaged 6degrees to assist us in communicating with our investors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that ongoing, appropriate, and transparent communication with our stockholders is critical to our success long-term. We will continue to have a
strong stockholder engagement program and communicate with our stockholders and prospective stockholders through our press releases, investor conferences, SEC filings, individual meetings and investor presentations. We believe that all of these
communications together enable us to have a meaningful <FONT STYLE="white-space:nowrap">two-way</FONT> dialogue, where the management team and Board can better listen to and understand stockholder perspectives, answer questions, and provide context
to ongoing activities. Over the course of 2023, our stockholders have provided us with valuable feedback and external viewpoints that inform how we think about our business and strategy, and we are committed to continuing this dialogue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;14, 2023, we announced a strategic reprioritization of our business and wind down of its <FONT STYLE="white-space:nowrap">TCR-T</FONT> Library
Phase 1/2 Trial. In connection with the reprioritization, we reduced our workforce by approximately 95% to date and continue working to reduce costs in order to extend our cash runway. We continue to explore strategic alternatives, including, but
not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. We engaged Cantor Fitzgerald&nbsp;&amp; Co., or Cantor, to act as strategic advisor for this process. Separately,
we are evaluating several potential <FONT STYLE="white-space:nowrap">in-licensing</FONT> opportunities in obesity, oncology and virology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_14">
</A>Pay Versus Performance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table and related disclosure provide information about (i)&nbsp;the &#147;total compensation&#148; of our
Chief Executive Officer, and our other named executive officers (the &#147;Other NEOs&#148; or the <FONT STYLE="white-space:nowrap">&#147;Non-CEO</FONT> NEOs&#148;) as presented in the &#147;<I>Summary Compensation Table</I>&#148; included elsewhere
in this proxy statement, (ii)&nbsp;the &#147;compensation actually paid&#148; to our Chief Executive Officer and our Other NEOs, as calculated pursuant to the SEC&#146;s <FONT STYLE="white-space:nowrap">pay-versus-performance</FONT> rules,
(iii)&nbsp;certain financial performance measures and (iv)&nbsp;the relationship of the &#147;compensation actually paid&#148; to those financial performance measures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This disclosure has been prepared in accordance with Item 402(v) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Exchange Act, and does
not necessarily reflect value actually realized by the executives or how our compensation committee evaluates compensation decisions in light of company or individual performance. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:7pt; font-family:Times New Roman; "><B>Year</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Summary<BR>Compensation<BR>Table Total<BR>for PEO:<BR>Boyle (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Compensation<BR>Actually Paid<BR>to PEO:<BR>Boyle(2)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Summary<BR>Compensation<BR>Table Total<BR>for PEO:<BR>Hagen(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Compensation<BR>Actually Paid<BR>to PEO:<BR>Hagen (2)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Summary<BR>Compensation<BR>Table Total<BR>for PEO:<BR>Cooper(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Compensation<BR>Actually Paid<BR>to PEO:<BR>Cooper (2)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>Summary<BR>Compensation<BR>Table Total<BR>for <FONT STYLE="white-space:nowrap">Non-PEO</FONT><BR>NEOs(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>Compensation<BR>Actually Paid<BR>to <FONT STYLE="white-space:nowrap">Non-CEO</FONT><BR>NEOs(1)(2)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value of<BR>Initial Fixed<BR>$100<BR>Investment<BR>Based On<BR>Total<BR>Shareholder<BR>Return(4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Net<BR>Income<BR>(Loss) (in<BR>thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,716,946</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,459,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">665,709</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">594,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(35,410</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,792,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,841,265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">856,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">486,598</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(37,730</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,573,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,964,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,730,871</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,531,130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,531,130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">590,678</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,690,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">732,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(78,751</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In 2021, each of Mr.&nbsp;Boyle, Ms.&nbsp;Hagen and Dr.&nbsp;Cooper served as our PEO for part of the year.
Mr.&nbsp;Boyle served as our only PEO in 2022 and 2023. <FONT STYLE="white-space:nowrap">The&nbsp;Non-PEO&nbsp;NEOs</FONT> for whom the average compensation is presented in this table for 2022 and 2023 are Dr.&nbsp;Deniger and Ms.&nbsp;Lackey and
for 2021 are Jill Buck, Eleanor de Groot and Raffaele Baffa. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts shown as Compensation Actually Paid have been calculated in accordance with Item 402(v) of
Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> and do not reflect compensation actually realized or received by the Company&#146;s NEOs. These amounts reflect total compensation as set forth in the Summary Compensation Table for each year,
adjusted as described in footnote 3 below. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Compensation Actually Paid reflects the exclusions and inclusions for the CEO and the <FONT
STYLE="white-space:nowrap">Non-CEO</FONT> NEOs set forth below. Amounts excluded, which are set forth in the &#147;Minus Stock and Option Awards from Summ. Comp. Table&#148; columns below, represent the Stock Awards and Option Awards reported in the
Stock Awards and Option Awards columns of the Summary Compensation Table for each applicable year. Amounts added back to determine Compensation Actually Paid are made up of the following components which are set forth in the table below, as
applicable: (i)&nbsp;the fair value as of the end of the fiscal year of outstanding and unvested equity awards granted in that year; (ii)&nbsp;the change in fair value during the year of equity awards granted in prior years that remained outstanding
and unvested at the end of the year; (iii)&nbsp;the fair value as of the vesting date of equity awards that were granted and vested in that year; and (iv)&nbsp;the change in fair value during the year through the vesting date of equity awards
granted in prior years that vested during that year. The fair value at the end of the prior year of awards granted in any prior year that failed to meet applicable vesting conditions during the covered year are subtracted, although there were no
such awards for the CEO or the <FONT STYLE="white-space:nowrap">Non-CEO</FONT> NEOs in 2021, 2022 or 2023. Equity values are calculated in accordance with ASC Topic 718. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Summary<BR>Comp.<BR>Table<BR>Total for<BR>PEO</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I>Minus</I></B><B>&nbsp;Stock<BR>and Option<BR>Awards<BR>from<BR>Summ.<BR>Comp.<BR>Table</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I>Plus</I></B><B><FONT STYLE="white-space:nowrap">&nbsp;Year-End</FONT><BR>Fair Value
of<BR>Outstanding<BR>Unvested<BR>Awards<BR>Granted<BR>During Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I>Plus</I></B><B>&nbsp;Change<BR>in Fair<BR>Value of<BR>Unvested<BR>Awards<BR>Granted in<BR>Prior Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I>Plus</I></B><B>&nbsp;Fair<BR>Value of<BR>Awards<BR>Granted<BR>and<BR>Vested<BR>During<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I>Plus</I></B><B>&nbsp;Change<BR>in Fair<BR>Value of<BR>Prior Years&#146;<BR>Awards<BR>Vested<BR>During<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I>Minus</I></B><B><BR>Fair<BR>Value of<BR>Stock<BR>and<BR>Option<BR>Awards<BR>Forfeited<BR>During<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Comp.<BR>Actually<BR>Paid to<BR>PEO</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2023 &#150; Kevin Boyle</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,716,946</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(689,580</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">679,749</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(247,749</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,459,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2022 &#150; Kevin Boyle</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,792,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(904,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">795,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(685,522</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">354,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">487,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,841,265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 &#150; Kevin Boyle</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,573,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,225,638</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,476,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">139,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,964,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 &#150; Laurence Cooper</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,531,130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,426,712</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(158,833</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">918,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(273,245</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">590,678</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 &#150; Heidi Hagen</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,730,871</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,183,670</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">844,104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,414,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Avg.&nbsp;Summary<BR>Comp. Table<BR>Total for<BR>Other NEOs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I>Minus</I></B><B>&nbsp;Avg.<BR>Stock and<BR>Option&nbsp;Awards<BR>from Summ.<BR>Comp. Table</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I>Plus</I></B><B>&nbsp;Avg.<BR><FONT STYLE="white-space:nowrap">Year-End</FONT><BR>Fair&nbsp;Value<BR>of&nbsp;
Outstanding<BR>Unvested<BR>Awards<BR>Granted<BR>During Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I>Plus</I></B><B>&nbsp;Avg.<BR>Change&nbsp;in<BR>Fair&nbsp;Value<BR>of&nbsp;Unvested<BR>Awards<BR>Granted in<BR>Prior Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I>Plus</I></B><B>&nbsp;Avg.<BR>Fair<BR>Value of<BR>Awards<BR>Granted<BR>and<BR>Vested<BR>During<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I>Plus</I></B><B>&nbsp;Avg.<BR>Change<BR>in Fair<BR>Value of<BR>Prior<BR>Years&#146;<BR>Awards<BR>Vested<BR>During<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I>Minus</I></B><B>&nbsp;Fair<BR>Value of<BR>Stock and<BR>Option<BR>Awards<BR>Forfeited<BR>During<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>Comp.<BR>Actually<BR>Paid to<BR>Other&nbsp;NEOs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">665,709</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(62,254</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,904</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(19,996</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">594,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">856,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(386,561</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(66,031</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,117</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">486,598</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,694,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(784,987</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69,853</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(162,823</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(68,066</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(95,910</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">732,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC
rules, assuming an investment of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement of the applicable fiscal year and the
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
measurement end point of the closing price of our common stock on the last trading day in the applicable fiscal year. For 2023, the closing price of our common stock on December&nbsp;31, 2023 was
$1.05. For 2022, the closing price of our common stock on December&nbsp;31, 2021 was $1.09 and the closing price of our common stock on December&nbsp;31, 2022 was $16.35. For 2021, the closing price of our common stock on December&nbsp;31, 2020 was
$9.75. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_18"></A>INFORMATION REGARDING THE BOARD AND CORPORATE GOVERNANCE
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This section provides further information regarding the Board and the independence of our directors and describes key Corporate Governance Guidelines
(the &#147;Corporate Governance Guidelines&#148;) and practices that we have adopted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_19"></A>Independence of the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board has undertaken a review of the independence of our directors and considered whether any director has a relationship that, in the opinion of the
Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a member of our Board. Based upon information requested from and provided by each director concerning such director&#146;s background,
employment and affiliations, including family relationships, the Board has determined that all of our directors, other than Mr.&nbsp;Hogue are &#147;independent directors,&#148; as such term is defined in Nasdaq Rule 5605(a)(2). In making these
determinations, our Board considered the current and prior relationships that each <FONT STYLE="white-space:nowrap">non-employee</FONT> director has with the Company and all other facts and circumstances that our Board deemed relevant in determining
their independence, including the beneficial ownership of our capital stock by each <FONT STYLE="white-space:nowrap">non-employee</FONT> director. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_20">
</A>Board Leadership Structure </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;22, 2023, the Board appointed Mr.&nbsp;Weis to serve as its Chair. Prior to that, Mr.&nbsp;Weis had
served as a member and chair of the audit committee for all of 2023 and 2022. The Board has elected to separate the chair function from that of the Chief Executive Officer, who serves as our principal executive officer, due to a belief that
separating these functions, and empowering a <FONT STYLE="white-space:nowrap">non-executive</FONT> director to chair the Board meetings, reinforces the independence of the Board in its oversight of our business and affairs. In addition, we believe
that having a chair separate from the Chief Executive Officer creates an environment that is more conducive to objective evaluation and oversight of management&#146;s performance, increasing management accountability and improving the ability of the
Board to monitor whether management&#146;s actions are in the best interest of the Company and our stockholders. As a result, we believe that having a chair separate from the Chief Executive Officer can enhance the effectiveness of the Board as a
whole. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_21"></A>Nasdaq Board Diversity Matrix </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Board Diversity Matrix (As of April&nbsp;9, 2024) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Number of Directors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Female</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Male</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><FONT STYLE="white-space:nowrap">Non-Binary</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Did&nbsp;Not&nbsp;Disclose&nbsp;Gender</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Part I: Gender Identity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Part II: Demographic Background</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">African American or Black</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Asian</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hispanic or Latinx</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Native Hawaiian or Pacific Islander</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">White</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Two or More Races or Ethnicities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LGBTQ+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Did Not Disclose Demographic Background</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_22"></A>Director Attendance at Board and Stockholder Meetings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board met 43 times during 2023, either in person, by teleconference or videoconference. Each current director attended at least 75% of the aggregate number
of meetings of the Board and of the committees on which he or she served which were held during 2023 or the portion thereof that he or she served as a director or committee member. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As provided in our Corporate Governance Guidelines, we encourage attendance at our annual meetings by members of the Board. All of the then-current directors
attended our 2023 annual meeting of stockholders either in person or by teleconference. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_23"></A>Board Committees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has established three standing committees: an audit committee, a compensation committee and a corporate governance and nominating committee. Each
committee operates under a charter that has been approved by the Board. Current copies of each committee&#146;s charter are posted on the &#147;Investors&#151;Corporate Governance&#148; section of our website, <I>www.alaunos.com</I>. Our website and
its contents are not incorporated into this proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current members of the committees are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Audit</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Compensation</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Corporate<BR>Governance<BR>and&nbsp;Nominating</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert J. Hofmeister, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert W. Postma</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jaime Vieser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holger Weis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Committee Chairperson </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Audit Committee </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current members of the audit
committee are Mr.&nbsp;Weis, who serves as the committee&#146;s Chair, Mr.&nbsp;Postma and Mr.&nbsp;Vieser. As set forth in the audit committee charter, the primary responsibility of the audit committee is to oversee our financial reporting
processes and internal control system on behalf of the Board. In that regard, the audit committee is responsible for, among other things, the appointment, compensation, retention and oversight of the work performed by the independent registered
public accounting firm employed by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each member of the audit committee is an &#147;independent director,&#148; as such term is defined in Nasdaq Rule
5605(a)(2) and meets the criteria for independence set forth in Rule <FONT STYLE="white-space:nowrap">10A-3(b)(1)</FONT> under the Exchange Act. The Board has also determined that each of the audit committee members is able to read and understand
fundamental financial statements and that at least one member of the audit committee has past employment experience in finance or accounting. The Board has determined that at least one member of the audit committee, Mr.&nbsp;Weis, is an &#147;audit
committee financial expert,&#148; as that term is defined in Item 407(d)(5)(ii) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audit committee held five meetings during 2023. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Compensation Committee </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current members of the
compensation committee are Dr.&nbsp;Hofmeister, who serves as the committee&#146;s Chair, Mr.&nbsp;Postma and Mr.&nbsp;Weis. As set forth in the compensation committee charter, the compensation committee reviews our compensation policies and
practices and makes recommendations to the Board in connection with all compensation matters affecting our executive officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each member of the compensation committee is an &#147;independent director,&#148; as such term is defined in
Nasdaq Rule 5605(a)(2) and meets the criteria for independence set forth in Rule <FONT STYLE="white-space:nowrap">10A-3(b)(1)</FONT> under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The compensation committee held five meetings during 2023. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Corporate Governance and Nominating Committee </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
current members of the corporate governance and nominating committee are Mr.&nbsp;Postma, who serves as the committee&#146;s Chair, Dr.&nbsp;Hofmeister and Mr.&nbsp;Vieser. As set forth in the corporate governance and nominating committee charter,
the primary responsibility of the corporate governance and nominating committee is to consider and make recommendations to the Board concerning the appropriate size, function and needs of the Board and its committees. In that regard, the corporate
governance and nominating committee is, among other things, responsible for establishing criteria for membership on the Board, recruiting and recommending candidates to fill newly created or vacant positions on the Board and reviewing any candidates
recommended by stockholders. In addition, the corporate governance and nominating committee evaluates and assesses the performance of the Board as a whole and its committees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each member of the corporate governance and nominating committee is an &#147;independent director,&#148; as such term is defined in Nasdaq Rule 5605(a)(2) and
meets the criteria for independence set forth in Rule <FONT STYLE="white-space:nowrap">10A-3(b)(1)</FONT> under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The corporate
governance and nominating committee held four meetings during 2023. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_24"></A>Director Nomination Process </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The corporate governance and nominating committee (or a subcommittee thereof) recruits and considers director candidates and presents qualified candidates to
the full Board for consideration in accordance with the Corporate Governance Guidelines and the corporate governance and nominating committee&#146;s charter, which is available on our website. Our website and its contents are not incorporated into
this proxy statement. The Board and the corporate governance and nominating committee will consider the minimum general criteria set forth in the Corporate Governance Guidelines and may add any specific additional criteria with respect to specific
searches in selecting candidates and existing directors for service on the Board. The corporate governance and nominating committee considers a nominee&#146;s education, general business and industry experience, ability to act on behalf of
stockholders, potential concerns regarding independence or conflicts of interest and other factors relevant in evaluating Board nominees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The corporate
governance and nominating committee believes that a Board comprised of directors with diverse skills and experiences relevant to our industry and operations will result in efficient and competent oversight of our various core competencies, which
include drug development, strategic partnering, commercialization activities, regulatory compliance, corporate finance and accounting. As such, the corporate governance and nominating committee gives consideration to the interplay of a director
candidate&#146;s experience with that of other members of the Board and the evolving needs of our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board continues to ensure that our
corporate governance policies reflect the importance our Board places on diversity. More specifically, our policies emphasize our commitment to seeking to attain diversity and balance among directors of race, gender, geography, thought, viewpoints,
backgrounds, skills, experience, and expertise. As a result, under our policies any search firm retained to assist the corporate governance and nominating committee in seeking candidates for the Board will be instructed to seek to include diverse
candidates in terms of race, gender, geography, thought, viewpoints, backgrounds, skills, experience, and expertise from, among other areas, the traditional corporate environment, government, academia, private enterprise, <FONT
STYLE="white-space:nowrap">non-profit</FONT> organizations, and professions such as accounting, finance, marketing, human resources, and legal services. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Qualified candidates will be considered without regard to race, color, religion, sex, ancestry, national
origin or disability, and the corporate governance and nominating committee will consider director candidates recommended by security holders. If the corporate governance and nominating committee approves a candidate for further review following an
initial screening, the corporate governance and nominating committee will establish an interview process for the candidate. Generally, the candidate will meet with at least one member of the corporate governance and nominating committee, along with
other members of the Board and management, including our Chief Executive Officer. Contemporaneously with the interview process, the corporate governance and nominating committee will conduct a comprehensive <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">conflicts-of-interest</FONT></FONT> assessment of the candidate. The corporate governance and nominating committee will consider reports of the interviews and the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">conflicts-of-interest</FONT></FONT> assessment to determine whether to recommend the candidate to the full Board. The corporate governance and nominating committee will also take into consideration the candidate&#146;s
personal attributes, including, without limitation, personal integrity, loyalty to us and concern for our success and welfare, willingness to apply sound and independent business judgment, awareness of a director&#146;s vital part in our good
corporate citizenship and image, time available for meetings and consultation on our matters and willingness to assume broad, fiduciary responsibility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the individuals nominated for <FONT STYLE="white-space:nowrap">re-election</FONT> to the Board pursuant to Proposal 1 were approved for such
nomination by the corporate governance and nominating committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_25"></A>Risk Management and Oversight </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One of the Board&#146;s key functions is informed oversight of the Company&#146;s risk management process. The Board does not have a standing risk management
committee, but rather administers this oversight function directly through the Board as a whole, as well as through various Board standing committees that address risks inherent in their respective areas of oversight. In particular, our Board is
responsible for monitoring and assessing strategic risk exposure, including a determination of the nature and level of risk appropriate for the Company. Our audit committee has the responsibility to consider and discuss our major financial risk
exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. Our corporate governance and nominating committee
monitors the effectiveness of our Corporate Governance Guidelines. Our compensation committee assesses and monitors whether any of our compensation policies and programs have the potential to encourage excessive risk-taking. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In carrying out their risk oversight functions, the Board and its committees routinely request and review management updates, reports from the independent
auditors and legal and regulatory advice from outside experts, as appropriate, to assist in discerning and managing important risks that may be faced by the Company. The Board is committed to continuing to evolve its risk oversight practices as
appropriate given the stage of the Company&#146;s evolution as an immuno-oncology company and the fast-paced changes in the biotechnology industry. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_26">
</A>Stockholder Communications with Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have established means for stockholders and others to communicate with the Board or individual
directors. If a stockholder wishes to address a matter regarding our financial statements, accounting practices or internal controls, the matter should be submitted in writing addressed to the chairperson of the audit committee in care of the
Secretary at our principal executive offices at 2617 Bissonnet, Suite 225, Houston TX 77005. If the matter relates to our governance practices, business ethics or corporate conduct, it should be submitted in writing addressed to the chairperson of
the corporate governance and nominating committee in care of the principal financial officer at our principal executive offices at the address stated above. If a stockholder wishes to address a communication to an individual director, it should be
submitted in writing addressed to such individual director in care of the principal financial officer at our principal executive offices at the address stated above. If a stockholder is unsure where to direct a communication, the stockholder may
direct it in writing to the chairperson of the audit committee, or to any one of our independent directors, in care of the principal financial officer at our principal executive offices at the address stated above. All of these stockholder
communications will be forwarded by the principal financial officer to the addressee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_27"></A>Code of Ethics and Business Conduct </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board adopted a Code of Ethics and Business Conduct to be applicable to all officers, directors and employees. The Code of Ethics and Business Conduct is
intended to be designed to deter wrong-doing and promote honest and ethical behavior, full, fair, timely, accurate and understandable disclosure, and compliance with applicable laws. In addition to provisions that are applicable to officers,
directors and employees generally, the Code of Ethics and Business Conduct contains provisions that are specifically applicable to our Chief Executive Officer and senior financial officer(s). The Code of Ethics and Business Conduct is available on
our website at <I>www.alaunos.com</I> and a copy may be obtained without charge upon written request to our Legal department at our principal executive offices at 2617 Bissonnet, Suite 225, Houston, TX 77005. Our website and its contents are not
incorporated into this proxy statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_28"></A>Corporate Governance Guidelines </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has adopted Corporate Governance Guidelines to ensure that the Board will have the necessary authority and practices in place to review and evaluate
our business operations as needed and to make decisions that are independent of our management. The Corporate Governance Guidelines are also intended to align the interests of directors and management with those of our stockholders. The Corporate
Governance Guidelines set forth the practices the Board intends to follow with respect to, among other things, Board composition and selection including diversity, Board meetings and involvement of senior management, Chief Executive Officer
performance evaluation and succession planning, and Board committees and compensation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_29"></A>Whistleblower Policy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have adopted a whistleblower policy applicable to our employees that provides for protection from retaliation or discrimination by the Company due to
reporting issues relating to compliance with applicable laws and regulations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clawback Policy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has adopted a compensation clawback policy which provides for the recoupment of incentive-based compensation in the event of an accounting
restatement. The clawback policy is intended to comply with Section&nbsp;10D of the Exchange Act, the rules promulgated thereunder by the SEC, and applicable Nasdaq listing standards.&nbsp;In the event we are required to prepare an accounting
restatement (as defined in the clawback policy), any executive officer who received excess compensation (as defined in the clawback policy) during the three completed fiscal years preceding the date of the accounting restatement will be required to
repay or forfeit such excess compensation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_30"></A>Corporate Governance Documents </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please visit our investor relations website at <I>www.alaunos.com</I> for additional information on our corporate governance, including: the charters approved
by the Board for the audit committee, compensation committee and nominating and governance committee, and our Code of Ethics and Business Conduct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the
event of any amendment to, or waiver from, a provision of our Code of Ethics and Business Conduct, we will promptly post on our website relevant information regarding the amendment or waiver, including the date and the nature of the event. Our
website and its contents are not incorporated into this proxy statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_31"></A>Report of the Audit Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audit committee reviewed and discussed the audited financial statements for the fiscal year ended December&nbsp;31, 2023 with management of the Company.
The audit committee discussed with the independent registered public accounting firm the matters required to be discussed by the applicable requirements of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Public Company Accounting Oversight Board (the &#147;PCAOB&#148;) and the SEC. The audit committee also received the written disclosures and the letter from the independent registered public
accounting firm required by applicable requirements of the PCAOB regarding the independent accountants&#146; communications with the audit committee concerning independence and has discussed with the independent registered public accounting firm the
accounting firm&#146;s independence. Based on the foregoing, the audit committee recommended to the Board that the audited financial statements be included in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for
the fiscal year ended December&nbsp;31, 2023 that was filed with the SEC on April&nbsp;1, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AUDIT COMMITTEE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holger Weis (chairperson) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert W. Postma </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jaime Vieser </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This report is not &#147;soliciting
material,&#148; is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference in any of our filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended,
whether before or after the date hereof and irrespective of any general incorporation language in any such filing. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_32"></A>DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_33"></A><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2023, each of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors was compensated as described below pursuant to our <FONT
STYLE="white-space:nowrap">non-employee</FONT> director compensation policy: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an annual cash retainer fee of $50,000 for service on the Board; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additional annual cash retainer fees for board committee service as follows: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Chair</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Member</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Governance and Nominating Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The chair of our Board also received further annualized cash compensation of $30,000 for 2023. All cash retainers were paid on
a quarterly basis in arrears to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors who continue to serve as members of the Board on the last business day of each calendar quarter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in connection with a director&#146;s initial election of the Board, he or she receives options to purchase 150,000 shares of our common stock on
the date of each new <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s appointment to our Board. Dr.&nbsp;Hofmeister received this award in 2023. <FONT STYLE="white-space:nowrap">Non-employee</FONT> directors are also entitled to
receive an option to purchase 100,000 shares of our common stock on an annual basis upon their election at the annual meeting of our stockholders. <FONT STYLE="white-space:nowrap">One-twelfth</FONT> of the annual option grant will vest each month on
the monthly anniversary of the grant. If a new director is appointed to the Board between annual meetings of our stockholders, they will be entitled to a pro rated option grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As set forth in its written charter, the compensation committee annually reviews director compensation practices in consultation with our compensation
consultant and recommends any changes for adoption by the full Board. As such, the director compensation described above is subject to change at the discretion of the Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_34"></A>Director Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the compensation earned for service on our Board by our
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors during the year ended December&nbsp;31, 2023. We reimburse members of our Board for reasonable travel and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred in connection with attending Board and committee meetings. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees</B><br><B>Earned or</B><br><B>Paid in</B><br><B>Cash ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Awards&nbsp;(1)</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock</B><br><B>Awards&nbsp;(1)</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christopher Bowden (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert J Hofmeister</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Huang (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert W. Postma</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mary Thistle (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">112,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jaime Vieser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holger Weis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86,5000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">121,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Curtis Hogue, Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts reported in the &#147;Option Awards&#148; and &#147;Stock Awards&#148; columns represent
compensation expense recognized (or that will be recognized) for financial statement purposes under ASC Topic 718. In the case of each of our directors, the option award and/or stock award was granted on June 06, 2023, except for Mr.&nbsp;Hogue that
was issued on December&nbsp;29, 2023. For a discussion of the assumptions relating </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
to our valuations of these stock options, please see Note 3 to the financial statements included our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended
December&nbsp;31, 2023. These costs reflect our accounting expense for these stock options and do not correspond to the actual value that may be recognized by the directors. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Bowden resigned from the Board in March 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Huang resigned from the Board in September 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ms.&nbsp;Thistle resigned from the Board in December 2023. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_35"></A>SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION
PLANS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our 2012 Equity Incentive Plan (the &#147;2012 Plan&#148;) and our 2020 Equity Incentive Plan (the &#147;2020 Plan&#148;) are our only equity
compensation plans approved by our stockholders. The following table sets forth certain information as of December&nbsp;31, 2023 with respect to the 2012 Plan and 2020 Plan: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Plan Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Securities to</B><br><B>be Issued</B><br><B>Upon</B><br><B>Exercise</B><br><B>of</B><br><B>Outstanding</B><br><B>Options (A)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-</B><br><B>Average</B><br><B>Exercise</B><br><B>Price of</B><br><B>Outstanding</B><br><B>Options (B)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Securities</B><br><B>Remaining</B><br><B>Available for</B><br><B>Future</B><br><B>Issuance</B><br><B>Under
Equity</B><br><B>Compensation</B><br><B>Plans</B><br><B>(Excluding</B><br><B>Securities</B><br><B>Reflected in</B><br><B>Column (A))</B><br><B>(C)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Equity compensation plans approved by stockholders:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2012 Equity Incentive Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020 Equity Incentive Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">205,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,370,899</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">271,552</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,370,899</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_36"></A>LIMITATION OF LIABILITY AND INDEMNIFICATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Charter limits the personal liability of directors for breach of fiduciary duty to the maximum extent permitted by the Delaware General Corporation Law.
Our Charter provides that no director will have personal liability to us or to stockholders for monetary damages for breach of fiduciary duty as a director. These provisions do not, however, eliminate or limit the liability of any of the directors
for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any breach of the director&#146;s duty of loyalty to us or our stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">voting or assenting to unlawful payments of dividends, stock repurchases or other distributions; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any transaction from which the director derived an improper personal benefit. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any amendment, repeal or modification of these provisions will not adversely affect any right or protection of a director in respect of any act or omission
occurring prior to such amendment, repeal or modification. If the Delaware General Corporation Law is amended to provide for further limitations on the personal liability of directors of corporations, then the personal liability of the directors
will be further limited to the greatest extent permitted by the Delaware General Corporation Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Charter also provides that we must indemnify
directors and officers in certain circumstances. We believe this provision is important in attracting and retaining qualified individuals to serve as directors and executive officers. Our bylaws, as amended, also provide for the indemnification of
our directors, officers, employees and other agents to the maximum extent permitted by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We maintain director and officer insurance providing for
indemnification of our directors and officers for certain liabilities, including certain liabilities under the Securities Act of 1933, as amended. We also maintain a general liability insurance policy that covers certain liabilities of directors and
officers arising out of claims based on acts or omissions in their capacities as directors or officers. We have also entered into indemnification agreements with each of our directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_37"></A>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following discussion relates to certain transactions that involve both the Company and one of our executive officers, directors, director nominees or
five-percent stockholders, each of whom we refer to as a &#147;related party.&#148; For purposes of this discussion, a &#147;related-party transaction&#148; is a transaction, arrangement or relationship: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in which we participate; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">that involves an amount in excess of $120,000; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in which a related party has a direct or indirect material interest. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_38"></A>Related-Party Transaction Policy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have a related person transaction policy that sets forth our procedures for the identification, review, consideration and approval or ratification of
related person transactions. For purposes of our policy only, a related person transaction is a transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we and any related person,
directly or indirectly, are, were or will be participants in which the amount involved will or may reasonably be expected to exceed $120,000 in any calendar year. Transactions involving compensation for services provided to us as an employee or
director are not covered by this policy. A related person is any person who is, or at any time since the beginning of the Company&#146;s last fiscal year was, an executive officer, director, or nominee to become a director of the Company or a
beneficial owner of more than 5% of any class of our voting securities, including any of such persons&#146; immediate family members and any entity that such persons owned, controlled, held a control position in or held a 5% or greater beneficial
ownership interest in. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the policy, if a transaction has been identified as a related person transaction, including any transaction that was not a
related person transaction when originally consummated or any transaction that was not initially identified as a related person transaction prior to consummation, our management must present information regarding the related person transaction to
our audit committee, or, if audit committee approval would be inappropriate, to another independent body of our Board, for review, consideration and approval or ratification. The presentation must include a description of, among other things, the
material facts, the interests, direct and indirect, of the related persons, the benefits to us of the transaction and whether the transaction is on terms that are comparable to the terms available to or from, as the case may be, an unrelated third
party or to or from employees generally. Under the policy, we will collect information that we deem reasonably necessary from each director, executive officer and, to the extent feasible, significant stockholder to enable us to identify any existing
or potential related person transactions and to effectuate the terms of the policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In considering related person transactions, our audit committee, or
other independent body of our Board, will take into account the relevant available facts and circumstances including, but not limited to: the risks, costs and benefits to us; the impact on a director&#146;s independence in the event that the related
person is a director, immediate family member of a director or an entity with which a director is affiliated; the availability of other sources for comparable services or products; and the terms available to or from, as the case may be, unrelated
third parties or to or from employees generally. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The policy requires that, in determining whether to approve, ratify or reject a related person
transaction, our audit committee, or other independent body of our Board, must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, our best interest and those of our stockholders, as our audit
committee, or other independent body of our Board, determines in the good faith exercise of its discretion. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc778708_39"></A>Certain
Related-Party Transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as described below, there have been no transactions since January&nbsp;1, 2022 in which we have been a participant
in which the amount involved exceeded or will exceed $120,000, and in which any of our directors, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
executive officers or holders of more than 5% of our common stock, or any members of their immediate family, had or will have a direct or indirect material interest, other than compensation
arrangements which are described elsewhere in this filing under the sections titled &#147;&#151;<I>Executive Compensation</I>&#148; and &#147;&#151;<I>Director Compensation</I>.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Underwritten Offering </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;29, 2022, we
entered into an underwriting agreement (the &#147;Underwriting Agreement&#148;) with Cantor Fitzgerald&nbsp;&amp; Co. (the &#147;Underwriter&#148;), as the sole underwriter, relating to the issuance and sale in an underwritten offering (the
&#147;Offering&#148;) of 24,228,719 shares (the &#147;Firm Shares&#148;) of the Company&#146;s common stock, par value $0.001 per share, to the Underwriter at a price of $0.6191 per share. Under the terms of the Underwriting Agreement, the Company
granted the Underwriter an option, exercisable for 30 days, to purchase up to an additional 3,634,307 shares of common stock (the &#147;Option Shares&#148; and, together with the Firm Shares, the &#147;Shares&#148;) at the same price per share as
the Firm Shares. All of the Shares sold in the Offering were sold by the Company. The net proceeds to the Company from the Offering, excluding any exercise by the Underwriter of its option to purchase any of the Option Shares, are expected to be
approximately $14.6&nbsp;million after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. Entities affiliated with our directors, Messrs. Postma and Vieser purchased an aggregate of 2,000,000
Firm Shares at a price per share of $0.65. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Underwriting Agreement contains customary representations, warranties and agreements by the Company,
customary conditions to closing, indemnification obligations of the Company and the Underwriter, including for liabilities under the Securities Act, and other obligations of the parties and termination provisions. The representations, warranties and
covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates and were solely for the benefit of the parties to such agreement. The Offering is expected to close on or about December&nbsp;1,
2022, subject to customary conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Underwriting Agreement does not purport to be complete and is subject to, and
qualified in its entirety by, reference to the full text of the Underwriting Agreement, which was filed as Exhibit 1.1 on our Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on November&nbsp;30, 2022. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>WaterMill Settlement Agreement </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&nbsp;4, 2021,
we entered into the WaterMill Settlement Agreement with the WaterMill Parties. Pursuant to the WaterMill Settlement Agreement, we increased the size of our Board from eight to nine directors and appointed Mr.&nbsp;Postma to fill the newly created
directorship. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The WaterMill Settlement Agreement included certain customary standstill restrictions applicable from February&nbsp;4, 2021 until the date
that was the earlier of (i)&nbsp;January&nbsp;1, 2022 and (ii)&nbsp;thirty (30)&nbsp;calendar days prior to the nomination deadline for our 2022 annual meeting of stockholders (the &#147;Standstill Period&#148;). During the Standstill Period, the
WaterMill Parties were, among other things, restricted from engaging in any solicitation of proxies or written consents with respect to the election or removal of directors or, with certain exceptions, any other matter or proposal, or acquiring
voting stock that would result in the WaterMill Parties having beneficial ownership of more than 9.9% of our outstanding voting stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the
WaterMill Settlement Agreement, we agreed that during the Standstill Period, we would nominate each of Mr.&nbsp;Postma, Jaime Vieser and Holger Weis for election at any stockholder meeting at which directors are to be elected and will recommend,
support and solicit proxies for the election of each of Messrs. Postma, Vieser and Weis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The WaterMill Settlement Agreement also provided that at any
meeting of our stockholders held prior to the expiration of the Standstill Period, the WaterMill Parties would vote all of their shares of our securities in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
accordance with the recommendation of our Board, with respect to the election, removal and/or replacement of directors. The WaterMill Parties retained the right to vote in their sole discretion
with respect to any other publicly announced proposal not made in breach of the WaterMill Settlement Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, pursuant to the WaterMill
Settlement Agreement, we agreed to reimburse the WaterMill Parties for up to $400,000 of their <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">reasonable&nbsp;out-of-pocket&nbsp;fees</FONT></FONT> and expenses out of a total of
approximately $650,000 in fees and expenses actually incurred by the WaterMill Parties in connection with (i)&nbsp;the WaterMill Parties&#146; solicitation of written consents from our stockholders to vote in favor of certain proposals, as set forth
in the definitive consent statement filed by the WaterMill Parties on October&nbsp;30, 2020, and (ii)&nbsp;the negotiation, execution and effectuation of the WaterMill Settlement Agreement. As of February&nbsp;19, 2021, we have fully reimbursed the
WaterMill Parties an aggregate amount of $400,000. During the year ended December&nbsp;31, 2021, we received $250,000 in insurance recoveries associated with legal expenses incurred on this matter. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Joint Venture with TriArm Therapeutics Ltd. </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
December&nbsp;18, 2018, we launched Eden BioCell, a joint venture with TriArm Therapeutics Ltd, or TriArm, to lead the commercialization of our<I>&nbsp;Sleeping Beauty</I><FONT STYLE="white-space:nowrap">-generated&nbsp;CAR-T&nbsp;therapies</FONT>
in the People&#146;s Republic of China (including Macau and Hong Kong), Taiwan and Korea. Under our agreements with TriArm, we licensed to Eden BioCell the rights in Greater China for its third-generation<I>&nbsp;Sleeping Beauty</I><FONT
STYLE="white-space:nowrap">-generated&nbsp;CAR-T&nbsp;therapies</FONT> targeting the CD19 antigen. Eden BioCell is owned equally by us and TriArm and the parties share decision-making authority. TriArm agreed to contribute up to $10.0&nbsp;million
to Eden BioCell and has committed up to an additional $25.0&nbsp;million to this joint venture. TriArm also manages all clinical development in the territory pursuant to a Master Services Agreement between TriArm and Eden BioCell. In March 2021 and
as announced by the Company in April 2021, Eden BioCell began treating patients in a clinical trial with the Company&#146;s investigational CD19 <FONT STYLE="white-space:nowrap">RPM&nbsp;CAR-T&nbsp;cell</FONT> therapy, under the IND cleared by the
Taiwan FDA in December. In September 2021, it was mutually agreed between the parties to dissolve the joint venture. The dissolution of the joint venture and the related entity was wound down and terminated in 2023.&#8195;James Huang, who became a
director of our Company in July 2020, and was appointed Chair of our Board of directors in January 2021 and then Executive Chair of our Board in February 2021, was the founder and serves as managing partner of Panacea Venture, which is an investor
in TriArm. Mr.&nbsp;Huang also serves as a member of Eden BioCell&#146;s board of directors. Mr.&nbsp;Huang resigned from the Board in 2023. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Indemnification Agreements </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have entered into an
indemnification agreement with each of our directors. These indemnification agreements and our charter and our bylaws indemnify each of our directors and officers to the fullest extent permitted by the Delaware General Corporation Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_40"></A>DELINQUENT SECTION 16(A) REPORTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than 10% of a registered class of our equity
securities, to file with the SEC reports of beneficial ownership and reports of changes in beneficial ownership in our securities. Based solely on a review of such reports filed electronically with the SEC, we believe that during 2023,
Dr.&nbsp;Hofmeister filed two late Section&nbsp;16(a) filings (a Form&nbsp;3 filed on April&nbsp;19, 2023 and a Form&nbsp;4 filed on April&nbsp;19, 2023 (option grant)) due to administrative delays and all other Section&nbsp;16(a) filings applicable
to our directors, officers, and 10% stockholders were filed on a timely basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_41"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information with respect to the beneficial ownership of common stock as of April 7, 2024 for: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person, or group of affiliated persons, who is known by us to be the beneficial owner of greater than five
percent of our outstanding common stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors and director nominees; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our named executive officers named in the &#147;Executive Compensation&#151;Executive Compensation
Table&#148; section above; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of our directors and executive officers as a group. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who
possess sole or shared voting power or investment power with respect to those securities, or have the right to acquire such powers within 60 days. Common stock subject to options that are currently exercisable or exercisable within 60 days of April
7, 2024 are deemed to be outstanding and beneficially owned by the person holding the options. These shares, however, are not deemed outstanding for the purposes of computing the percentage ownership of any other person. Except as otherwise
indicated, all persons listed below have sole voting and investment power with respect to the shares beneficially owned by them, subject to applicable community property laws. Percentage ownership calculations are based on 16,012,479 shares
outstanding as of April 7, 2024. Except as otherwise noted below, the addresses for persons listed in the table is c/o Alaunos Therapeutics, Inc., 2617 Bissonnet, Suite 225, Houston, Texas 77005. All share numbers have been adjusted to reflect the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15</FONT></FONT> reverse stock split of the Company&#146;s common stock effected on January&nbsp;31, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Shares</B><br><B>Beneficially</B><br><B>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage&nbsp;of</B><br><B>Common&nbsp;Stock</B><br><B>Beneficially</B><br><B>Owned (%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5% Stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level One Parties (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,611,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.07</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MSD Credit Opportunity Master Fund, L.P. (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,515,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.17</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Named Executive Officers and Directors:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin S. Boyle, Sr. (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53,216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Drew Deniger (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Melinda Lackey (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert J. Hofmeister (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert W. Postma (7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">445,593</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.77</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jaime Vieser (8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">228,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holger Weis (9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,857</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Curtis Hogue, Jr. (10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All executive officers and directors as a group (11 persons)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">826,830</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.11</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents ownership of less than one percent. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based solely on a Schedule 13G jointly filed with the SEC on February&nbsp;11, 2022 by Robert D. Hardie, Mollie
G. Hardie and Level One Partners, LLC (collectively, the &#147;Level One Parties&#148;), adjusted to reflect the reverse stock split effected on January&nbsp;31, 2024. The Level One Parties beneficially own 1,611,925 shares. Robert D. Hardie is the
beneficial owner of 681,796, and has shared voting and dispositive power with respect to 493,788 shares, and sole dispositive and voting power with respect 190,674. Molly G. Hardie is the beneficial owner of 511,681, and has shared voting and
dispositive power with respect to 485,115 shares, and sole dispositive and voting power with respect 26,566. Level One Partners, LLC is the beneficial </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
owner of 415,782 shares, and has shared voting and dispositive power with respect to all 415,782 shares. The address of the Level One Parties is 210 Ridge McIntire Road, Suite 350,
Charlottesville, Virginia 22903. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based in part on a Schedule 13G/A filed with the SEC on February&nbsp;13, 2024 by MSD Partners, L.P. (&#147;MSD
Partners&#148;) and MSD Credit Opportunity Master Fund, L.P. (&#147;MSD Credit Opportunity Master Fund&#148;), adjusted to reflect the reverse stock split effected on January&nbsp;31, 2024. MSD Partners has shared voting power with respect to
1,010,102 shares of our common stock and may be deemed to beneficially own 1,010,102 shares of our common stock. MSD Partners is the investment manager of, and may be deemed to beneficially own securities beneficially owned by, MSD Credit
Opportunity Master Fund. MSD Partners (GP), LLC (&#147;MSD GP&#148;) is the general partner of, and may be deemed to beneficially own securities beneficially owned by, MSD Partners. Gregg R. Lemkau maintains investment discretion over this
investment and therefore may be deemed to beneficially own securities beneficially owned by MSD GP. The 1,515,152 shares include 505,051 shares of common stock issuable upon the full exercise of a warrant. Such warrant is only exercisable to the
extent that the holder thereof, together with its affiliates, would beneficially own no more than 9.99% of the outstanding shares of our common stock after giving effect to such exercise (the &#147;Beneficial Ownership Limitation&#148;). As a result
of the Beneficial Ownership Limitation, the number of shares that may be issued to the holder upon exercise of the warrant may change depending upon changes in the outstanding shares of our common stock. Upon 61 days&#146; prior notice to the
Company, the holder may increase, decrease or terminate the Beneficial Ownership Limitation. The address of MSD Credit Opportunity Master Fund is One Vanderbilt Avenue, 26th Floor, New York, New York 10017. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 53,216 shares of common stock held by Mr. Boyle. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 1,000 shares of common stock held by Dr. Deniger. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All options were forfeited 90 days after the effective date of Ms.&nbsp;Lackey&#146;s separation agreement.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of shares of common stock issuable upon the exercise of options exercisable within 60 days of
April&nbsp;7, 2024. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 82,791 shares of common stock held by Mr.&nbsp;Postma, (ii) 333,333 shares of common stock held
by WaterMill Asset Management Corp., where Mr.&nbsp;Postma serves as the principal, (iii) 238 shares of common stock held by the IRA of Mr.&nbsp;Postma&#146;s spouse, (iv) 63,131 shares of common stock issuable upon the exercise of warrants
exercisable within 60 days of April&nbsp;7, 2024 and (v) 23,471 shares of common stock issuable upon the exercise of options exercisable within 60 days of April&nbsp;7, 2024. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 49,688 shares of common stock held by Mr.&nbsp;Vieser, (ii) 83,333 shares of common stock held
in Brushwood LLC, where Mr.&nbsp;Vieser serves as the manager, (iii) 21,667 shares of common stock held in Uniform Transfer to Minors Act accounts by Mr.&nbsp;Vieser&#146;s children, (iv) 50,505 shares of common stock issuable upon the exercise of
warrants exercisable within 60 days of April&nbsp;7, 2024 and (v) 23,750 shares of common stock issuable upon the exercise of options exercisable within 60 days of April&nbsp;7, 2024. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 10,678 shares of common stock held by Mr.&nbsp;Weis, (ii) 1,267 shares of common stock held by
Mr.&nbsp;Weis&#146; spouse, (iii) 163 shares of common stock held by Mr.&nbsp;Weis&#146; children, and (iv) 23,750 shares of common stock issuable upon the exercise of options exercisable within 60 days of April&nbsp;7, 2024. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 40,000 shares of common stock held by Mr.&nbsp;Hogue, (ii) 12,777 shares of common stock
issuable upon the exercise of options exercisable within 60 days of April&nbsp;7, 2024. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_42"></A>HOUSEHOLDING OF PROXY MATERIALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC has adopted rules that permit companies and intermediaries (such as brokers) to satisfy the delivery requirements for Notices of Internet Availability
of Proxy Materials or other annual meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice of Internet Availability of Proxy Materials or other annual meeting materials addressed to those
stockholders sharing the same address. This process, which is commonly referred to as &#147;householding,&#148; potentially provides extra convenience for stockholders and cost savings for companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This year, a number of brokers with account holders who are our stockholders will be &#147;householding&#148; our proxy materials. A single Notice of Internet
Availability of Proxy Materials or other annual meeting materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your
broker that they will be &#147;householding&#148; communications to your address, &#147;householding&#148; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in
&#147;householding&#148; and would prefer to receive a separate Notice of Internet Availability of Proxy Materials or other annual meeting materials, please notify your broker. Alternatively, you may direct your written request to Alaunos
Therapeutics, Inc., 2617 Bissonnet, Suite 225, Houston, TX 77005, Attention: Legal Department or contact us at (346) <FONT STYLE="white-space:nowrap">355-4099.</FONT> Stockholders who currently receive multiple copies of the Notice of Internet
Availability of Proxy Materials or other annual meeting materials at their addresses and would like to request &#147;householding&#148; of their communications should contact their brokers or contact us in the way described above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc778708_43"></A>OTHER MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the
Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By Order of the Board of Directors,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Melinda Lackey</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Melinda Lackey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Legal and Administration; Secretary</I></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">[&#9679;], 2024</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>We have filed our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended
December&nbsp;31, 2023 with the SEC. It is available free of charge at the SEC&#146;s web site at www.sec.gov. Upon written request by an Alaunos stockholder, we will mail without charge a copy of our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K,</FONT> including the consolidated financial statements and financial statement schedules, but excluding exhibits to the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> Exhibits to the Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> are available upon payment of a reasonable fee, which is limited to our expenses in furnishing the requested exhibit. All written requests should be directed to Melinda Lackey, Secretary,
Alaunos Therapeutics, Inc., 2617 Bissonnet, Suite 225, Houston, TX 77005. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U><A NAME="toc778708_44"></A>Annex A </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THIRD AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ALAUNOS THERAPEUTICS,
INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Alaunos Therapeutics, Inc. (the &#147;Corporation&#148;), a corporation organized and existing under and by virtue of the
provisions of the General Corporation Law of the State of Delaware (the &#147;General Corporation Law&#148;), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>DOES HEREBY CERTIFY:
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The name under which the Corporation was originally incorporated is EasyWeb, Inc. The date of filing of its original Certificate of
Incorporation with the Secretary of State of the State of Delaware was May&nbsp;16, 2005. The date of filing of its first Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware was April&nbsp;26, 2006,
the date of filing its Second Amended and Restated Certificate of Incorporation was January&nbsp;31, 2024 (as amended, the &#147;Existing Certificate&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. The Board of Directors of the Corporation duly adopted resolutions proposing to amend and restate the Existing Certificate in its entirety
in the form set forth on Exhibit 1, declaring said amendment and restatement to be advisable and in the best interests of the Corporation and its stockholders, and authorizing the officers of the Corporation to solicit the approval of the
stockholders therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. This Third Amended and Restated Certificate of Incorporation, which restates and integrates and further amends
the provisions of the Corporation&#146;s Existing Certificate, was duly adopted in accordance with the provisions of Sections 242 and 245 of the General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Remainder of page intentionally blank] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, this Corporation has caused this Third Amended and Restated
Certificate of Incorporation to be signed by its Chief Executive Officer this [&#9679;] day of [&#9679;], 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Name:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Title: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT 1 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THIRD AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ALAUNOS THERAPEUTICS,
INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <I>Name</I>. The name of the corporation is Alaunos Therapeutics, Inc. (the &#147;Corporation&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <I>Address; Registered Office and Agent.</I> The address of the Corporation&#146;s registered office is 2711 Centerville Road, Suite 400,
Wilmington, Delaware 19808. The Corporation&#146;s registered agent is the Corporation Service Company. The Corporation may from time to time, in the manner provided by law, change the registered agent and the registered office within the State of
Delaware. The Corporation may also maintain offices for the conduct of its business, either within or without the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.
<I>Purposes. </I>The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the Delaware General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <I>Number of Shares. </I>The total number of shares of all classes of stock that the Corporation shall have the authority to issue is [the
sum of the shares of common stock and the shares of preferred stock] shares, consisting of: [the then-current amount, divided by any whole number between five (5)&nbsp;and fifteen (15), rounded up to the nearest whole share] shares of common stock,
$0.001 par value per share (the &#147;Common Stock&#148;), and Thirty Million (30,000,000) shares of preferred stock, $0.001 par value per share (the &#147;Preferred Stock&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Delaware General Corporation Law, upon the filing and effectiveness (the &#147;Effective Time&#148;) of this Third Amended and
Restated Certificate of Incorporation, each [any whole number between [&#9679;] ([&#9679;]) and [&#9679;] ([&#9679;]] shares of Common Stock issued and outstanding or held by the Corporation in treasury stock immediately prior to the Effective Time
shall be combined into one validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> share of Common Stock, without any further action by the Corporation or the holder thereof, subject to the treatment of fractional share
interests as described below (the &#147;Reverse Stock Split&#148;). No fractional shares shall be issued and, in lieu thereof, any holder who otherwise would be entitled to receive fractional shares of Common Stock shall be entitled to receive cash
(without interest) in lieu of such fractional share interest, upon the submission of a transmission letter by a holder holding the shares in book-entry form and, where shares are held in certificated form, upon the surrender of the holder&#146;s Old
Certificates (as defined below), in an amount equal to such fraction multiplied by the closing sales price of the Corporation&#146;s Common Stock as reported on the Nasdaq Capital Market on the trading day immediately preceding the date of the
Effective Time. Each certificate that immediately prior to the Effective Time represented shares of Common Stock (each, an &#147;Old Certificate&#148;) shall thereafter represent that number of shares of Common Stock into which the shares of Common
Stock represented by the Old Certificate shall have been combined, subject to the elimination of fractional share interests as described above. As soon as practicable following the Effective Time, the Corporation will notify its stockholders holding
shares of Common Stock in certificated form to transmit their Old Certificates to the transfer agent, and the Corporation will cause the transfer agent to issue new certificates representing the appropriate number of whole shares of Common Stock
following the Reverse Stock Split for every one share of Common Stock transmitted and held of record as of the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Preferred Stock may be divided into, and may be issued from time to time in one or more series. The Board of Directors of the Corporation (the &#147;Board&#148;) is authorized from time to time to establish and designate any such series of Preferred
Stock, to fix and determine the variations in the relative rights, preferences, privileges and restrictions as between and among such series and any other class of capital stock of the Corporation and any series thereof, and to fix or alter the
number of shares comprising any such series and the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
designation thereof. The authority of the Board from time to time with respect to each such series shall include, but not be limited to, determination of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">a. The designation of the series; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">b. The number of shares of the series and (except where otherwise provided in the creation of the series) any subsequent increase or decrease
therein; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">c. The dividends, if any, for shares of the series and the rates, conditions, times and relative preferences thereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">d. The redemption rights, if any, and price or prices for shares of the series; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">e. The terms and amounts of any sinking fund provided for the purchase or redemption of the series; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">f. The relative rights of shares of the series in the event of any voluntary or involuntary liquidation, dissolution or winding up of the
affairs of the Corporation; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">g. Whether the shares of the series shall be convertible into shares of any other class or series of shares
of the Corporation, and, if so, the specification of such other class or series, the conversion prices or rate or rates, any adjustments thereof, the date or dates as of which such shares shall be convertible and all other terms and conditions upon
which such conversion may be made; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">h. The voting rights, if any, of the holders of such series; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">i. Such other designations, powers, preference and relative, participating, optional or other special rights and qualifications, limitations
or restrictions thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <I>Election of Directors.</I> Unless and except to the extent that the
<FONT STYLE="white-space:nowrap">by-laws</FONT> of the Corporation (the <FONT STYLE="white-space:nowrap">&#147;By-laws&#148;)</FONT> shall so require, the election of directors of the Corporation need not be by written ballot. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <I>Limitation of Liability.</I> To the fullest extent permitted under the General Corporation Law, as amended from time to time, no
director of the Corporation shall be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director. Any amendment, repeal or modification of the foregoing provision shall not adversely
affect any right or protection of a director of the Corporation hereunder in respect of any act or omission occurring prior to the time of such amendment, repeal or modification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <I>Indemnification.</I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.1.
<I>Right to Indemnification.</I> The Corporation shall indemnify and hold harmless, to the fullest extent permitted by applicable law as it presently exists or may hereafter be amended, any person (a &#147;Covered Person&#148;) who was or is made or
is threatened to be made a party or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (a &#147;Proceeding&#148;), by reason of the fact that he or she, or a person for whom he or she is
the legal representative, is or was a director or officer of the Corporation or, while a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or
of a partnership, joint venture, trust, enterprise or nonprofit entity (an &#147;Other Entity&#148;), including service with respect to employee benefit plans, against all liability and loss suffered and expenses (including attorneys&#146; fees)
reasonably incurred by such Covered Person. Notwithstanding the preceding sentence, except as otherwise provided in Section&nbsp;7.3, the Corporation shall be required to indemnify a Covered Person in connection with a Proceeding (or part thereof)
commenced by such Covered Person only if the commencement of such Proceeding (or part thereof) by the Covered Person was authorized by the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.2. <I>Prepayment of Expenses.</I> The Corporation shall pay the expenses (including
attorneys&#146; fees) incurred by a Covered Person in defending any Proceeding in advance of its final disposition, provided, however, that, to the extent required by applicable law, such payment of expenses in advance of the final disposition of
the Proceeding shall be made only upon receipt of an undertaking by the Covered Person to repay all amounts advanced if it should be ultimately determined that the Covered Person is not entitled to be indemnified under this Article 7 or otherwise.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.3. <I>Claims.</I> If a claim for indemnification or advancement of expenses under this Article 7 is not paid in full within 30 days
after a written claim therefor by the Covered Person has been received by the Corporation, the Covered Person may file suit to recover the unpaid amount of such claim and, if successful in whole or in part, shall be entitled to be paid the expense
of prosecuting such claim. In any such action the Corporation shall have the burden of proving that the Covered Person is not entitled to the requested indemnification or advancement of expenses under applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.4. <I>Nonexclusivity of Rights.</I> The rights conferred on any Covered Person by this Article 7 shall not be exclusive of any other rights
that such Covered Person may have or hereafter acquire under any statute, provision of this Third Amended and Restated Certificate of Incorporation, the <FONT STYLE="white-space:nowrap">By-laws,</FONT> agreement, vote of stockholders or
disinterested directors or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.5. <I>Other Sources.</I> The Corporation&#146;s obligation, if any, to indemnify or to advance
expenses to any Covered Person who was or is serving at its request as a director, officer, employee or agent of an Other Entity shall be reduced by any amount such Covered Person may collect as indemnification or advancement of expenses from such
Other Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.6. <I>Amendment or Repeal.</I> Any repeal or modification of the foregoing provisions of this Article 7 shall not
adversely affect any right or protection hereunder of any Covered Person in respect of any act or omission occurring prior to the time of such repeal or modification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.7. <I>Other Indemnification and Prepayment of Expenses.</I> This Article 7 shall not limit the right of the Corporation, to the extent and
in the manner permitted by applicable law, to indemnify and to advance expenses to persons other than Covered Persons when and as authorized by appropriate corporate action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <I>Adoption, Amendment and/or Repeal of <FONT STYLE="white-space:nowrap">By-Laws.</FONT></I> In furtherance and not in limitation of the
powers conferred by the laws of the State of Delaware, the Board is expressly authorized to make, alter and repeal the <FONT STYLE="white-space:nowrap">By-laws,</FONT> subject to the power of the stockholders of the Corporation to alter or repeal
any <FONT STYLE="white-space:nowrap">By-law</FONT> whether adopted by them or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <I>Certificate Amendments.</I> The
Corporation reserves the right at any time, and from time to time, to amend, alter, change or repeal any provision contained in this Third Amended and Restated Certificate of Incorporation, and other provisions authorized by the laws of the State of
Delaware at the time in force may be added or inserted, in the manner now or hereafter prescribed by applicable law; and all rights, preferences and privileges of whatsoever nature conferred upon stockholders, directors or any other persons
whomsoever by and pursuant to this Third Amended and Restated Certificate of Incorporation in its present form or as hereafter amended are granted subject to the rights reserved in this article. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U><A NAME="toc778708_45"></A>Annex B </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF AMENDMENT OF THE SECOND AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF INCORPORATION OF ALAUNOS THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Pursuant to Section&nbsp;242 of the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">General Corporation Law of the State of Delaware) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Alaunos Therapeutics, Inc. (the &#147;Corporation&#148;), a corporation organized and existing under and by virtue of the provisions of the
General Corporation Law of the State of Delaware (the &#147;General Corporation Law&#148;), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>DOES HEREBY CERTIFY: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. A resolution was duly adopted by the Board of Directors of the Corporation pursuant to Section&nbsp;242 of the General Corporation Law
proposing this Amendment of the Second Amended and Restated Certificate of Incorporation and declaring the advisability of this Amendment of the Second Amended and Restated Certificate of Incorporation, and authorizing the appropriate officers of
the Corporation to solicit the approval of the stockholders therefor, which resolution setting forth the proposed amendment is as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>RESOLVED</B>: that the first paragraph of section four of the Second Amended and Restated Certificate of Incorporation of the Corporation,
as amended, be and it hereby is, deleted in its entirety and the following paragraph is inserted in lieu thereof: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;4.<I> Number of
Shares.</I> The total number of shares of all classes of stock that the Corporation shall have authority to issue is Eighty Million (80,000,000) shares consisting of: Fifty Million (50,000,000) shares of common stock, $0.001 par value per share
(&#147;Common Stock&#148;); and Thirty Million (30,000,000) shares of preferred stock, $0.001 par value per share (&#147;Preferred Stock&#148;).&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. This Certificate of Amendment of the Second Amended and Restated Certificate of Incorporation has been duly adopted by the stockholders of
the Corporation in accordance with the provisions of Section&nbsp;242 of the General Corporation Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Remainder of page intentionally
blank] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, this Corporation has caused this Certificate of Amendment of the
Second Amended and Restated Certificate of Incorporation to be signed by its Chief Executive Officer this [&#9679;] day of [&#9679;], 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Name: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Title: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g778708g01g01.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">ALAUNOS THERAPEUTICS, INC. ATTN: SECRETARY 8030 EL RIO STREET HOUSTON, TX 77054 SCAN TO VIEW MATERIALS&nbsp;&amp; VOTE VOTE BY INTERNET
Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 P.M. ET on June&nbsp;5, 2024. Have your proxy card in hand when
you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/TCRT2024 You may attend the meeting via the Internet and
vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE -
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903</FONT></FONT></FONT> Use any touch-tone telephone to transmit your voting instructions. Vote by 11:59 P.M. ET on June&nbsp;5, 2024.
Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes
Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: V48660-P09834 KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY ALAUNOS THERAPEUTICS, INC.
For All Withhold All Except For All To withhold authority to vote for any individual nominee(s), mark &#147;For All Except&#148; and write the The Board of Directors recommends you vote FOR number(s) of the nominee(s) on the line below. the
following: 1. To elect each of the five nominees for director named in the accompanying proxy statement (the &#147;proxy statement&#148;) to hold office until the 2025 annual meeting of stockholders and until his or her successor is duly elected and
qualified or, if sooner, until his or her earlier death, resignation or removal. Nominees: 01) Robert J. Hofmeister 02) Dale Curtis Hogue, Jr. 03) Robert W. Postma 04) Jaime Vieser 05) Holger Weis The Board of Directors recommends you vote FOR
proposals 2, 3, 4, 5 and 6. For Against Abstain 2. To ratify the selection of RSM US LLP as the independent registered public accounting firm of the Company for its fiscal year ending December&nbsp;31, 2024 by the audit committee (the &#147;audit
committee&#148;) of the board of directors of the Company (the &#147;Board&#148;). 3. To approve, on an advisory basis, the compensation of the Company&#146;s named executive officers as disclosed in the proxy statement. 4. To approve the amendment
and restatement of the Company&#146;s second amended and restated certificate of incorporation, as amended (our &#147;Charter&#148;), in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the Board, effect a
reverse stock split with respect to the Company&#146;s issued and outstanding common stock, par value $0.001 per share, including stock held by the Company as treasury shares, at a reverse stock split ratio of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-for-5</FONT></FONT> to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-15,</FONT></FONT> inclusive. 5. To approve an amendment to the Company&#146;s Charter, in substantially the form attached to
the proxy statement as Annex B, to, at the discretion of the Board, increase the number of shares of common stock authorized for issuance thereunder from 34,666,667 shares to 50,000,000 shares. 6. To approve a proposal to adjourn the Annual Meeting
to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal 5 and Proposal 6 (&#147;Proposal 6&#148;).
NOTE: To transact any other business as may properly come before the Annual Meeting or any adjournments or postponements thereof. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other
fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX]
Date Signature (Joint Owners) Date </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g778708g02g02.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and Form <FONT
STYLE="white-space:nowrap">10-K</FONT> are available at www.proxyvote.com. ALAUNOS THERAPEUTICS, INC. Annual Meeting of Stockholders June&nbsp;6, 2024 9:00 AM This proxy is solicited by the Board of Directors The undersigned hereby appoint(s) Dale
Curtis Hogue, Jr. and Melinda Lackey or any of them, as proxies, each with the power to act without the other and to appoint his or her substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side, all of the
shares of common stock of, ALAUNOS THERAPEUTICS, INC. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders of the Company to be held at 9:00 AM EDT on June&nbsp;6, 2024, virtually via live webcast at
www.virtualshareholdermeeting.com/TCRT2024, and any adjournment or postponement thereof. This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the
Board of Directors&#146; recommendations. Continued and to be signed on reverse side </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g778708g01g01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g778708g01g01.jpg
M_]C_X1"C17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    ?    <@$R  (    4
M    D8=I  0    !    J    -0 +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P(#(R+C @*%=I;F1O=W,I #(P,C0Z,#0Z,38@,#(Z,S Z,3,
M  .@ 0 #     ?__  "@ @ $     0   S2@ P $     0  !"4
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   /:0        !(     0   $@
M   !_]C_[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@     '_VP"$  P(" @)
M" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,
M# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( *  ? ,!
M(@ "$0$#$0'_W0 $  C_Q $_   !!0$! 0$! 0         #  $"! 4&!P@)
M"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q   00! P($ @4'!@@%
M PPS 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A
M\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%
MU>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"! 0#! 4&!P<&!34!
M  (1 R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:B
MLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F
M=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$  A$#$0 _ /54DDDE*22224I)
M)))2DDDDE*26!=5C_M"W*.9>W*;FTUMH&58*]I&.ST_L/J_9_?4^RS^9]_\
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M+74; 00/?NW;?<DI%31BFMEEU^TF8;ZC'-D'\UX8S<K%&+CN(L;:ZX-T$.$
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MYGTMG_3W(/\ W@?^@G_HM)3_ /_7](DCJEI:-Q&,R!Q)WVI9?I&X!]%MKBT
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M$$N:]CV?UW*L.G]6B#D G37?8./FDILC!B(LN $GEI_U_.3?L\?Z2_D'1P'
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M<" S+C  .$))300$       /' %:  ,;)4<< @   @   #A"24T$)0
M$,W/^GVHQ[X)!7!VKJ\%PTXX0DE-!#H      .4    0     0      "W!R
M:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT
M90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).
M86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '(
M;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N
M96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "
M+0   !     !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N
M8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;
M    0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL
M1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#
M     P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M    0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M  !";&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q <L
M      IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !0
M9U!#     $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
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M0DE-!!D       0    >.$))30/S       )           ! #A"24TG$
M    "@ !          $X0DE- _4      $@ +V9F  $ ;&9F  8       $
M+V9F  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $ +0
M  8       $X0DE- _@      '   /____________________________\#
MZ     #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z   .$))
M300(       0     0   D    )      #A"24T$'@      !      X0DE-
M!!H      VL    &              0E   #-    !L 00!, $$ 50!. $\
M4P @ %0 2 !% %( 00!0 $4 50!4 $D 0P!3 "  7P!0 $, ,P M #$    !
M                          $              S0   0E
M          $                         $     $       !N=6QL
M @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M          !,969T;&]N9P          0G1O;6QO;F<   0E     %)G:'1L
M;VYG   #-     9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4
M   2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &
M;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9
M  !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J
M8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO
M;F<          $)T;VUL;VYG   $)0    !29VAT;&]N9P   S0    #=7)L
M5$585     $       !N=6QL5$585     $       !-<V=E5$585     $
M      9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $
M   (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L
M:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%
M4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T
M   115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N
M9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "
M/_         X0DE-!!$       $! #A"24T$%       !     (X0DE-! P
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MQ $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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MB!M>VT6VCW.V_P W9E%N[:S\S_!(P.;DN]$^AM+OI^B_;+/Y;<C^JKOHV_\
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MM)3_ /_7](DCJEI:-Q&,R!Q)WVI9?I&X!]%MKBT %FX  [^X+6;F_P">F?\
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M_P!@  'J7:2/I-X.W_R*63C91R#?CN9^DJ])X?N!$$N:]CV?UW*L.G]6B#D
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M0?8/L>[3TO1WQ_)]/=M24__9 #A"24T$(0      5P    $!    #P!! &0
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M P,# P,# P,# P/_P@ 1" 0E S0# 1$  A$! Q$!_\0!$  !  (" P$! 0$
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M    ]_
M
M
M
M
M
M                                 !UB-=0;<G2)37?C>6YB
M                                        #R8NE)KL.SJY-]CMQZ.6
M                                                !YN&O2.R!YW6
MO1$R!YAITC=:?2]PEQU.NG=<QY>IU[=V.\"\_'<Z[A)A#TAN?8&@'D,=.]UC
ML60                                     #S<->D=D#SNM>B)D#I1:
M\H,Z[$V=XC'01-W,<RM>)?\ 0KO#Q\.DY77&/0%<=K3('12UO$G70UW!,[$H
M                                    !YN&O2.R!YW6NW]-+FK 37XW
MI3K::VX2OS'K71M"E^)0B\@L!-/IK'592=LS/1>UVRL],[>_+/8@@
M                             'FR:]"S/\/T="37H#9\^+I9:?TWS9ZQ
M%C;79RSU:S6.MGC.QAA36XW63ZE?D2E[W+CQRSIW%7/<RR
M                       !X[)V\/$]'>5KAT;Y[_Z1E\GH,N         ,
M690                ZW6L<L.+S2A%R!#R[4_!914B]E#'+
M                                !_#1YK$%EI UQIR2V4N5/ROQ3F$I
M.0               "F5JY;02,&?(P8E;+2F%V_9Y(
M     /X:1-?4D:8DP2P0VM2WTS                  //\ -V(NQ"=8J]AB
M:]$<6.%J1WM7F       !^3]  'Y/T?D_0           .G=N?$Y2 K,$P2\
M!.PIFP0                 =,#>>+6,439-0&MADJTN-.4O+DI2W5:6(5_2
M&RSZR)RYA,3;::5<NYS-BFOZVL:=+O\ ,=-,Z;3V<$OU-;UWS9Z_FMDTV]9[
M)V0         !U+-XDR1PRVTD9K4MQ)V7,@                    #^']
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MHB_$I!;O3LH9R8    !A#-@        PASSF
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MEQ\3YF#)"80YQE3&&0,&<LCQ.3B''.,<HR!CSEG'(Z9 YQ_"VD
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M#Y'%*57:-+12RTTO:X!EB"+NTSJRL!E[-+B7
M       '54W499QE#&&QJ<TN9*R7!FVC.7
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                      .I%JRR&$?795-<%@152[[LT^L<)FEU&CTNUUE-
M+*4CB_HMM(,7Z:3-2J21UL0E;&H"[J)4:R,Q1,TPBTD;+)V3L@
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MI(EL%FA6N:;3LZSK@5LE(BNXK.T"                 >6QO\J
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MA"RBS$I(CZY [7V!U"MY4[96!I>UUEM=_#GS =0S>2.V=@
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M4HM=+M6G9(P                              /,I-^FNX  'F4F_37<
M =-;=N)5:]@S.ILL5MPQ](FE72F+*37[F>3YKV<L<4Y0
M                   !YE)OTUW   \RDWZ:[@ "HEYQ^SFI@%KXM YQQ3(F
M92-G,.$<%;40                                    #S*3?IKN  !Y
ME)OTUW  'C]=;Z,0<LLA-GT[K6
M       !YE)OTUW   \RDWZ:[@
M            #S*3?IKN  !YE)OTUW  '7HW=S.SJ==S4D)VG+)65.L:)XGW
M,.NT3,L                                     !YE)OTUW   \RDWZ
M:[@ #J:;N!.P5GJ(;DY*DL<YY!#Z'Y)(54=CC.>
M                !YE)OTUW   \RDWZ:[@ #IA=-F6>P5GJB;K5=NF8246M
MC)RS5MJV$W&2;ILJ@                                     \RDWZ:
M[@  >92;]-=P !TDMV\=K#'14Z? M1/J?<^AP"ORRCM]8
M                       'F4F_37<  #S*3?IKN  .C&=+2L[?&.F%N>'P
M/T00^!W#L2(                                       'F4F_37<
M#S*3?IKN  .FYO8U.P1GJG:^RRY)D:RK<R=B[//
M                  !YE)OTUW   \RDWZ:[@ #7!<Z7DE6E,KQ%OAF&K\"]
M4YX                                       /,I-^FNX  'F4F_37<
M#3AK<=FCUO!!!05JMBD_3C')   (^?PD(!^3Y%-+'2R2Q4 $%(XLW3&GS(.M
MZ(*R7G$_0                  :SKL<GZ*#6[4PICR3&HB[-IQ5GZ?8\RDW
MZ:[@  >92;]-=P//8ZU270S"ECDMR7.ALUVU7.A$O-MY4EE5,BFSA1C3(5QC
M%QO!9U]+RCL335.6J5W@N>M1K:%GY+ILMMFT+.KB[R)O<SITNFS6U*90T&FK
MNL[!V>QUD                  =)C<!7LZ8Z*6\O+):LYGLE9Z6G27)QUVD
M9[N6/,I-^FNX  'F4F_37<
M         >92;]-=P  /,I-^FNX
M       &KRV$6^@^9H0UOVR!K:LE+M0>92;]-=P  /,I-^FNX'6,WV<L#II;
MV 359K,)9!_3[%7+.TB$6_5?E4F#+A,%%Z64TNP281=8UVA9UO:FJ?4QBPHV
M;2 D6,:9\@2[2,ZYKB%W"9I9?@9DK%90DC(H7>D.769=S6:67(G%/T7"FG\U
MO%<TRM7%OF.(T2 YI C(%O&CDNU"06W'$R2UTMPU>74]=L$[:F!U1M\0[9V!
MI UH*UWLN8'4\WR#M98'F4F_37<  #S*3?IKN!%R4 ZP6[G37%;R3EFM:[AI
M4)'5P!)RV$TYFM@[G;--:%J!;W3'D'.8L,.43=)T5\M>EG)Q"M%MM*@6WD@"
MY],H6Z:EK9)R$MA-9VIXDJ,<?8AZ[%,Z0M[*,U"MJ):1LNSSS$GW.(?$X2Y]
M/X?TY14JV4GP.0?<_!_#$'-.(2,Y -)&K(39-!A3K#:[5F0-,UE!M(@\RDWZ
M:[@  >92;]-=P !HVULRD',D10X99)#SE'X/B6 5 3DO!-3UY"VFE:K(4^QC
MS\%HI!%G)69)RMC,F;,"9T_1^"*ELI6ZS4Q9D"&$6,Z0DO8Q)8R5\L4.4668
MHM]                  /,I-^FNX  'F4F_37<"HEMU!2"W>@'\/Z  1(S)
ME")$M,4?HP9+P #'G&,R0TQ2S1*W6S4YP!$B6@$5)2?TXAAB2%?+P2ST AI)
M",DT(82(A98H/X#&GQ,R 8@RX    !U2-V$G8RR*,7IT;[_G,#JQ;E:=D;(\
MRDWZ:[@  >92;]-=P-#FM\61UF-8Q=.EO-,\6LE/KM:FE+6T;.H#5GIB"5$*
M/B;D)K(MG)6*P>(#;>*1\_A?2:_KM0FIR[RIJBN$B 6SE+M3)&K[4]2?IK:U
M,TL)(.MYIK\H_*[;,ZE2VE54F8(FMVIQ23I7"Y @A72[9,T*N8,H9XVI3;=D
M    #J!;GR=H#(UV7I:;]%SF!U'-RI.T=D>92;]-=P  /,I-^FNX
M                                       \RDWZ:[@  >92;]-=P
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M                                \RDWZ:[@  >92;]-=P
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MZRI(L2XPQF#!G',@8TQ:R!.<?TXAQ3\G.(FLM3&&*60)_#('&,4LZ0
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MMQ-5UUSFKOLEYS4OM-I4          'F4F_37<  #S*3?IKN
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M]9@G\.<<,X9ECB &6.6           #S*3?IKN  !YE)OTUW K\L '&/X<H
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MZ/P?L       'F4F_37<  #S*3?IKN!72@          #\G\  ,LDR
M !79_%           _)_  #)I-0      #S*3?IKN  !YE)OTUW&-*H6QD
M         IE;C  *9-C$       &OZVZ@          %5+:0 !49L$@
M 'F4F_37<  #S*3?IKN,:0E;(0          "E5NI  **6]4       %/K<"
M           52MK( !2RW2@      'F4F_37<  #S*3?IKN,:0E;(0
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M@                                              8"NX=GL#0
M
M
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M*7LZ'M.'M.'M.'M.'M.'M.'Z$,XZQ[T>]'O1[T=?TKK'O1[T>]'O1U_(!_X
M_P#_V@ ( 0,  04 _P#$'IH&L?V:H#;$1_9KBH-(^T5%0T@.Z(P%8 /[U45C
M,?:(/3QJ]?';I 1JE$J: J$!C;IIE53*K<V@"-(?M@(!'N:*:0& T5#4$A\1
MTC TB'L<'IXU>OC2$XJ'W*A#< :914-$JQIJ#=J]ZJH!VXG\.BH)4T@%50ZA
M\:H 1")!5 @(>Q@>GC5Z@$X"@1C3TTB,2C15/2,AID T" Z!U!2(@(2 :9 %
M(B  (QHZA0(P%,PBJ)3B5(0(B/L93Z2&)#$ABKU]("N56H-.N)]=0@.N!JF
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MSC3&GH-,:>F@8TQI"6GKI&-,:8"F<:!C3(=,!3.!IC3&F-,"$A_7Y=! 92$
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M(B,:AB8P R'4,:H&H1B8RU#*8QJ&)QJ&-0Q/H(B(:AC4,3C4,:A]@= P% C
MTB$#0(#(1C0,#2(![03J")B,5#.!JJ$0U4P%=43&  1&0^$AB0Q*)#$AB0Q(
M8D,Y#$AG(8D,2$($!")"$:1'PD,2&)#$AB0P "/A(8D,2&)1(?8&8QJ$8$=0
M@(P(P B !4, (A&H1@9C U0-0Q.03&!'4 ",:ACJ S&)C.8P(C(1G S&.M43
M&0B(P(C$QC5$Q&!&4=9@(@$QG,8U=!F,:A@>OL!,9C4, /75UF(P%0P,Y3&0
M (1.J!J@1G C.-4 ,HU0(S#4,:H&J<:HU= &0ZH"J0ZHU1J@*@F-4P 9!&KH
M-0C&J-8P(S@:IQJ]@=4:@EJC5&H( 91J&4^@C&K_ ,H[ (D$Y2 0 (J"0Z0E
MI"0TA$@U#2$2 8  &!E+2$I1(($ EIF  $]/4*>@ $AI    D%,X&0!4$HT]
M1  #2&F0#4 !$@F 1(($ E[!S&/6)C.8Q,8F,3&)C$QB8Q,8F(Q,93&)C$Q&
M)C$QB8SF,3& $0B8Q,8F(Q,8F,3&)C$QB8P B$3&)C$QB8_F)#X2&)#$A]H
M]0$ $*@E,($0&)A$P@1G$P'\.F6KT#T$!Z])U>G2 E #TBJ4O6!E "$ND2E
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M'0*  9 -84TA% 3C3&@)!0$] 2&D( )AH">@)?MA 4TC&@): G52$Z0"J I
M::J!I   0T  Z0TT $@ )5  4^ "(1J'Q 1")CXZAD%0P%8S&H1\9U1.J!U2
MG5$QCU@-4"-4"(B  (1.H(Z@,ZHZ@$ZA@)B(ZA@ $($:IC,0G4(3J@1$8&H1
M@1G^,$HGMQ/;B>W$]N*Z0I'PJ]/-7Z^ 4=!I$ TAI"D(T#(*!GH&0TR_' 1#
M\SJC5&N-<3"050%4H"KH%4H&J-<:N@U3B<:H"J0A5T"J4:N@52#5&L('K^5W
M?\O"KT\U?KX:A@:JAB8QJJB8Q,8U#%54_P T "," AY--4O$ $8$!#]/W?\
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M&D #2$:8"D!C2$PI"84A(*90-, $QTA&F I"-(0%(#  $@I"-(3$  !I"!
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MZ4P(=/ ?\*O\?"C_ "I_]3Q_]L?\/"KT\U?KY9# 4S"0QIZ:1&-,:8 .HTP
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M)4P$HZ1[L!ICW8&0U#IE[L -,>[ #(?2KH,!*<PF,HZ:AE'2/="/=@93$0
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M74*I1JF%(RC5 " !J"-4:@&!JG UP%4@U0-01J 8&J<",XUP-4PU1J 1U1J
M(U=9A #*-4:P"-4#4 @-4P"4ORU7IYJ_7V?J]/-7Z^$J8$  -(3]!&F  ):>
MFF-( (!,=(0 ==(!&D(  GIC2$#2 0-,@TP%(".F)==(1I"-(0(= IG&D(TA
M( G3I (&D @0 !&D(&F0B 0-,HT=9!J"D(TA(:0@:8"GI+KI (EUTA/3&F4:
M0C0$!2$"'0:0" IF&B-(#&D(TA&D(&D C2$4@ QI"0T@ :0#\U5Z>:OU\DQ\
MLQ\0&0_@3'QF,XF/A/I^',?&?A,0#QF,3$(F/GF,IC$Q\LQ_/5>GFK]?"0_F
MY>P57IYJ_7PU!'NS#3 2CI*83Z0.F.E4!*?2/= ?=" $(]V4Z9S".FKI'NS#
M3+UB8 /NQ.F/=@.@S"8#3 RETG[H1.F*@Z>[ 2D(@,3IB=,J@ (G3'NQT@1I
M@93G3.=, (0 @ AIB815*4Z8IE&H(G3 "$ITRZ1[H0(!+II$:8]V.@U" 0(A
M+H(B(2$0F(@(!IETCW8&0@$H]V!$)?CU>GFK]? :0B5,:0@0")!+2$:0B0".
MD)" 2D$:0F%("$@"-(1I")!*77I/H(2 (TA$@@ "6F! (D$#2$4R" "8 $:0
MC2$:0C2$#2$!2$J0 8TA*5(QI (D$M(# !UTA&D)#2 !((TTP !()0 2@ Z:
M0C2$!2 C()  2  GIICW9:0@ "6D(  C2$M(0  ," 1I")4RTA$@$-(1I 1Z
M2TA @$OQZO3S5^OXHC/R^GX0#+\M.?E]/TBKT\U?KX2&)#$AB0Q(8D,2&)#$
MAB0Q(8D,2&)#$AB0Q(8D,2&)#$AB0Q(8D,2&)#$AB0Q(8D/Y*0Q(8D,2&)#$
MAB0Q(8D,2&)#$AB0Q(8D,2&)#$AB0Q(8D,2&)#$AB0Q(8D,2&)#$AB7Y"KT\
MU?KX"/68Q,8F,3&)C$QB8Q,8F,3&)C$QB8Q,8F,3&)C$QB8Q,8F,3&)C'^DQ
MB8Q,8F,3&/\ 3\@(]9C$QB8Q,8F,3&)C$QB8Q,8F,3&)C$QB8Q,8F,3&)C$Q
MB8Q,8F/A,8F,3&)C$Q_(U>GFK]? ?7\N'IY0]/R ^OZ;5Z>:OU\!]?RX>GE#
MT_(#Z_IM7IYJ_7PEMQ\./AQ\./AQ*B);<2VXEMQ+;B6W$MN);<2VXEMQ+;B6
MW$J(EMR^''PX^''PX^' ?MQ+;"/AQ\*/A1\*!T2_(2HCX<?#CX<?#B6W'PX^
M'$MN7PX^''PX^''PX^''PX^''PX^''PX^''PX^''PX^'$ML(^%'PH^%'PH'1
M+\>KT\U?KX3"!$ @!I" TP(A*<H$0G,(F$@$)"(#&H) (2F$YA&H( 0TS"!$
M!\P#*)A$PE^4G3 B 1.D(G3 B$NDITP(A(!")TQ,(F$#Z_AAZSIB8#^4J]/,
M%02G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1
M$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1
M$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1
M$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G1$Z(G2
M$"(B/_9Q_]H " $!  $% /\ Q!^3;EB;7Q4DS9[O/C\N0O>Z\9MC<:/=^\>4
M,(?2B?(PVWVB[F9OMDZ]>,%V?1>*P&_MM'%J"G0=FDF\^UFQ%& XLO:+FP^X
MIX]L-]M#Q[F_D2=DQ5%N(<BOQS"O8%Y_++SVNHX[V9\P#2'(\['(P_G-OZXG
M>0:]Y ^*KA2[BYQA$4K;>RZRONG7^((Z1QJ%[&0YJ-[F&>6]?D^X^;-QS2^X
MHXX40XO'Z%CDH93XL747EX+%+*>4-K+X,A[&\V'W%/'MAOMH>/-DY"U0%'.,
M%(\&JO-^V0^.P[8-SK4.=PV/'53BK:'S6N35WA^2]WG%;R*\#/&*37T<+?$4
MTE\39.X,BQ3E1@[P[GH90[DBO1=GW"2L/\;7PKL",'&OQ\>/ I_Q*];C7::_
M7'_WERA\6 -B=HVYYR7^Q?-A]Q3Q[8;[:#SG4%ID[<'$<S+9&_7Q:Y)*U"<]
M=\]S),&FJ!O;3AQIEQ'<@<;^>;*H7*ZW%.^0)#N6._6URB%\PQ37%M.WSU-U
MQ:++URIML;L^)%'@)\NCC6H\FZ?O+4I;.4%"4,>2I3_4719TI0YK$X5+ *%S
MB(^6"29^53*859+;=KW[?@4_XE<.Y9 FF)>#J.2;E(J85Q?-3X[L;[%\W-Q;
MVG(:*FIN$?V<FTZ5+3FNKMA1IJXSS852X>RJ5^ O#IAQ4X#B>4\G<BV8X&V]
MFEPC%V08)D;&<+P!IIB&0JCP('Y4MM$V4G%-GJ-)X/5H;>UW.]OKGR^AB^<#
M1G<T8$T9#R!(>\1%.)]1R)R6/KX-'!NG<YR)\22:\AS;5$X^'!)DZ&[X=+$N
M-9>]Q-*:XY]%G3<T6G'4[AY>!AO/#T2[14?8WN]$$6U8TJK9FYT:%E1Q@.7X
M<A9HYF7;'(ZJZ)\4WY/#X/"EVQ_02]R!X<XK>3^2(FFTRXCDA,^9S*).J.RI
M*)@N1<^8_%8WD5S>&S%_R8*;;D<XO4-Y4+)%=JNIWSGU67V*9\37R']3+W'[
M]=S8^S0@ @IZT-<L+X'6-9-Y@510VU%2K%.?;26K>_=FVK:*N0<FTXAXHGGU
MNRT93;39.MF]S29IN9*\$EJ<EK&Y-.T_S=O:6=IC[7] V7&-_N,3D7\LBQ)*
M(SBT#4XX$!X33U5W,HYANN#):@/,:2E&1R+ZF78C&V3A4$R>3O.1!A^/P]E>
M6F1L_P!0$)@7&K-4()FRK9FOFK969"$B7\;AL*!7V4+#8&PX,M7K.F&YS+E*
MY0I-\G@C#@#3C?T13>&]1U%,X<=B]'H[,X: LC>CX0N$-;:&B<@7'F:'38XC
M\3:R$G*;7$NXO/)\5.'EP1=.B'<9CAR.U3\B-= 5>4:Z*:H"NBH?S%_QQ*IG
MC'EF**,<5#P;65CPRQJ_Q['-5SI=,[.]RE:DL#SIZ-)#8ZIY6H2A.\$DB:?H
MENG+NL>IEHD+OR4IB<X-\E!^71M)\5->&\;;S]X]8UM3P]\K%&U?6!@)J?/U
M+)8:T?W#*?G7BI^M1FPZ05O/^H)+RP^HBW[K%PY/2(YBS77DPQR[IPZ7E Q2
MGXUW'(*I^>SJ]\C6W=8EU3Z3^I6)=!R@Y_)(PI;_ !*U25YTKV3(>-E8>4 R
MU+D:.4(U)&8R[R+V[*SGGN6H2BV_8Y4]QP9@;#R96"]-PQW);DUQ*+(G5&K$
MK,T%U.5XK++ \V)&3TZ[/*+AC1DDPYICPK^/N^1?&\?I))'-B6CF7['EROLE
MQV _S=MORUYG'S7].-S3W/X5EL$YNSOD>,3TB<I;EBTZ6Z5/.8I8\SC]G!O7
MPF103=>#E5;_ $P*0I#V>.!T=GB+HCJ<^!4<&53X_)/2M?Y=\F3S=*J\@=F>
M-M5^2+9+R*GIZ!N4U$E1?5@M^R4%YI/S&"6'D:RQ%QRL\@ABH+9\="0["[<R
M_G*X5*U%=ZKIKP:^/F/N73-1.0"RP9(7US*@9"P5!]&*MD]6![J?E'*J8]4W
M8_%*Z_R[-:6+:ZZTS)*5WD#S%D3<$[-;2.G:L/Q.Q]4-2W^9<ZF527^FI,#D
MLSZ<09,HHK^R_CG)'%TV4PY>.+\5"S>%<7R'F<SE=>'M[&21"ER2A.;SUT_Q
M4$?QJL/SS9NP2O<@1:PM2L<A5>'L5=?G<&/$Y.VS6._7\RK+GTW,URZ]\N(,
M:XJNY4C.GSJO+2X_CLSF84@L/!SIG<-B$P4*IV>4/%!X>3MF%Z"D&"QVB'>K
M>C24E=SKN,[GG#N#/!'5(U.>>:6,>X@_+QM)Z\M:BE<M7-:Q*V4%&1S-N*(2
MHNH-3E?Y857@.LW;%'5Z=F?2-@'LNT.F^A;C%B7-7TG>:\97K#"._=V8;?&.
MZ7@VM7L'2N?.*THPM[D#^7,2J+I3<AEVYYU2<'%5G.O<J0]S[H7$(4JN^NKX
M$:+B&*VY3*+19O=<_EZT@=0KQMRI;><ZO+8&]=VZK?R*5N#797"84W&O3)*?
M(&:3R=D?_7S ]IYF#RY;<HZ45H<(N3D<]G$7<JLU[9IVZ1Y)NQN!4=U*X(FJ
MZ^NM4*UJ>*[ZC);R].M,B#6+D7T)21UJ61RY05?*.T=M=W1S>,X,J7MPY-SQ
M7,& <J[H<(HCDG%698OW5+WLH'N.(>T&/RCOG,FG.JXOJV%5',:^1Q)4##K
MZK,IJFSK'([&,L'9._,V.:LOJKX]3A>.[0XW2'K4OBMNA;DZMT^;R^0=J\&Y
MP)K=H['*X1M[GU].N<)KQWBFNP49?'29Q5TG<JYK(8K$NW=]BDKJ<,\FXL[M
MRZXV*'9=UCN#(%ZY-WQ<LV<+&:' -F_7[AX[B\(8D\>*YP[J"E3^E 5]4DY?
M8X.SQ:<.L<>H*>6CRW+IL1]IUKH+15L+F<68L/\ AY,M%[-9#\D8BV7S?A<?
MCL?B+#_I-;O4/V(,QGY&K;=QYNY$3B4=MVRS+X1%13IXYE/ZCJ@]Y>+ ;1^I
MMRM[:<@*B?[PCCSKI8U26MQYTW2XCW(/9G//&3D).2>F-V/*_BFAK4;N;C*I
MCF]GF1SFPMKD.5>^+6?/W+"NA9SV;YDD\MC6/*>Z>S;(9>8W&DG=4/F%67.I
M.:^8,XI3&2Y27!8O(I;S$&E4,-AN< S4%8F<K)]-JJM[Y9G%*$5D6YE"DKRW
M*)S%7!+V3)S2&VQO5,<*\T^J89>0][1B;U@7O.4W,J0^25[E1QQ7+,["S1'V
M$MR$1;38I+!:IM#>AZ;'LT;F.Q^]O4%0K;>4HP."VMT"$1@IVBT7-@2FC">D
MP[YS X,SXFU)I0LK^^)),R=Z=VX(>I1@WFAMNNMW<:"VS>W-MG#8]FVK9VV?
M<BW9,T^TMMIES6-BXWV8M:N]VY9BUR^N-UG+9+FO<9JU_>NK1E[6L?N[#/VU
MVF[:,C:;C[>U9>UJPKNN-ED.04V]92U/)[MPT!M=YO T-N(;?T9M>#/5,P:S
M7:63)6GXRUPC.&PE>Q]A,B]]6RPMI:?VC9N+V)Y'B[=[)'Y"D6/EMB>1(V&T
MW%SDR(ILLS#R '&W+._R("0]H\/ML"WGJ.4)(\GC\%R&YC([J6<B!,6(W7_)
M^E6QCEM>.J)&5FQY$2PHI(,?(G189.ODR)E)2.?)QB<-BEG?J0$&N<J_?+Y'
M/F#D.)./.B=\CV*.)HR#[-FV<#8<EA1,6)Q#^2QDU()G(,;MX\VG()@,BBU_
MRB);@KJYY%KNYIO>2XOV6 <RZ#--_4-/N2M-<O9X7D7L#^@@<BUP2;I07U8(
MA7)8Y#<GB;T.16FZN,UR-8'*FS%<DQ2O[5%56PJWI?\ KYR<N0C8I*:+,AZE
MN:))Q0)9%.+SD&ZXO&91=4=IJR[R$'VD9654F\H ;7)*F32GDDS=$@ZOK0E[
MB$=/F)2]Q[3%),Y!51O>VNF=<^ULS[IT? A.9#,+TG:2Y#/KRBAG0LJ.Z0HH
MDQ5U@:D0CM0X1O><N"2ZMEJZ*2K#A68;RBJ$Z5"MHQ*ZY!M>ZL:/N-;QG#BI
M*D-WS+L$R<4CRE.()#JRT5&U6KFDJQ,(BIS.%Q/9K7Q&UL)?U()1LH]DUQ;?
M;%(CN20^Z#*K^D!I+FV\I#SSOHT;6U.<,^RE296^\#:F^T[=B@:)8PT8 O8$
MJXG]?K0I%]V[+B$HT4;K%(TE.#.R7M,;TD1%RB))!FL?EFOMWS^$S:7IN9,E
MEDH33.Y3')"F&'-]RUIN-UBK%%TCQF[ET/1W/6-2$HK67LTV5OQCPN>1!'C/
MD2>WM+RBE.3;^B.8Q!@1M*#88S4@2)GC#6J*I!8FJ_;B@.5NZ$ 1#;RV2:FV
MK,6P)$F%)IQ*))!@C3A$'18MG2\;TA>0R&\@Z+W!@)".I.FF_B4(17!;%@C"
M48TFW:&(Y?&/(-?;IEBW2W5"Z;DOH.BY5,)809&268O8,X\S./(6&/W)VXHE
M&-ISWS<Y-14VYU,QFD2=SR1*FT/!9/G-3K#X0]\LIX1 X-0Y.S,ZIP)_7W#X
M]*U;Y:2FGK+<MS7VF,RQQY:"B46\F/F]+!<.QOY92H4&]F?G")Q2-19Y,#OD
MCU[+G3(L1QY@15+^.#)Y9)E1X^DF-N%23C&2Q!K]<F6*0HAZRG'66J[<M<:[
M<S,BP\7: GG<=JW+))B9C]QJ'!-3S9\3Q9)!@ON,K:1C;M.*G,WQKNN/TMD0
M]DSCC)*A6N)XQTY,6>?FVTMVF&>>G.?40P/F;F7<GG'D-ZPA>/#MD,3W.6_(
M$A-QE;-ZZ"WN1,[TT.(AWV7]HCO&$'CH#<7!6Y!$:,F%WN01KH;RFK/CDNNM
MKDD2"A,3 ]M%=LF%AX*%&O+'QX67)EBLSJ+-)5!)?(P53;;%/D6Q&:,*-NVQ
M:PH0G[V#:H]1D>TWPJF1.E"*:K$G]?HP+-,R9"4:N,])TNPA";RECBC.E*>M
M>0_/7#7[I&2>0VQG1QJO9]FEVI>$L.,[?3_ 7#-3$WDF%'CK5/"8 H,9-EL9
M=KC:.)MLLJP/+K0?"&S-6SSDE)X^S<<4UQK&2DAQTV&1E/>SYC860E#M"PTD
M\N!->;X\$IQBI&KCG-9T+B>\?QQ)V9QK.%16<TEUDIDM\C<,_)*I&A+&"(>>
M\QAF*Y(Y7N587?&PZK#QTFM$%8PC3,"X\H*&SVVMB1N,2+:PKTK+84]/]\9&
M=.H-N"5QA(X)7CFP11[DV*&SI)<0F)I9\F^V4!X]U$5M/$]*B5E#]?SK $4,
MEGFV+(9FLFK[=,4KA@,K;<6<3T''NCMIOE-F" IVJB@M&1=3=^CCA;3O8Y2V
M?X$\(M] 2*[&_D68$'&-CM&+HUC[)1^,M&3$1%0::EZJ9.R8NBV-+U@SM&<>
M6[ILB67>,39B"$I8>$U8^BB3*%L\>+:=C)YQB:"YTU+DSPK*HBV;8@B69,>.
M9NE>#)A*X_&_$6\N68HU>*Z7V0(P5E R[-4;SN>Q+$D&Q&,/C6$Q4'?MN/QO
MEAB-SCI;)OW!T;J0#XJ*',Y1INY@L6-(IAR#LL<0[;VBTQ1)RS<9;C]0G/49
MEEB39BK%V56-QGZ_GN6AL!6*AGY8$[*FVWQ\:<N//)%YQ&=FTBGWD&2E*]['
M<TS/\BE)%?>C*@N"]H#(B/&4?<]DFN,U)F!:&W%&B3<DOCE8DG"-NL21B;][
M)4N(?CM,QAN4!9JF%@J#CTE1E+#8X]#R-NXA2T]SUGO+FC&QF+Q9T@Q^UEU3
M33 ':U<>W^^&P5]*,IOY=7DNP.>S;AT)+NQA%N3G+I)=KDC%CERNXM'S0DYH
M<LA!-O<DL22X?:):MIBI.*3A>DM5C(%%=$E.V<-;S&Y$H^8T^DG,F??<&A-M
M6='4MU3\O&%>$5*5@7U-3HUYK;7M$]ZE478HFCI-SYX)Q5R>!<&A)HLL@X]'
M;+,V#B4%RE&)4M/,];[BSI#M6N"SV%-&&_7R:WMJYKSF&9D@9#A$DNQC34_5
MIL*"&[:(S329MD9<B:W9?E[.#16^Y\V.%0Y(56L;9HR8%#=;RG35&?6J7L:2
M\F%A%&KI1B3!?I:2G1N5)C?VPF.W+;9$-:DNBJ%A%<7:%%D"08S$Y'#ML7Q%
MC*V9K>5QEDE:,6Z%8QLC>BF8DT;,A)$.B?-^3!N)<0RP0!$,X9D[;LQNDY)0
M@)E4I#FXMW;>H26H:G*Q6!'0]L-OA\VRJPNA++6&VHHJR.M-)BXEW.)(S7.I
MBKR+-P7E6:6IMF.V$*3661&G'YAF&#SI]:ODV?(?OX?CQ:YOX-($SP2.IQ^O
M[R!(4:2EBV(H:<BRH[>,1G6SX=C"4E'#4LX0A%KU2F-H(23BA);;>3%^55M3
M=#LIRIJ"VY2KLIHDS9,43+?'9B=B$E;,6$?(;=FXVS>JK_C=P5YM.*;3A'"W
M6>X^,;FLBWEHA1;Z><.PE'L3<$WCH_@YE+G&J5";@+;CU+&]8&-A>>QRRJLB
M)B71$#MQZ6QWQ[J6<8-S9-4+CN+!SB\X^ANS\4N-1/RX2E-XYCWMDQ&6>Y)N
M9I7UMMLNQE31+K5-\IO<<)7N382^,I-2R5=SCRP.>--GQ<ENO&( AE"#8L@<
M<F 3TSXCCGR!8SQ"V3SL$W]?S_'1G,P6LWQN'[/JF;^,N_SM.;XVJ;DP_P#U
MR&$NF5>6K9MR^$2]H.&(2D5I-J60F-DW"U=[[2/G"YA]O/;>W_Y1SE%6<D4L
MUL+0X6S1@'/*BM2P)VNCB5#4E@:GJ<LJ$J.\!=T]7'#<A)SL%5*+_P!U.-*I
MV6!4L2R5'G@KE62CFZ1P""EYT2ZN#:#L%M05@)[J#8])S):-Y<<4K!1S%TXY
MR*<X)''5+<HZZFAZ2S$1;5^<ZY+ ()4Z8_U(.M3E%NLG&+0>U<,KC46>XXA4
MG%+TZYQ2=N0=V^8WHBGZ2*&I3A%?X[7)*VZ3!T\@3BRZ3FO.-4]<7!7+[#UG
M'BY)R:MEEAQS6YP]5."="L&;(RRN168LYZ^?\M1&SB=*ZY@G+%[!F!)DQ-9?
M(*>$9+"O>MM0'()=ATL30O;)2:DA"?9*]2Q-<CFK-%TCQY2VT/1S9O<B@B,9
M4A6+7&\8O-DAN*!IM;$]N"#$'&%!N:%$$TTMB;U3G,6U)NV%R)4;,WHC[1<1
MQ)B?G-Q($JWMXUMF;X>"=?-N0?)FVX9^V*Z**HH4CBV8[?1=(KB]R3<D'S*A
MI@WY%47LMMM" [!E+R0)84<Q?MV07*%2A*DVVL]NHXE&^5BT@2*%!.%(0)%%
MARV?:8VTT9:ILS?]TRY%#49S%INMP0G?,GY2]R6.QH7YH+.+V[,ZDW(F*E8$
MDJ+N+-96SF5W5/379WMP_D3:N[M6TIL+"HP8&G;]GG1)1D%D1-;FN.O6=LY]
M:6Y\WJ/D4J<WO&=!$4<>4SH864*!9YV^:4L5]2AJ&JVF-N2VCNA+U/X7(+DU
M0P[0,69L-=+!BP-!V3%=$$SFTW/-FIQUAAFG&S(XMTFX2UV+9/6K<.F>Q!Y*
M&/QABSYJSFZ6V=F!8\:XI,\)63DC+N16W?4!QY&4^X<[CLV>C"7E*5(Q.#VS
M)_:9SX_48.BD9,T9$Q(_;M[6>D_&4KD8X;&95KCD,EI=DSS5L\Y2:MYO[<7W
MITJKFD%><J9ZNV;\J6]:JFGZV&U!_H[Y2H:TDCFDFQ)Z:CR2Y\\I8UOD4*2F
M.E1EUBL[_P!'?*7&&3M<[%M]#.N4RFAKR'N]2@Q+2V;D"/*IE]H_)MCC$Y]+
MG$JL4?H[Y2H0E/%P3](-AG'*?M[+<V]/@3-2G&-Z? IBE;S..4^O:7A/%Q4%
M(/H[Y2H;"ESB$J*)@:/R;9$Q(LV;D"(RINA0]WJKF*MG7*;51FT[7*_;A]'?
M*7#6D9=8DV^J;6^10VJ816H\DI?/3I4D<TK.)^COE*A+4_6PIH/:LWY4=FU;
M(@KSDL/3@&XOO455-MGG*13ON53I=503CZ.^4J&SINO*6IY=,^Y1=V]05MS]
M$]59SJ#O*54ZW+-^5#=ME"3Y;3(WWZ.^4J&LI"Y]);%1&J\CYE4-,VL<C)64
MATR/.D5K9^COE*@G)ZM^$;KLLYY3J-EL"%O$2DV+FVI_1^5;%-"Y/K3,.;3-
MP"J$7Z.^4J&\)VN2;)92SKE,"&\MV?.FZGN3;^]=3U#NF;\J.[;+*GJWG=%/
MH[Y2H:ZE+D4H+IL:7R7Y@VI"V'D+)BH.C11VBL94YMMY'D]*UPK>(MV=XDM/
M#S6?02_4AN1:5E)7FGA2<6@#_B(I#G+H\+"44Q2-^"TXU%UR*)/;;885WO\
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M'G8. = ]GEM=<VXRJ]S7'@A9%9>>$]@4C'S)KZFRS.2Y$5Z23C"5KF85!O\
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M&,T,F;JAQ(P5S@]K9]C.#;[DGF[4/[;?EO$$54@8IM2348 Y1BD,5(\YRS8
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MN%5PS6CILHX#8V$?QRYK5>/Q\$>P)?S?+^RW'8K#\E'AR:[@[/&YR+D4B6'
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MFX]?HF<K=W(L;7T4N/R=G]RS2S*Q%7S!N8QII^M&;9AG2U9Q0 X^C\EQ:P#
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MP6T?]G'_V@ ( 0("!C\ _P"H3;Q2_$[_ $X\./Q._$[_ .G3'A[A_P"G_O\
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M*1[BC$M!,@O0<NI#8MY*8B]3B3(U629+U);+CQ^?\'9YO'M\Q*:3L3K(O/\
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M>7!E1S12 _ :1P+)1):=7SBTIS)>&^'OFEO6E7W!0'E+:,6RNEY+/O>)^/\
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MZ#2.=Y^;O.VL#^;_ /S_ ([S]85']><YWO/O8!]><[^UWO/K_P W._'$(O\
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MS!8^8YW-BVG03-B?D1OHW*>!.RX\N1&;^J>>FNI?;C.=2XXCFAB,X-UR0O-
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M1XB?W2-C!,VNV5"T1L?LMB\=[C0O'H[+LFKN-NS9LXA>(USIP@+E6O9X@,N
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MM7)1D26'S4>S+DI5&57"_5O[["H ^G(.;'&SSA1VM'+IS*\UK)IC-]2VXS2
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M.N(LEP;QI:6N2?B3:E9E7I@*D6416E &*-=(Y;>V+-K-\H(BSTJY2I\"NTT
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M+!DU UJB;1*AUB#5MAG.>>H' -,SX/G,$$4$4494:0:@C)QX_(%O/2BR90:
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MU2@BB[$WQ".M!I1.XIG\LQ&:$94I$%]Z4MV&A:DLJ0E:N=4/<Q*E/"UQD0'
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M;9X7?ZI<-OG'$M) 5^MX1KMOEV&@T6YLI?Y3Z1*$DM&HVGZ57*790UTL@D\
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M*HEJ!P^JYTJ()Q%^]GBGE,#JN0Q^Y(EV>_6-NH\IWU5YFRL)B7BAYO6-G-B
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M0D T(>GBN%A[SH^;)4II2'OE+]FE(_\  K715JGY-;+&:I=Y!Y8.J5L*TO-
M6^99BR;7$X>IQ*[WBKC8%BX"B*<>',"91%QIYP?U7=O@V#QWFTJ58*EJ![6H
MKW*(3K>G%LPS7.K9L(EE+1[D8Q _^S3&%MS9\>$V:F=F./(0CVNO92/K7B77
MI6%ZG7O) U4[P>Y26)+%5Q:GQM$;N0^@QB,*T/\ ;E>*VRAR'(GB2K:XK$Q]
M;;G>\9I3E?\ %POH5@UP8V)\??F#<PCRM8H<)N\4 V3D3[*=97G=="0WB41R
M$;6U)=&&^);9<Z].8CLQ8^%UP(O/HP#5\QY>Z_60UH."KO%"D7-0J=)]BB;E
M&GFQ,2,R=1\\?/+A^\XI+\%KO(DB/GM*9?@(!-P7FJP&0[#;JX8M7:TB,XF'
MQ;"0  _.A0^)[SD:+,?:;]J'5I4=:;QG-F&[-]WN'$1ZB&C<GMU,F.-UIE7R
M(K?R(P0V)C38[37L;;F-)?YSYOJOLFZC\GSZ%:Y;8!IX[&J@9J=Q-6>#R*\I
MA:(G$Q'A#U='*9<:XAQ/1T7\_P#U9GV1@-8"BJ\$A*DKAB D"*+&1539;\^8
MJ/!A-,QF52ITIUYSJ4\][KBE=]5*[W_,"WSG\JS^5*O[SK]V<F5,+,Y:G'YP
M\I)X<;E0WFB+<PH*C2GD.)4AZ4REY?%.?NO@'.K&9TT#/K1TI9P1$6#A1"(P
M\:KB:<3)QY[3:9G)$NHMMBN^Y?4\&L,QD\XRPRA#VCA\^JHV\/QB,55EAB(K
M!%MLS->(FW(RT(XU#EG9SZG9S[24/S5]YU];GIST&9Y4,MJ/  Z(1BNN%P8H
MJ3+K-UO[GGYIJ=(A>Z?-L%94J#-5U*4OQ7%M=3\M74]6+)YG294!;"XWTZJX
M,;XAERXP]#6AEQF.VZQ[KZ.8->J%)[]J,HE>OSD\7Q-9/8SGARMHN$Z^M5XS
M6QY0$Q;";"8I(M&#SFGQT;I".CB'V&VTQG><Y[F^^GQ,,6&A4\X6(0GQT\F6
MKHDA/F#Y0,O69,*5*E177WXDBNGYT%;:E=2J),>:[SV.+3VGFC-$JI,KGT5R
M%29LP+!?>J\)R0$F]B!O>SU,**B=6ATAMM/.(;D0([J.)<9;4EF^AZ+6Q%P9
MAE8'#XH:R.G.QC9.:9*)E]A<8:G.2RI.5(ZX\EQQ+LIY25<ZZY[KB#=Q+-4B
M- .0[-<1T>J"H<4[81\\D5AFI342.QQLFR5-3I7SFOEK5*GRGN]ZY)?4Y-?'
M9I1X#A(.?KI!4.M"8W)U>M4<#$L8&8AF*A$D*9BU8:T_$7SL=;<".GJ/1I'$
MI'%\QH\V*T^B5&2NMBVWH,UJO!:DP0&RV8S4L83C5>MCQ[4F.MI]J'!890M*
M&D<2Y4NY-G::N]!C#7*^W3P+0?L"%6B--AQ.#VX*8R6(E4,2QS2>)Y\N')<:
M3Z(6KG;)6[!D%$-UVWF(-@LH$L!B$ Q<T/B2H#)*4+E)=@_5/PI\EJ2I*$_6
M-RY"7_F<?>]]$+G\QHI0IE_(J,Z(2JP(7,I4>$\-E0X-;?Y$XL4,BS D&0W$
M:]L9,B#&=XW\R.RI!+&W0+%NIMB*6^P7-NY119:;>K/?[64O-SM-M5&'#X!*
MP6&VF9$]Z0B.U[9"DJ;XCV(XE@%/RNC.#(L&*,AL,UX?"=A0(9U^T1XL&;"9
MCSH32+%*>F]^4XCJI3SCBO53B^J&VZSYW3[!91 E8(:9, 1Y&;#$JCE8:8;2
MY3+J?9'AGR#+*N\ZMADA+0WU*)+_ !Q->MN5T0\#28'V#@N?6QCD/ID77(%-
MA3U-)CHXMYNGBXXA7KZI=%,IB+XJ/SY?PQ>H67T&)=(MLL=\C6R/4P;-B8NU
MPJXZD6NVM&&X29[=CLE-$114Z;QSDB4.C-1W%J:0E/+C.+8UFA:7H$F',NCQ
M6F@B2K)('V$?;HBRG)L)]+Z6;>*CE_;Z<0HLRF8KG9/\+\6 ]^J;/W#=JF$)
M]A+2*J(E$"LDLHPX4[)ER8KK_P DC(L1%Y]I*DM.R"$IY2>NR'EKG1"N%Y:0
M8)'E6>7R730C[BC:UE5N3&7W(BGXB7OM\BE;+*D,+02F(4CJ9<CC@>[,T2LQ
M;: DV"8*L$(7'@DH\FURY)"Q/.OPTL=F++D9CTE[Y_S.=DNK=YZ.*4KI.[A\
MSI(^XF2KIPC9X]<&)./E9"BKLB8DGV/V7'<DR3T]]WC2D)<DSY+RN==D/+7!
MT6OY70@UZ%5R-4!5K&U<1$-B:Q$'#PS(05.9BH=&#_L</#AJ0QUOCD2%'97[
MFV&DHK!29D>>OSZ9'LD.K/JJH?GV)$N#A!^SQ8;2(J64QS4DM*>?0I*DJ?DN
MN>G%N+5VI6IW+:)VQ4,@3*TXNFM"VYE>)F?D=)3QJVXZ.,S)+D9MSYGIU27F
MTN)[QSG%?#$K/,UHM'DQJF'H<>14ZJ% /,4FO&+'80-1:=%PHRVZT%/6\K,B
MPN=Y&CRB4EU"$K?<ZJ=%$93G\",2L*;7.CL50-QF38D3#!%DLMI412/JXTZP
MSW6>\YSC*YK_ %'$_-<]PW/8V?59=(#S7"(NKSA,8F'@37.RN]DQ89),MMEU
M"9KJ&^\]/EMKZA'M1^Y^(=MEYE2G[% 'R!<8HNOC_G<@R:[RH.,NM\9Y'D]3
M4^=%MK=0M;0Y:XR%)96M"@-/*8GFA&K5@NLZ# SJB'E#(1=T:R'DSNQGXJT2
MG9HJ,U&D<>^8F0RRVAWBTMHXDA+YE-(Z\5N!B_S^+!1%L2+E8@!"JV.P]B+0
MJ*W/L==+2H9'J$)3/9DN\?XY\Q?J5ME<RZC!K(;.1K*2-0*X-8GO'H;9=N,4
M;?2Q[HDMKM@(+]6?E\Z]/DN]YUQ]U2^VVI9G3Z[9/5KC1D0&BPIL1A@;)$M0
M!SC*$\&"4P9CJ?HX_&HO5KZYUOYG??\ YB71L]@DB5H6.R/+ 9MN="=(@_:5
M1/8EY YMXXX$-%$RE6'0IL+RON.S5H@)(3^#(@<(X0E.]E<@*2Z;R-7C'CS^
M[YYY2>.OB]IX%WR)MW,S8E^7XJN$O'S3Z#?8_C^]8+'4^.%9T>TCB=?"&13H
MWJHC,]F1'><\MJT4R^O4RM>,6GZ+D+$J#8-(-'[?9LML9.M6 NX0-8[4<JC@
MC,D8I^"P)LYPI#9<0DE&AN*]G.^16B>*10/DU?)XHUHY?.+G<+P>J SR?R\S
M8\$<@U"RX[GEGM4B;LT(9G1R?$B_==HM8X) 48+08Y?HWPWA7#QK%&]=\F*W
M?2]IR@1IQXJ5KETSBB5BX%<,RJ53LINLC7M<MA2QK"UWCD4$#G3X:ERI\&.Z
MEU!8C+PR[=-4ND><MOT>HJFF1A"M$?$K8ZEC-(I@:T':.+SFZV'9;#=QZ9JQ
MAJ1"ISJW$3GGFVEO?$3+MR\9!HW1:EY,8EDN\+S'8I%]H6<83N.(:%M$3R6K
MI\GF%0LES&9>SG)*#;*Z^&$D8<:!**1'9<!#*WJ+D0S&:W2ZV>P*E;>>LDB[
MZ!<R*V[\;W0*'%5*94,5F9:H?"_4TW(7+L-HKSY%@KSHV++['[\W=[MB$6O>
M1][PV#<AQ7*,^TBAQ"[NFU(-TJYEMGL)0Q]AYY9.]=8^L05ZW(@L.\=['<5U
M#3F)^30.FU&SZ;JF?^.&CV_!(FERC5GQBJ>1E*G6ZNVFV@*%1;KM%CJ:YHMX
M4.DA:3,E%)'?JOIF($8A)AR&%^/+G1-A0C-,N>CZR#-$+#Y1Q*'XS7HYF%H<
MKU<*U,%F<!/E**@,W(:7-IDR0)5?!Z6E#E3 %M51 93RJ-;G.\9YWBV&OTRS
MEZSJ87:=)Q$Y;3#U(H]LU2=AZ2V1'BPTV+I) F8'1VF8XWZUU;#)^L<R$99@
MQ.@L$<-LM4TF3.9VNXR:5XZ6L):P[!&A"H0[Q=T AY)01=<OK4N=)F3*Z81)
M#Q76&V5CK2_1 9/RNF[].\69GBP!O\^T%0^NB-UO6"$[/)DU"B6+4RF(N&\V
M+EAQL;29Q,J.:;88&=GK7&:.B)&4#+/7)V8(L&,V>E:)-))VJYNYMA-^$62N
M13%! PXGB]>">]1@ 2^)F2YCA>O%V9@2(N.EM7BA4#N @H/-[\@=[\3]#4&T
MX^0D9EMGCG;],I>AEP1TUDU:S"WY<HGFW'1*2-DKUW/1RS71U<DNPYC2/\U]
M'TK2_& "[+_$3D:QA?D>?)H[;'=-%^(Y*V8]2JX?KO79D27]ZXT=Q@=P>U!Z
MRMYA<Y[KK#3K=B\>,VJ(HE9<RUVO^4]C&62R:!;KT1VK&K  "P]+L%^N%IL-
MZOUJR"TA!@*3PF2G(%O0XX[K?R64,IT*S9?]^017?+9H]RV 1%F[I:\\#7DW
MHTNM7RQ6FFR3=DR+++;H&I/-P'GAT0?.-SY49*OFMK;5PW7LSPBP7_(-+U+P
MZQJX#P;VMZ!*BR 1>A73QK"SK!?+;,L%=RK NVP:5;#P9S(>J\DR6?HFG79;
M"\WVBQ]>=TG%P&NE<>LY^J7X49AY[;<[Y:- OE'&_0,-6;/;_G]$Z] +\CR8
MA),#K<)?7_5"LQKG_A_1=,AGN^:^=+M[%6TD_1(5>WP =V7RY:##4BS,#5*=
MHA\%-:M3[2GAP65%D(^8SQE;/Q2J16\P7:8?"NJ;,]I(LO=]['P-)%YG5?&2
M=7=$O1NX7FVV[2;=D^XQ*=6JX164=Z)FMPX<=A'TW.T@UD@>T8X;RW-*5A!1
M;9KR$J]!S&JY_$UB)F^6^00HI9$YHJW5KDJTMA6K:Q/,1G)/'&'4\E0''H-W
MJ(,U=:EJ&[5SQ\N4.C5#KA<)>M&D#Q4TKI<",J%-%"!@,S%(%"#BG'F1DAI[
MT5[D\^,5PJ%3*^8PG.(]9I^:%*E:+A4;MG-ASFE52%XQ5G*[%4RPK5Y!74LT
MTN8FHS(!J,[/!NS4=6['DRT\TZ_YKX_5O0X1/!*WG:XM6':/7,OL^=,53%Y'
MW)R\W'9<SX?JPG*(%2GN+JT=%MD1*Y 87(Z\*;1# ^.YRK*#9'366R[Z6 FP
M5H]CEFJEKOYP._==2&+&ZOF>QFKR+M#\%V86C6@R5?G*XMYXCWZL+63M*@AI
MFB9'7O%@9F^A-:=6FLVPQ^?G%=HU8 Y=;#$*#@-(O1^94$C"P,:%6;*J&R%2
M7947CL>^>(=OQ"]US/\ ![D,@QF!]8U%5F5,K($)Y#'MPHVH4XO(V-$7/9NH
M?:9R[\*1B+9@L^I<IY^?WLAG,++A1DY7[/XBYADM+*AA^BZ'B;.':OH C(\]
MQ#&0(0^=KE!-W0_71DQY^M#!3DIJ'$(S)ZEQVWF\K=9IAKISQIT>PU6@U)<C
M:] "9[H%< 672;+M]KHO3]HI,NYC*KJA@_(TRRQ)%DXR5EO=)_/ZZGC1(K9K
M+P1(+709',CJ#<S8EZ+GMV#9E;+!V>%"D&(M>':58H %$A_K2I)*6VEE#C:O
MF<SW/0P"ZEY>CVSE*BR1M7/_ %6?6./GM\OY,9LPDJ($2,YFPTYV1&\94N:\
MD@RI$A,;B>=4D"_9["4LW(]XFR:K7J%=#UE'#LRM1>H:,0*!QH-^4.C4DF"D
MN3N.\2YR&EM]I#C;['7:59TW62>%Z2=Y6L\[4JO:K5)NQE=Z%9PQ&KD8$&FK
MG,2;4;C-M2?W,1<5?9?'?I4+>21JECLQ'EP@6AZDM5 96+&6LIBX?=FK6T96
MP(N ,>>+E+*'N8[HI+/N00>>6TRI2V)"6K9Q;EG$TNDUFM7(SI!ZKV.'52@*
MP436+S.AT_@X.8*GKC3&,>+1381^/!GPI##K24NR&E1U4\.@I<FRUML\6F21
MKF<7E<V@6DG?6\P!!-8CQP3[N83+'?'DCH'VSR(B0M7S>*Y']7?@S0;M8) D
MR%*S6"<D<"MAP)6Z]"EU,)]Z;Y88]:C@:8.?M5QAC6_G2G4K>>;6E:D?-^2"
M$I%:CT-::!5+[6+DSF]DFUVP??[6X6,T.JC/LZ+,+.VFWVPE'7$95%0PW$=^
M9(=8ZVZAO/QH>TEK*?U,0-L.?U>MTVW&+/9Z_.,&0LTZ."10JIJA5:D5^8Z8
M=4E/!<9I+LCV(>8Z[633PF^!I=T&6\C4\ZD4RSEMH.,T+1[]GEK(P<SK@4Q+
MDUP9S/I13LYF6ZK@YUI;C+:G6./$FX%V*FF8QMFK R8FH69X'?;>N;7A\NIY
MV??&1@MS-AY=M&)G)AOK9B?6)ZXYSV/?+R-\Z%F\J^GWR'0"%E?>X/;H9$Y6
M#YNL3[&/DQ^O('&#05H0XOJVOHYDYE3G\'[^I*7R93-0D6$6$?.)S2L5.=9K
M2:XR<!19%<K,YIJ!7;%>@=2MX:P&0L66N8('$?X;G5QY/&O(*Q4.P#[\=\>:
M':= L56ASE#GC82IRK8$)3@4WL2>X0%1[C1#()Z3'CR/E%ADB/[%.)1Q<6MP
MK =&V^3:P5(<I5BI5NK]Q@6>PRC\:"-)5PJ&C$H7([=;D2);ZT?30XBF7WW$
M-R&5+\TGXN&6JP3_ !!'4XU'%L6^FCW]<K]IH4"\RK !DRIJH=5&@&U3V'D$
M5_6N\&.N-Q^]<8;<R*E.5>.@/IEJ,U@CHU],6+/\_K+XR#0IHYF/8F*#;AYD
MK<%WU$0,A]P:.F$8$J)V>W(;]G=]Z[GDX08QK$M"WX;4W+7 D6HK2L[M6@T@
MF#T44X)A)Q[1G[)GSO.AICA#Y$28TXM_YS4J-'\; AW*IXH1O^H;#D[^CUZ[
MA[CEM<,9C6X!L!:ZQ;HPL6YI>9Z26)-!(!V'$B1HIGO67T\1SYG=<WB'GUFK
MHG+[=O%?BUHM,'*/6T-C!H]"$VF$EOV1Q473 (F.6&QY"OFL1"#/'N\5[N<\
M1GZWE.?&@OE3#LD]1ZN;N\<'YPU6*7&T&? )*_5- 58S?*^\N.J/&^2VT7:5
M'<=2QZ3/@W52EBL;I858YE'&)$T.Y'(MXT068#U\WF^<RA 6:U>;W7C1^)'(
M#A_7G8:EN]=]J(DU4:NZ%1R?VO5K3 ^O%3>QY$-_VH>>B2X<V#,;9F#R8V?&
M=C2HSR$/1Y+*VUIXI/>?Y@>016SE;MEQ4-;]6JT^,4OA;HVNQ+%>:4"UR_Y0
M 8E'A-'$[+?;-"@&EMQV'R#[LCBFFT/R%.7N-7=%"5/$]08EY@<IQ.;=!%:1
M"M%+6:L)8*-*"X=J%5JW4Z9TK/LR'?L9QGW34S&_X1WHGQ9K6:/?:=BJM/T\
MQ?+EKZ1$\^7CZ19M-KWW6I\\O#-:.7"77)&9QEL.B,Q @N1D.)['6XCF.X0>
MI1>\T?0?(@.1N>CU,Z#H9T1M^M[S$O82U5ZFK+R[*>C/Z;9NK4)'.3>BZI!>
M;=^IB1UM+N]I?P+:)-0K$ZA'8DN/N/!U]YXBZG#T7(:(YE!9%J8.C\S/Q6#@
M&%FT&9$(J5+8ZCGU+L5Q.I>/0>@:0H/2\^L=N@3G;64A8@+G:\NZX_M=+QP'
M$/,RPY*'Q#JK#]+&;$Q2Y9?TBTD43^-#L+L%6?%7VC[#G&&!*_3[R$IEK.$=
MVI6>749I*!PVRB[0<9IJZJ((H+N-K+Q"U83(BJ5\A75W*1-N%</52QVZJE=9
M-WVQ7-4FVZ$"/:,*BE]/[84P7'[0Z;&G8A;DMEGVHAM,26VV68:$TRNP-0FG
M<K8T:8BJ6.8=L,>TA-%Q=LQH,VJDYO1@\\!L%/ 9Y.1($EH[,N2,B.QWVW^/
M*2[FV:4ZX*.10QJ-9?';B"%P&KK#I6.TS536%DR0B +/ :0WE*X PC%Z5BA7
M(;T!U]#CRV'/)?;C>N%] SBCR@YO0I$\E>QF:91]GXODK3A(:Q&9B R%_D42
MECII(H,0HHF(6[&?0CZCO'C+Q.P&9%A.D3DZ^T 9%V=J;;[I9M$NX@)"T+.X
M0/ILEJ0*^V(XFI")<5!R)SW.CXJHT..N/1]/KNA#8>LV2-1H8XR(*6/YMKIY
M.O!>4,!:U3QTN!#H$V10F>1.R>PHW;(-F1./<)(GQOB$>G6FZ2KCO5"9TYON
M>F]2BO'LCF4D95#10VU4X;B:IG6G4NO#1TU)'Z",:>$1.1_6?&2M.0WJ'=6G
MC0&H5&-G(2CP=*9%S0%:UB;6<YKLFCU8)V/)-UO6*H2@A@C\5!-,F)/:1&6T
MP_QO(-'+55ZCT'R)SRRS8L6SW^U'+$FHV'/JMCHNJ" =>1.(6E+M$+BPD1N&
MVF=&XZTXKKLQQQWM=V0U"N=\ ^7)ZQ5ZV:LZ:T<H4@1,<"3-5ABC52'Q4VR(
MS1I.#<'.L)&-$1;8UULDOY;+W.$+,[?)@71Q>I478GVJK,TL\<L5JTBLZFBI
MDJ[7P \X]>*;?:O:[*VI :/,%2$>O%=2ZPS\N?0QADS?+_Y5ZAI>S&-+R*79
MLT'5$(-\>LL#+S]-G&2W85A8MV-3:_\ >"$/F\F2II-!:3%AO.15LV?::B4=
MN)+(JWE^Q4S+Z]>KB/JU,#Z"]8;MGJ<YISCT:G5 1?"F4EB3["(_&42!,E,A
M+"4K:Z3T:^Z*+J.D:G4@U8<L[AB]4&V /_#I>;A8*X75 EQ1R\TT>E7?[38A
MS9\6 7(JC)'I^K9:;C<"V0.6(+I!A58\>VHQ(MIU6C$;:5KUTDUN191!I@*<
M;OEJJFVEI#9\BVVX5AV!N3\]WCL5WXS"PY_O**=]9L8'1SH8$/T6(SO^C-7^
M@WNMT^1;RA"'3+*U6+L>"3I %B'/G@T$5+7]"Q(>[U.AE9KIOODJ=>I8F56I
M^DES-Y.5RWCK+/;K=<JO)9V(FJV7-FILZ?&B,QAK$!;LEYJ-U:E55BFB;MJ%
MW#:X7'Z.53?#PDB)U27M6"G![^IUTM]C?;,AJR7H?8 SC<1$%^- DJ9Z]R2Y
MU9..8O-USS4,W&5VYUN3!M^J.6C/:":T3@F#3\B8BQB<== LEXU=L21 AF9O
M):B\2++;[QJ EC#:IG+]Q,7K3+7.%4.WYM<;]5+#D56V)G<-GL V%;V6H4>D
MP;+* 6-I^L.OQCJ8J^(3';9@1_IY& 1JY?LP"#+IY&Y7.LD&-H-/ #;?/*^/
ME0U.FQNN#IHB1G.B1].!1NF7/:!CN-]:^?'DR65.V?QAM>M,6/*Y_#F?EJD-
M-Z>5-":]1F$GR/V><K,9ZW",ZHHJO]6FQ-24AX<0>[U4_P!&'U)OE"N%0MXU
MJZ^/TS3+-:@I>\-T^N$-4O%3Q8$G&:M4!))2]WU0I6HC'S@/6C+G!K'([3[D
M^1\S8<DAAS<K -<!6>&2.L6 F0K]C:N8W-R)VLYS6JM%:TR!<-$O7D--9<%#
M4=-ILL>9\EEE[B&V\;VP1NT(M.J0+RACTZ59)5Z.WBV7HE4*/H7D!:;O<S4I
M^98)=*R*JBVF1DN RX,8X\EM:W4_3L:AGUJHNB'K%Y*#O'^G;.L8"TE, I2-
ME1IV24!P"_ '25$+#%[4)\*2' H0;]93+ORU+2YUH3D3>V3;W)F/L:>K*!M]
MLL2FWD*,KM#E.U,N%4B,"MM<K\)X*5*5?CKCL%TE\XA&0W.=2[MQ.^Z5'G&=
M>I-B [#8+'8[K;D)HY&%)(+RFIZ-! #A'&X072?JH%?".),?*()<2R[UI"V]
M!R[="-RA-#Y>CX)(#7 =L-8A,AC&,8GH>DP*"^.@PW15,K]%B5N;-+L*C,AB
MBWE=D,2)*NO;X'<.64O!^[6Y6#9\QHL'2+NMJ/ &LF]0(3Z[6X)!%9(R!<]@
M>.?<=@1W&^)B0%^K3B49$(,Z'9G9^*D2C>4$=&N=_N1O/JS=ZC3*1&3IY&4)
MCQLS%+A7.""AQ[>MA#4Y:4-R'):U>E1N57M9.QWNX:8W>\RI7S-58B#]&.00
M&HG-6HF>RA4-P&.O82'%(EK(B.D!/AN2NJD<3*(?.%42D#G!-8"N%71T!V;.
M(K8<-&"!XBI4PC(E3'?GE"C[G/>XKV\7[4^B><YS_E],8J?U9R00LEQLMV*1
MKRJ 4TIV[:G6MA(B+I)@BXZ5 (%QIPWD.,,0-XP.C=@]4N*_):>K9SC-F'G:
MK&IPP4700$FWON_3J.O.DUN7 MX*RA98>R5-2&"?%1?J'G66WVG67T<<^*W:
MY=YN@,M08T@IG :,Z%)9_4].BBK"-I^N/4PD(=0?MM)58W78;$F7]EN];;^?
M&<4VA:<)TJPZ;JSMOP,3-@ %CSH2#6K.3-Q0H^SVBXT]VN30!"S'A(IZ!]:P
MU&D#QY2>Q!7&3+>ZJL2 5UVFMJI>BA]"JD<9?8\L<$;J4"U0\\S]H180!P3/
MS/,)=Y,$:\)F,24CBT]4WCBI#,5R/+V7,ZM,S:\D0358)R:87EC1!&ONZ@4V
M&P#)%>?[,"MHN=[-291=YEEJ3+X\I/S4>Y7>WF5:AMA7*T/0*/IEAFB+29 D
M4VK.Z; HE6D""@>3#)A(L, /3Q349YOBWG'5][ZNK]8(TV-M]FC1P^ZA2;1F
MS=:@V1GR&Y7EWR4< A( >M*F#YE98E >Q845L!,<??@H9=?=6JG8='/NJ!#-
MDSS4[7;S8X4Q?"ZZ/?X&D3)(LE2!M-#P+=9B86.+F3UPEH?"RIC+[3ZGN]ZW
M,$GM3KI #/5)RR> N;8Z1AHV59S-L-5K(D(#KBU^NV$B?DLRV9;9!S[/XQ#9
M<9C1(;3&M>,V:ESU1":J'+0)-A-%"MN+B2!:M JHX9CRYI&(2<FL#*]'<0OD
ME#G)?.O^_P"8KO>V%R$6T>/=++?:QJY#4.6Y+U^1J=1GVF0&T"+*DBWZXV;X
M)M\L1(84-6,E!N-Q'8JVT]]ULJ-&F'ZL6T2C5[&KM<B=B.&+ _CL*]![^7#C
M);<J));L[-L;-'1,];OK"LEH+3U\=Y,=85)(3YUWI[!;+U8S: V<VE^FA;;F
M\65.(UNN&80^,I45NEE2DN0*?'+@2&4S)$9UQZ%(>BN/AADR]#2KEJ!7V'<Q
M]@A0[,%OM>T'1-*@V\ S'"HJH4@NP:J=:<B1QB!2ATWL/D1,=#:$^/U698MK
M@WQHC0XV:.RK>8E$>]AS*T0Y*M1!]U<FTS94VJQ77W975*=7UWO?_6*^*R(=
MBG_HJE8=GLX=*+!.2M)7>F[XUH2Y:_=_UN/(3HY/Z-M?JF'U376__5)^ ]_K
M/WZ>-UR,!'UMLW<9Q6(%%5YH_P A"TK>:22,Q%2;-+>]2DF>\S[FV([C,1AF
M,W4=#I;]\@R*1".) 51^X3)%*;L-IIU6H=KO) )UA#I>XV2M4R U)DRGW64O
M(=?99:?DR7'C!=D':FYIJO\ D'4W^HN)A+$2L>2=Z$Z'=Z^,B\<Y'@"*W8AC
MO*LPVGC=8BDI[$#C3<Q[BK-;WH-ABE+S^LAN^)9(CYC%PB:8LG()1)SIH.5(
M!>UZ<9EOAI09\9/'KD*3Q]37HWS9\: %IU8@^0,^@L:,=DD"\TG$ 5(-0:9,
M>J+L2;!?#V95'S^,S!D<=XVP2[]8XESO%-KDV-N;?P:HA\K=:"% VAJ!7L@T
M4Z[7WC6BY8+6*D)KUG(.UMGORWU3!C"7YB&(C3<Z8E_$*A73.C5^7X^DS!+/
M;W N+TG04HM:YRKV,/V,S#*<.B[\V1=24;>8]RN\;=CJCOL,.MN$!2;[,G+.
MU8XF46NDZ2\A5(F4B74H#JF&(GVBP(1GHUI<F7]02()2ZN=*E/O..J+[3+5<
MY5L*V.+;$QI%KENB!AYD[DMBE2!J%LJ+<'D"6)5_O1S\Q\9#0S(3"CQ?K9?S
MJ?H0*9H$"53;$W<F*VW<97W1/72*.T0(*MEJ$]C?4&RX4#IY.%&XN0F-QA$3
MKC+CL.,XWI)XG]\G_P!:$\F4-AOO7-2#%SSY+)S-GD5R&EOCHS[SF,5 R9B%
M.NM_,9>XTEI$AU"B@2/$LB@TP1K]9%CT%!XWE:J&W!V@MSJ0F<$#BBQ -'BM
M>X6LM()31JU=XS(2CT1Q! D]:Q1N#4<\J=?/@COTQ.J*RFYKOU M%=3.AD1T
M6W5^R.+7R6['>3)C..1I#;L9UUI<,<+9O P@))(LP*T1[C-D64%H2)5+)_K/
M'2R3$^$J^.G*0Q.=E2([\=Y^9.2XPIB6ZST9,E K7*FCYV&EY,N1<S2WCQ[!
M;]==' V"P\XZEHH8O5@OY!JW.J3SED&_(@RTJB1V6D5O6SLFU)L58Y2EQ1HZ
MQ28-:GR\Z-VL_2R!8.VWU,N:"FWDNE'4N(0\S.6AY+G$-?+F'<RB&1[,YLM)
M>"E9 DY!1:+&H7][+Q'+$0KUPC6BVLA8K9'V%.0)"6>*^E2YZKZSGM?D7D$,
MAE[H='E&+*V7,02.@9H]DEF6GEH&'PT^/+I$EV.AB9#DL-.N=>2CCO$J2<AO
MJOI(2>H)/.I(<O>3!6-'"&\KH6.')T>;.4^;=L9>F9@"^=/D2WY')\#DQ'42
M'7EN6J8W;]A+SM+'Z$+V>:<OO9KVUP-%$R \N/H3;0F+%[RJQIC_ $ H0V)4
M(^>XAGO&5J:Z48-3]*)P[C'%P-9@2KJ]V%MHL&W7.@Q6H,-P&_M2()EUII]G
ML#HU[O9,ME;BXLIZ.L1WAK21*1;60(>Z%N3L&>4<P@.7$9A,?/\ 8+UF$$ 7
M33TB1($S1SQ5SO69ZI,1;L9P<.7.G%%P(,2$LF4<9>)D518[;"IQ%V.Q%CNS
MI?6_F/*;:;0IQ7>I2GGISG_+Z[98Q&M"D"^>6C=SK_:<,GVJA$_#O6:QA=\
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MM2WAL^R/,+0PJ3QIGBT*2M:>I[S@5XIIU @MV217HE=5)MX!OI^3;9!6+5V
MB>S_ 'EG;%( STPN1^.=E=@R/E^[Y#OL.&LYOU0OPRN27(1F;3K&'L$6!-;A
M-$4QI$H?->BLK?@/H>:4I:4.-+2M*NH[[OB\@Z/:(1FQYBW3OUBUZ.ZP]/IT
MR^4H7H-9'%)<5Z2$DR9]6,,2.+ARY4;GNZGYO>I5Z#Z@!O\ 4)-[G5J!;'*
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M$Z/+*BJI?(PBS=TJN72HZ^Y1$&=CIH:OZ+?]);A1+*=MI*L%+R@EIIF Q8)
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MTK+,/5NQ_JJKK[M-C=JD6;$9Y$0Y\B=]%[W>\4\OXC-2?QEILN2TPRW(E_\
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M3U5Y-==;7];#2J0W\KT3ST5WXHB/&?S%>\2':_+L#UV>9\?\TW;]8,4C%&M
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MDF9B537><^3].AMA.*[)=]@\C+_7/'(W2KGAGCM:[U5'?'W--)H&3-XW7-+
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M6B-QR<V8UQU]]Q?>][/OF042)193N09U@X*L@7%#Z)1LLS$]=[2!K%$IL1+
M2L-DK-H)$@6?8:^I*RU-.27%J9;]+1ETGQ?R!_/+KG8O);73W*I$4".9N$TV
MW[0&I\Z%Z^Q8@3K%^,V&,GGM4P6(O2$*XXKG>"/(&V>/N<%-J"UUZI1M*0&Z
M-M4RN.U@O2VA!\B*?@JM,4=5#\V!!X3Y+4/C2G$QNM>[OQ3LWH0*%5Z-GU5K
MU(IE:&)<0-KM3J@B&!KH(>AUQUU,(2'@,QVN*4I7&V^>O>]_/_D6':O5, H/
MD1Y6DM1+9_XMT^VEP53,0II;/;5=-S*5R]E8$Z=4$(PC/3B7E1>)^TYO8(]S
MU^J0GKND>(WAEXDNU4[X]>!GG?FFFM9V-I]T+W'SG\Q'/$,]89;]5%,]%3AF
M)Z%/F19##OU2B!*7'?[V.^]QRT9SI51K=^H%V"$*U<*5< H^Q5:T5XK'7$)A
M#X(M'E#2PN?&<4V\P^VMMQ/>\[SO/BV\(^/F,SN7[*0>$W?DK-JB_P MV*UE
MJ4Q7<GL?S!*OMC.P;$YY$4._[X#"'%<0USG?C.].B>&N%Z]KVUKTB_\ DI;"
M@JF5VZ5KPQS"E5.B^5>T.E9@>61OEH"Y_:JZ%9!N*;<L@WBHCC_6H2&^"_".
MK^*/C"+R@!Y)V957N]?K$5FPPCM2_"_P2_UW30T*$/\ NVU<)%#U)^A<FL^B
MDTF)'AH7\OJV_B!4:1XOX'5*J+/7&T#ZV!R:CC 46PZ'2I^:7DPT)BA&X/)]
MLS<I(KT]?6^]D@G>CU^L3T9Y-J&"Y#F^-58D19+DJ]F5, 4D.1+L"1H%HK/'
MUZ! C32: @:)$^H=2I[L>*TWU7M;3SGDKX\+Q'!'EXMC-3KUALD4!IUR\O=[
MS*5A9?R,:HV=P@&:2<V>KU?N5EE0XU<.6>.\0DR9+\5GYKR4.Y28\;/'F/*%
MR_)<@"\<Z'AWBRB-<;?Y)6#&G">TV;(:.+!B2;)C&\G/$06D6=;<"!5/HIX"
M=-1(C+@\\EXLX&#NK6PO56BZY]E8DF]O^7P4IHL+PNB,#1 8:9L&W52KZ(2:
MHLAF;$4F.T]SK#+@QU,E?AKG6!>(]H;N/D58/,^FR+\.QD'0K5XR:1D;V;Q_
M)'/]G D(\.\52WV,U5JTFP\2GK4F,/$SW'I<54-W\NF5W2:=!L;#%HF/FG3^
M,6EYC4M'RZV0\()AL](N5E,G4= IUI*PZLJ,*5+E*;)-1FOFQ'U_$;++V&>L
M%()C1P&U987P^UG0=%^SM 9S"N4G3*DFJ30].*NZL-A@18J6VEQP@[#6PCZ5
MUB0HM:':@#<7>+ Y>ONG6L-N)38R6N$Z-K-+U0A?JC"ICLB/=Q.98B:$%52%
M=(L#0<N',[QI4)N0]2__ +%PJM52G!B\&6JHQ.U1]D!DH9=>I($K+@]:+W@1
MA^CC6X(1KJYK5?-,1F4<:<ZRF=4C&1TJUYW$GYI5;/![1H\ZYM^1LXE9,NS+
M!%4.% X4CZ%5J;3S\4A%DK1]")<8A\XN--]J[/%TO <KGV/)MBO])M $A4A!
MH U;!4>NP^%X22 UM)85;\^AUJ;UN4Q[>H:B-N-]5"94@UE>U5\CHSU%M!L5
M)$/8[<[H&3=:M0(E^N];$3F*[)&&BE<QVQJ,G(\=QZ/]WGI#;_7.?.C_ !9+
M9;\_IG+/.RBK/C;-#R"3:GM-S&^LT?)!(C+D5\ 9E7>"5BWZN5N7&%,+^9$F
MPXKO%1F/1DQ4@>24H.8S&SZ"$/UN!4T%@]*?&%+/APT+93\T,@= T\_DE8BL
MF0+CKI0<)DMQ9B>1G(_7MW?">$^6"<.RO/812FZ(4M5-!5*\6'93-4H&C5:P
M!T5XS8ZC6Q87Z+[8GR&Y,>8(%MQD-\:990C,7](G4<=8:;>J#L5^)X[7YEG\
M>S>PT7-BJO'UFPZ\_5&8Z;76*"&1/KD)B1#ER5Q1\9WYJ%CHTD!Y,6@+(*95
M4A#'D-3B5RIY('81C53'D2]<NP.NV>**/B34\2M:QG'&H\F5&G)1[?;(ZA54
M*T3Q3H&*:%?[!H@_R RH4::8F9QJ&>W3)JU]U)Y\-4A\2S-)K6M,D8BV6&84
M>,ZRW'1Q#J^IRG"U8UXSN#O*;2[_ *-;2NQF(&=U2;H5,"U'DRQ\4+JY.=:M
M?N$ @Q$BR>NL2G(T-;:W7$=XW\%Q",VA78J?FTO$B>=UC&;+)N,T_E'WBL 3
M-7J@. PIHZQX$*;DDYC#B([U.'$8KCBXK9*$F2FNM%$6\*%LV<5VE4\#03EP
M<N121=CE:S(GFP$8*)+L(6+IV6D1L,LTA$&"8!K][S/L:<5Y3VWQC\0XFN:=
M7ZKC.DLDYM<KV=5WR,GWV6N\@X]<OUH'.0QYNHVJH]D&OKXT9]BP0$J=0N4S
MUQN$4W7)(UIBBPXZXELZ?"-:$0$6#[(ZDD%&1H$=Q)N5'20DCGE-)3'F17'D
M.\[&=<3V)2L_-1L\-6B$B5 TRLY,U#A8K;=+JMRS823.6<S5)5&H]](!,[+@
MF43^K2W]F<BR4\87'0\;\:,DH+T; <B\>L-'UB!;JF=KGWES[1(.D5>O0^52
MUU\3'+T<[2,]CR8<]OYK1%J:ZEYMI2/:J55'Q]3.BRV(MZ:]6>9.;E(GY1O6
MOHH<YMN#]UOENS[KLE;99*"4=^TN$XK$B4PCO&7?BI5$!X\U:ZX_KMWRS/1@
MD=ADV#]G5O5TZ-ND79M4%WFN"(KN/G3.7N61DYSZIR1,0HC)YQSG'O@[-%4+
M-=-=IQ^#<2T&ST0<[+?[J-9!&ZSH$@05@=6<K6L4T(*)#9K[;L<M$@Q'O3KD
M5OY7+#;?&2'G@OR)H(6VV.SW;,)D:ZP#)_R MV+\7J\X4%EB\YKY^\9F%EP#
M#Q2/]:1DL2'/:Y'[(1;!/CC J0ARK"ZM')PZY4XU3^U*/*(7#[A6<2AF%"^W
M*$:+Q[!T5.;]S#\E$U:?W2UJ7_DO_$3_ -^^E_O-E_9ZQ_?O\G/W]&_+^.6:
MIOFKY@6$EXHFO$6AX$-N^ZSI8RD=\E8GCCJ]J>[+' 84]!-=DM$H2.(N_5/!
MZY/?AL-N([[5&J?*P_%'MFIWF=Y6^*EHT)%ALL?QR[+\=\+JGD%2!SY6VG**
M_2+CN(.^00$)1DZB(.G#B4]MLBA# YW=O)6@E+'X]ZY*\?,ZOT&17;4#FV3+
M#=T+T)TX%AWV%%(5SLH'&.R1ZSK#3L-I/%36T];2GXY3GMHQ.^)LWG)Y/936
M_*_RSW";J'BQA69YAA=)W"CY&<\N\UK-.C^1MUOJC$Z$(,K0.?%3FR@>5]HS
MP#,<KX(5B'E=;J\/R8@^&PC;\6T!NS5C:\9MOFC4]'LU))56RD9<('HE9K#=
M':<F,Q:[U7(\GC9"8')+:&J5IS@WQV\>R'D_E'XF97+]9[H>CUUNBUCP\J%B
MHX.K4^S_ $7S)'F1L=Y3*/TD8Q_U.$+KTKVI)34+1'A^5T:F6;>+SGWB_E5W
MD ILPCTM9S)>LTZ$5N%Y+BAMB+Q*Y7G#+U@M,^+$G2HPB%-D-,O.(2A7B%G=
M;TS(0==%_BZYCXTZ[N'BA>].8Q#RSHC/B]:?*6,+QK30%I@V\?7:[,!2:_>@
M\<D0CRK '9A])NCGR@_O@Z%G^1]N\5\SUGSUS_,=MUBFZ4)QXA%S";A/D3;9
M .=IAEOZ2HBR]QIX?CC_ !V.XXXVAE+G.N>U6>V2VW.Y^1M&J('\:&U>,OD#
M<K2=S5KR;\;O#RFX=;,<T?2\XH8:L9MM4LI/L1*O1;?T8+2]&#*,#8_%F)#B
M_$+,+7X\8_#,;EEWB=MMRCB[C+!P+-0/,#0IM<A0<%M6CVJG0[19/&JHHC$+
M8UR"5D6(E(^A@Q!C?6)DBN[I0+QXF8-%&_BD8YXT:OG=QC6*W:+XV^/1G:[K
MBAN+YJ1S1H!'Q.Z7>P5B(1^K^D%Q( 0BEN'+?=ZR1<WO''LAS-58SISSFKXR
ME1SMR>\@\GYX79LJ]@O(#R.KBQK($#XY^44A"(],F1.1G%-%!"V9A)<^2V,_
M#@K>[4WQTS^L>=N*UC68\S-SUPU2X-6O6 %CO&:8[$H,,J+OM$'@\] *G%](
M*A2-)F%./B^+&.,LR9?A3@6,Y[1[Q.\FIGD&9M\BUR['PT%I7CG0J]I=CB9Z
M$KWLY9;W;1$Y\6*BRGHT5)*3'=>=XRVZARY[M+P[#J.@W=/$BN470KM?I$''
M?')GRGN5RJ=C3YI10]F-Z'1H'C4_5H[1TW*B56 =(%F8_& R&GI',Q\:&*3B
M-NJIBU^'&<$$U^QW#NK>0C?EE3Y5B->4WB4%CL&*[:/%+Q\E1E_>6?)>(*[$
M@E%NSX"X,9)1K53N$>+"Z7 P_$_+4W#!7K4NGY>%:5YI7#PW)T4.[/$_9S.I
MNRZJNRPBSWO#QD>@QV(^I?V@UY#E:CCGBA-IF85+\575*4]8[?K+%CE9Y^$O
MY'"\;U(;;X@X6H9VW[<&L<10)R$^B'79L=Y^8F>TXW&1Y!40/@])A9;CM,V<
MBCEQMD6N:A 3FOB"!\I*;LDX3*M3<Z_8[JA,RJM1&:X"=5!2ALDX5=XM^%$F
M2=$RKQCJ=XL$S\,(\$TY=TT:+X[XIEWXD%,O=FBV_P AB)2"P<@1<L,9?-#?
M7QY@X68)6 .VMX>GZA??P]:SIUEHMXIGESOGF-4K7M)^X6K9-(*7Q'FUN5$Q
M_+,MS<7*KVCB<413ZZI(S2" TO5@@P?#'DV1G%MRNY'J@?*Q.E9/=#F@Y9;W
M4+LCMP#;=9L_)S?$H$*'@(<]I54UG9A#5/+S9#?.#)!P?(XM#:7O6C^,%]S7
M DEH>U>+_C+HV3UVU:"OR,O=JWC' &C7SRMP2JS@_11'P_Q>QF9@Z;+GHD27
MX-<,RI) ?*B,#IF:8U8*=E  [.\)[?Y";:*I%BL92R9%M=8\I2N!]QTZ),--
MN@7600=Z?,ADTL&HLKB>.,H8<;4ND>"X[(*,7-[S<,7M?C[;)$^WM0"OC,)!
MVXKYM7.[2V870@[0L-D4AJ.#&MRF4%W+D!]R%<3-ZGS?MV/T')J9J68>%I_R
M]STA41ETU8KXN/5[6#-#L'C'Y?5(S @PA/EA"IE>FGH<%MB/!2Y#GIE#501[
M4TIF7C$(SO'-+H4N-XO![9J=/N,(%%V 9Y"X:9U8EY0^-!*SW:..O.!4D^,0
M%2,%0K*2)]1.D?:,14),:5^&7@>"W75Q(_7BGE58M'H>4;XUXUD+L$R:HY08
M'%R^F<H>A37X%%=L$B2D$U#9;-KE?)>D--IZKX\DCZ/*O1ZCYL97^(YBOCSX
MF_AJCI=3A9MN?B%;+#CXU5E*9(0K,^WZ) UO,K)<K@4TMLFVW3Y(;C$:2-8%
MRHLK<:7JN_:9^IV[ZG^)O7LGI>@76LWO.MA7XP^45+SL51\;IL2OA#GCO9/%
MNJ%EI*MO$"JKT+-MS4LM\'.NM?DS36-^S&O;*3R&JWVK4"GZ8-'7;, :])E5
M=VTVKF=6.$1J\R\/0JE&@QBKS#DJ' =D,L]0F0[[H>?C*SHS55&9YF.3!1SF
MKW5_[#S?&?*XEYE9?3Q#[I)3T,/2]A)J:A)YWJVZZRP(]W83+;:?R678?(7&
M*KM]JL6)->/K$+4AT*Z5>H9TLW8K"710*T<BRQM+M-F)V-2B1N EDK*;A0F^
MO\1$92G-]<ID32Y^@Y:W'17+#<-2MUKDRUQ?''._%1B18VRLYUBPRT8UE@:'
MUV2E:US(ZYJNJDO.N*_)K?E+6M-\D,\T#=*_$"ZK7L]W"U5G-+;/#Y*]B]7N
M,NAL=>$Q+M3::IE8HC'^2Y%)0XTST4^RA7 ]?SMK7<I=I^I"=IS*SYGK5HJE
MRR32TYQ'RK0K'G%EBNND K6]U%IWNACWNRA=R*3))0C&=)/KE]/YG@)\_B@&
MV^0N#;7/ 1S)R16Z-%S3R, >0>B1\;2%G!++G]NT<Y F.M$N$I214Z2E45IJ
M,E497C_8J>UJ(G0?'?7M9V\!JBM3M1+2M#O>_*2O>']KM!65.>U,7L#D6%TS
M&)-J3Q(N"B'V*W$90G\C5'YK,5VTY/9]!L0_E>UVO???+]!VC<P>AHLZ&&W9
M3X.T"-=!1X5?3,CJ:;ZMT<MF2E]QI1:-9MNBMW'3+(-MMC)7'6Z4*LM^N>9[
MG,U\E87!T5@$.^N@7ZO*%D8PV%%@0Q8I(UN/&1&ZE)D6%OY--]?^CT"K2IFE
MUOM9U*/Y#!?(PNF;E:&B#TJZP&!VEVE7NB-J:C_)C=;6[R,OOQ>5S=HK$C-+
MT#14"L6/=L@-O$KYD%'H\219*I:6*Q.T2;JP$#E(:>0$0BCPV7*@_42Q#RGW
MOFP*02T&S!*[Y+4C-<;VFKP@F(AM #6HW#M=_P ?>T\!7*:Q7<SLMRK!$M7V
MGX5<A2_K&QJX4N)/B,2NZK:+[Y+U)Z#4\UU/;==R1J4#[<)LWDT:=1J,Y)ZU
M%;VY"I>25 76!C#JDLRT(7+EOORY''$T/6-(,W.L6KR(!^0GD)1<WA7,4:LM
MNEVCQ88B:T!JB@+TZKE9P;'0J'H3;!!4-LDKCC4AWCB?7/-Q";0RY -6*LMT
M!\QKM 7%[=8Q3&K;RG?;T9GAVV6#I'&@+2PI J4X)8Y(B#&8,9_K7+#'KFDQ
M*3=/(&P6>XF,J.Z%7X<;2=#M]P/6PIHXFB3NQ2,R^2.27Q3I$<E+I$4/C,SN
M2G($=UF_T._[5G<2F"[#61-_FC=4J(9ZK6,#9XUH# CI1PFXT!)2B]/6A<23
MQ#K[<>0WQ/[E?MMMT7J\LC3;;:F2VR@*CLF=L9) T6C9 8A@+_>8,Z6X<'68
M/16X;_(PV4F$^L:-)$8#R(7)2,XP.SZ;2[/CUQDTZDU</W2*I-8V9G*#(5?W
M Z0^J>5=V99*N,1CD*!WZB2GYD=WJ4NK0I4VGFGG/UEZS)KU@K>5:.">JE<T
M6J5"KG]"NEHC_7/M5HF)HN*"%6>2^_Q]UJ#&X\VI]Y"EU:R4[2KK7+IX_"'+
M%4+?G9&BE*E?<^W,4@=,)CI%BK=[K-PJLTC0I(Y<B.TS*@$A;R6WD>[BEP-=
MHODU HYAG5"EB>U\3M^8D'#VTEJY.%ZI//S[9!L=-L%TU.F%1;%HB28;O7XH
M,+)99BOP6)'QF.?UC93&3R1^G$_*6DTD3'HW=#E47QI%7?2- J60DON@/>M\
MR*]H7S6H=[G6&*[#=<B(_@U>S@.Q9AMH)832*W2\: P"6K4VP +W:,S)6A39
M +,=6LB:U6<1M\ULTB#,ZB4^I/7(:7D\5\7GQRT28>K(RM1LVT"V7)1VE5FN
MA(L:99M(K!&1]])TP-<@T CD;G#0F<'+"G8CJ4D8CT!<A2!0<3JHHY7MKN]6
MG FI6L5&2+T^T9E9[63DURJPA:808O%F&;@0BEQ AE+*6EIBMM1T-H0G4\>%
M:?HAC6(&>^/E A#-DN]5D_79U4*YI)7,ZQD(2"P"F%&JP$DE_MF9V"Z2GN,I
M?GRICS;C_P 4Z]!]"+F&8%\\FO*B#?H.J5PIC-3)=%4?,]!I=A-,2OL432:4
M4TL>8KH!SO884\WV=Q3;Z4<<I+PG8FGH#;GC73ZN2@:_5I[%EYFM+N]'S.H)
M<>Y-@6!>KY[>3@TA&0A<DY$E..1.M/M-OMLU_++#]Z*ASZ04%)?(SQ?88>GQ
M$5$56TG:!4ZNJS-U:,([!^L,.$S*ELJ3*F/.<5WX/4ODW0"5</CPP%8XK:6Y
M"!U6KVVV+>@E5@N,BX[KH<?<;3,B\7+[*FO"%IB//N<0E?"P&BR2;P6?(8X,
M@EAU*:>K@:$N6H76H1JMU&NV.P"1#4SK49X_,,DD,H2A4I7.?G_]+0U_A?#/
M'0IK:M";1H3/DFZ9:JC>;?=PZIUP&H+.@2?O!]Y^#^<]RE)^GZY^Y]?S\_U0
M_"E_C^A?T[\?ZH?A2_Q_0OZ=^/\ 5#\*7^/Z%_3OPA"JG^%&TE2DI4XY.T7J
M&^*[SG5KXT:<<ZA'.^O?:E2O3]KG>_F^/,E/F(QD;&A^,WE$5\>D(QZM%:Y7
MN3JE6QJK<E?2UELCY=IJT.OHBR^*8X]'3Q7RT^OIS\G_ !$_]^^E_O-E_9ZQ
M_?O\G/W]&_+4(\CQ!.C\\;\O/Q'?'+6<S"LYII6R:U7O!C&9=XK]_IQ1W2*A
MG]7FCC(!])F&8G26N<0Q#&29CKC3BZ+XZU:M6RVQ]E;RTC%M<[/ TG/_ +\:
MYA8OR6SZL7,1)(O7" ?EY4] E22D@*L,,+/11DJ>R16B/SRWQ/7LR)R?'K$J
MCX<Y1DE"JM3I%NT?R;\F/-"SV2#1  HD8U$4, CYK-6?'CH!$;$&-,0BA,T5
M&M,PF)/*EXUYEGU;HE?S7['M..[=F(R1:\S\E\]_$_\ $OQ!TC/[&+J=Z?HR
M8=<JNSDY@]X9(G#Y4UX<5B3GXO/EO!#AS)=B9JEHL=TKN0;D2H5%DTS5JIBW
MD!5,+W71:.38NTZWAL\PN\6N,<*/'QX.3-K<>28#QR3+"N_&^HR>I7@/8\5J
M/G'=X1:T8M4[Q6Z:!\,P(HE+\A59[&T^KS;+E.P3;T-_5_(:GBG[<N<XU\V!
MU,AQJ\UV[TS;Z'4LR ^7JYVM'<]K[.:6LEX%UD':?)(-2QU9N]HNW.UVJFVY
MPQ<T3$@E4LR(D60[-C.Q^3<]I7B7Y T*PY/KF7YI?Z':J;C89_$/UO8&OR#J
M>G'F:UJQT+%H/W2.01DM\,].+1SAEN-V#UKDM]E0NR P]A&*<;>4..#(1: I
MYKUZTZJ)/8D1^N-][WVJ]OKSU_-\,_5#!\GZ>+*@Q_J(49[Y$*<TVQ-AL_,:
M5\J+,990AUM/HAQ*><5SO.<^ DF6!"RI%:<4[7'Y N"^]7W51OHU.!'76%+%
M.*A_P75,=;[UO]S_ -'\WP?3-J]=F)MB(S=I3*"#9";*W"8Y%AMG^.QE\,HB
M1N<;:Y)^9QMOGM3Z<_-\3R/ PGA K!CBRD_@Z']:2&1/J/I1T^5\GY\R#&^K
M=^6RXI3:/FK].<]W?6"7: AFBPP6H&-*-BX*"(X*M;3BP\&:ECDF(+6Y';5V
M.VI+7>H3WV^O.>D6:_$BO3(/S^0I;L=IR3#Y*0EN3R*^M'78_P!0VGB7/9WG
MO3SG.^O/@_&16:^B/;'9+]ICH##DLV5^9'Y$EO'VN1N-F7943G&G%2>.=6WS
MVJ]>?F^!<Q@$'8F QS@<)*9&0FY(<2\F,AX6+?0PET>.=3"9XIAGJ&E<:1ZI
M_<I].L)KP-+'8K4'K/!,#C78+$M<]B'UOD?V?2LSG%/(;]/8EY75\Y[N^OPZ
ME884M+[15AY*AT-27F3KR9)MEWG6>\<:,2$<<E)[Z\D+YQ3GN[^?XX6=KP-T
MKP0NO<)N"8"R' #J_FN@^351^R>"''?W2HWN^3U7Y^I]?B8/D5\(_ (P8HPA
M">%0'8DX;!0MN$/F1EL*9E08;;JDM-+2IMM*N\3SG.]^!Q5NO@T% [!",))(
M$P$SQ<8LZE\K''3$Q^2(3!-Y"5R$-*2EY7.=7SO>?&1&=3%F[&QB6C"=:I59
M1;;0)I4C0ZVMJ73K-<J<'+0*]?I5%-1VB@1HS'FQQ9=AF<PVB4RTZA@\X*&N
M'8L%\9%-+@Q5EHPV4\U(DCV"*FNS&8,A]A"UM)7QM:T)[WG>\YWXDSAX<7!F
MS79+\R9#'Q(LJ6_-<:>F/29##*'7W9;K"%.J5WO7%(3U7KWG/B,0=AQ79\-J
M0Q#FN1V5RXK,OY79;,:2I'7F&I78[?S$I5SB_8GU]?3GH4<@B1D-PW*5.-+B
M0(L=9><N.S$7,**9:0HA*7$CMM=<=]Z^MH2GU].<YP$^/JM;@OU> ^*K3T,&
M,C.UT9*;0U)' G&8J%B8$AIM*7&8_6VUI3SG>=YSGQ%FO1(SLR"F0F%+=8:<
MDQ$RTH1*3%?4CKL=,E#:>.<1WGOXGG.^OISXC'WA(QT["AR!T,TY BK+1!\M
MQMZ5!C$5-=F,0Y+K*%.-(7Q"U(YWO.]YSX8F-AQ:)<640G192!\1,F--+<4D
MI,8?2SQUF422KO)#B>\6]SO??WO^0AI55NP$'<JO;MVT@.7D4)AP::O.K>3F
M?>38!RYQ8!N"0,A !S/6!I!"9#<HDA[ZMMZ*^RWSX)D-!N]5M]ILCU2GV(FG
M+H$,>N4$\XK9YLE!PR%*L!*0P#EG;.@-';=><=:[!:(N*<?[UI.N0TZL%@YG
MO-FKI^]#QF<1Q.FTMJEZ/K>DUUC']#BV!QBK$'R.I?3KE/#G^CN1I+\)MMXB
M_P#+:#&3]&=N0[*=,RF/;Q56MCT@XT=Q>@XEFMXG*N%[MTJI6FF56B)9DQP2
MX@N5#D]BH80VCO7&;E.(U&G572-1Q+9=5S6GP5] "M*R1,"[6#1$/DB<[I31
MM'O%=% 9<L0T&'OUZ+V9.BR27L4G1&V=.#C\^O&H:3O<9,VD2"VF"]6TC!C.
M"S <JW_>:",*Y(.$%^SN#%0&Y\AEED6N7R WZ+R:M#+H/KS^=5'1\](2B%90
M8AEZGJF(67&;"_"@MD8+HTT,;-,$8?.O.1G/IUQGD=2\EYINQLVBMF:^0#!*
M!9<PM *XBJ#-S=K,L;SFP-CXN<Z#3"<6WRFL;A.,OK?7 <@.I@2(SJ([#Z#6
MF/V".(+%*GX[U.)*:K[<BP!HF#^0D[>%/C+0DE&)Q'K*],Y";ZW[%#WVTS$J
M=7SC?,5M%HOU1-"?'&.!JN7B N8#P;YVD5\A=34(CI4GI>3',Z6T5M3*VB<1
MJ-%8D-D)B(O))=[L>JY] OH0,&KWCO5L"FPXF9#4B3;%=H>MT1^P20[)Z/#0
MV4@ZJY[X:OF<XQ&4SUU2'^]08T(A:11^JWFTW)V_9V9AW4$*Y4K;=\NTMN55
M)U"OE8D1=$#W?,69?"$],R!*6N*ZN&EZ E4BK<0[G^DSX0:YX?:Y5CAW%N!H
MWC[=\S,TEM6J5XS=#8TM9 )A^-*EPZZJNP2$1\@VRB,N6GY6G@MDT,I9NV'Q
MOYXPUZ[!RDW[R]IED)7^U62?\PXLT0Y(ICE[AUZORB<LB5?@UY,PB_*ES'G%
M"+?H6@4*=8J]C=IP81"IN1PJ[4/N9.QF?C5=LDFORK 1[]^F1)>7V:_Q[L?[
M)<:#14,1&E./8I086@"82,UP[3?'RSSSM,Z<:M%,U?'(65V$T-@).PE";#!D
M!XDUAIYZ5#>94_'>2KWH=;*:'TU6B51MQ8B-N.1V /<15)[0R\K"SDCH)K.K
M]29";W$M&&Q)/U4SL@;-CO,-/P_=!:<=O1^??XP:#>*6Q3)(293(]ABL1.43
M3J/.4^J0;A(G1B471NK=84VE*FXW6E=4EWO43M)GV4'9ZS;KO:C%YSFRCKH+
M!]K=@TC,]='NUQRBWVKK^^P>_9LS*=E$N31I#JXSCL-+D/UDZ7;IVG1@F?;/
M&QKMW$"Z='CZA6R.%A]('U67G&F\*NH$(-RM$6N7R2,?7#9CR&XJN?:,A2*>
M]R\4X9HE&(4XZ@L+K%W*U'2+)D,O&&,BGZ: N6E6(DX$@UC($#B(@3-@1.<D
M178BF71D=;EW-_KI'UF^7]O1-6FF*[FD=P-4O,<C?8-VPGR(I8PK:)4F#&\<
MX:R0D8'=?4Z68).R),QN0M?5#<]'?8J*Q5F8 RILB!;XR2@6R'&?:DJPJ<(3
M8Y&P&;=TF0>D,(C-=;EMM];4ZVX^]_DGXQW_ ,]<WO\ ^H?E_P"(G_OWTO\
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M-]1-)/+A0D+CLLON*-*9SP!3<^ Y#DER>)NW!\]:2EWT]L_,>%C!<4)#%\H
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M1Z,<[V:\]R[0::\F>E3D4LU&['00CL]=;;^-$S^LYK8\^K]7N6IA[9:ZOCJ
M&9FM2SG+F=GOM?BSZ_&9=L%PDYJS((M2?HE1R2ALN*W)<F1EQ^5>JE\4LS]-
MNP+#1=C9NF,@'J;GWZU4.E?'*A:V/DR"#-7*VCA6&Z+'NQGV:^\<@H)]%OS6
MT*(6V!7YP</5>Z"B1.F9@R(>%Z!XW4^'^L',>1E,MSAVKY5#)NUWHMQMEULG
M%F"XBW'(S[:*U9;9G4=,"W6:MYD!KX6E5U4MT[IC,"KQ )21.<%5.L"YXX<Q
M"FRBI"$,ZU&9BJ>6M49ESRTU&^>,SM>'Y#I!KQVT:RD*MDCQ36J15:36[)-,
MM2C!T,]8J!"!D>--AYCSLMYN(EN+$?<6ACFCG8&$=IC6;G,5PO([G7:CFXB5
MN K7LO$[14*OE$]1*OH"UL0 *O2I$ Q+$Q8B(ZW5)0YWK26:](R*W;.)U,5B
M9)I0_%1=IK5]/Z]4"UXPZG3G;.[!@DK49KE:ENLKG)2- KCI;(S("GH_':C5
MZFE4&1?Z30SC1<36P@B$.38,TM>A9M1++!Y/A6B-9Y6<T4H[#B)'OPQZ8J8C
MS\9]^,P]3KY0/&FQ&;?M>W8#EEM3/S.FTS08E>\AJO&T#-]ENCI5WDPO1I 6
MO1'U-OR>E8LJ%QF1&CR8G6T>.-;%Y1G]HOAR\6=5'62J0J22I%6J53,7_2C5
M#D\@\<$6DG%$1Q\)#+\1N02),+?7\IMSO,E/&/%5O+:!J^343RDGK;S.MS;A
MEVGZ%JY#%8]RT>97U_8C:YJ#\=#)<?R:<<BS93SB$0VY*F[/B&-4VM5@_F\B
M_'QB -)J8&N%5UNY.9/JEAICM;6ZY$=#WF)T*2=F1QLF>XGBV.2HG/G_ !!0
M[D5 *X?]U6IU]U T<@=N4"=56[19PP\=4E#92S(D2>9'N1G'I+*HLF5)?;1S
MK:5.C+=4L+O]=-:-<\4G56O,8)"JUXT2=Y.L6Q&8:;%CN?9[#06SH'6%H@7,
M2H#XOZ6=]H\CI7ZNVR=><V<5CP:FKN[-JN6-BI^87;&\=N\2D6G4:PMZ.2CS
M\TP:>;;)$7ID:(\)K\C[8BQW!J^255(E7\Y0*V&\RZ15P)&5EP<9H$FOV[)K
M!IE6+O'66EDFJ-'S>K2N/.]D];'N)1!>;:D+2Q^6IZI=G-<H>LTVJ%L^&:OX
M_;KKOCQHT_.#A:'82.<6BUX[<*>2M]$59![!)@835+C0R".R(Z6G''E.:+/R
MR+?S=TUXP -:GJNQ:OH^XZ]H#U0#=KE*'6;3=7LULM\VNT>OJ7#"BTRD#AC+
MKWT[*%OOK<_)8*?;0@NRU2UA"M:LU<.08Y,*?KQV ^+-!# V8V[$("RHV4XQ
M(8=0IMUIQ2%<ZGO>? "F%2OEA<L<K3]80,\=K_YM>5MZ\=G*]1R(XM2:"8QF
MT:T4I-CS6I30T'L*O$8TH2EJ"PRMAQEOC?["C7?0>:C3M+S<;9*]4-9PC:-4
M\?\ 4Q]0N3@J1;:)+O>0VNH'S=%L<P%!DR1$YV3![*B-/H;0ZGW]T"TYPG3;
M5H>I-UF#?M7W'9-1WS5;" I#)*/2:B]H&N6JW6.%2Z>V9F='"8K[$".[,?=X
MUUUU:U?E-P1WX-^EF!8\Z;'"#;7FWX:PFCX8>6F0Q%A9@3+VW.',GQK#4Q$:
M0E,B,E_C3O..(5SG^"_IW_GC\+?^_P!\?X+^G?\ GC\+?^_WQ_@OZ=_YX_"W
M_O\ ?'^"_IW_ )X_"W_O]\?X+^G?^>/PM_[_ 'Q_@OZ=_P">/PM_[_?'^"_I
MW_GC\+?^_P!\?X+^G?\ GC\+?^_WQ_@OZ=_YX_"W_O\ ?'^"_IW_ )X_"W_O
M]\?X+^G?^>/PM_[_ 'Q_@OZ=_P">/PM_[_?'^"_IW_GC\+?^_P!\?X+^G?\
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MRCH0B;<G,FYXVZ#6J+-:(OJ:F7/+V$@3K,5Y4GYOI)97&(.=DKJ] L]*W&@
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M/K*R_(KUXS^S!;A4C;,64_!E+%6&OS2 F?R).C.L._*=5UIYM;:O1:5<X?R
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M<+#?,<+7PFCW[%ME\DL'LP*W6CR-^Z^[!\T:EV']<P'Q\JU,VJLYC7L9I3C
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M((3;=%1[R):%!^F&.+]PY2GXW77W?%^I;5:,OLTO616I@3]MIP%Q-I,[%4M
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M%S2G6(E>DRX469USK$/L,0 JQ>K4(4,L&BSKR:O%BT*Z_4[Y4L-?BUV0\4@
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M> P6LD X"RF/%VC>0Q:A6%0T_(.W>UR'/M=I)B".^S')3<*&IWKSB'.Z=?\
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MX49EI+;#"I766&T\2VE//S? 2U:53.V0R"#O5QA?WCM8<>4K3]CK]O>K%K"
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M2\/NEJ-U6O7@06\7Z/B(<U9S,0 9CP[!F-RKLXD-8[#G-_2$G)D9V,4C1?C
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M<<4GKB.*F:'XU[5FNY4@<=FU<I9<QMP:W#!-D',QI,T 7=$2I*A1F/$FL/\
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MQ1L<IQQ8R+41=?#8E+/:7)P-SGT4*_$XOCI/U[:"F=6')=LA*-BYMAURH5>
M]-8C-+JZYI022C/1(D5EJ<YC !\IF^2OFM)\)H!FOL$+C%OFM3M#\B"-.U!S
M'R+)!ECE"!+HRX$V%-@$OG,3)K$^;!2PTN9<J'00-3N35.JM\AEPED&$*V8&
MZ*%\>+9O52EME6KG,/V3/R$8+ A$9T.I(%QED%-,F'B,=P?\:V0N-%R2_<S8
MSKE&'A\Z&7\69L=HH."T;=(%JXDV:+L0:M!8M<L<5@<^:_R$+65;FM_,4.8
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MHIPM&9? PU/,\D[WN%ER.K2FL\S)[1Z/1J-:A<ZZ.6&,!NADYA]_K4&RV^U
M+U3Y%>@PI$N8,$2R$J9(;:"L.0_EO^-E-<OV6FL^K.R#CENNF(QK\UGFL/D/
M%VYZN(H\$K]^&I3!+*K/ ;?(QY$PF/*1R F1-'Q'N+']VX#1JKGKE?RQS0M
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MF8&S[#=/T685LUV!4*)"C4\1S4JUGU.K-SU"^U[MC/CV8%5$P+H)'Q6RRH!
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MPJJ(1A)ZN&EUGBDLWVC541J-M%4X'N5:J=$MUV7'L=1/;<G7:F0-36"C]*2
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M[= H\(N0T%FI^R!UQJ$8;SE=*.1Y;8A,N7Q,5Q3Z5M;/=G+K/,QM=+C2":9
M#0:K3JWP:LTMTPV%%/NQRF@V3AKC9RP>D:079@0N/-?,C]=<#@"VIV0Y;J9S
MQR<SN[%*U7.(K<WQ3L5[+8[*+U@<@<.MB(XB].CBS,AUIH@EGZAKD62OKB:D
M:AWGHL+21=8?K.=Q,]J'<RK]OK^<Z!G1%ZN4=Y#@*OYK=T://,GJQ%:1]J'?
M;)=G]3ZM=H9-&_Z++&@3>2VN]!7Q-?DHOE@P^[6.Z9J/@DRJ"Q&D4  BS."4
MA8:WN_9," RW*;6P\[*\=K7$>(?JU\8?&M[+A$^:;&*=U6\2R'1U/,V&E#A#
M$ 9,QJJR+']GD4.M=>?O$QMIA*6>K4C9"6AF D*,1S TBD5*O P8^SE\QN5-
MN@:5J13VRW]*Z)FTU+8)R4RQ,KS9";R-(4AY*&ZI/D:S>%5JL6C[[L521 "2
MX\.U1=LN^XQ"-5>=:X/J?#!Z\+@V!;,)Z8;'C!Z.R8ZHZU/5FY C(\BD1FN1
M4@R.N] J]T=(V7 \ZM.;9)I-<FDN,QZ-9 (:W2?JV84546;SG$(3'][ZG9-2
MFZ? N66,!9$T(!567 \\/>[#;K :/1*Q%:*RPM"QJJUQ8L75JI 0ZV,;1)ZJ
M2MOL=IJPV=K=;\4ODM^@_=N\V$4'.V"+$SGR'(^18%V]S)SBY.CG'S1=X'(D
MO.P8W*^W&8CQ8[\=,A5*NA[3+F' U5NE*D4&(B 1KSY+/]6K>N K'76B:7HU
M4M!4Q66!AD@B/*DSP7.1&51%)Z\K1IIFRFA)*\A<(BCI$2$)FQJM8O'72K7J
M^>6-F',B]^W&56RS]^T!TQQ<.5%8XA/&EK4[\3HEIL$J.$/^/UZQ:UTS/JM6
M<XHAJUW<M)G*W-BO!HTF1"TJO#C!4?!4[+E151"\KZE$A:_?\&2[]AJ,R[V3
M+-)SBT36L9HT3/;<0TJ\A;L9NUMR]798VP'9GW=AP""'YO6RD5A'S?:I#76P
M6A_?.5I$V/#JQ.R2-0JH>XVPEI5,IYB@5V_U6\DY+IJB]&THQ]DM06$RNM#H
MK+#<A"52>R/_ $__ !$_]^^E_O-E_9ZQ_?O\G/W]&_93EP@^9 8E?\F+UI^1
MG"IN3=M>SR)JV1Z_FUOU!6I$*I")VZU5&W:$*L=5@DDJ+#H(A0I9OK:!ZH=2
M,2*%BTRI4V;E#%S\8&+_ &61F7D,:SN@WVGE=MN1XY1R"(5])'K2-+QATT=/
MCE>A6G3<F02^DF0-=*W4G5K@#TXS8[;5BD<F4=L&/"BFBVZQC/'ZN0W@\ /.
MRD% LG"<*:TB$1X7DSVYO)Z>Q)3><Y:.S:CEJVH=YCQZ:NQW:U%&LB3IM8Q4
M%3]+T?5 %+'-ZGM%<ND<L7K9 B)8L2!4=#?VPX6C/$ESBAAO,=04&U?.=6KM
M>MTN>W#L)NE>4YK8BQ@FB56B(6MVZR48PI*YS$65["G.QN^L3J7D['K=(:H1
M&Y6?$<EQNCLW1OI=J#51>F7>T;L#CB;"$L=&"E=$II^'"'%9(PLTDA$9Z1AR
M849,=8Q<<Q0@UJG9%"S7]9PTX4FWK.0]2\V27D72:B**IJ /[R5X7F-C^RF6
M&F18J,4",QT0.#)">1;E-+'*UF")V #\5D$,X.&K7/UG5(1NQ%I'EI=6K$/$
M,P-$D-F>?+CR>E2#KDF0S*(O1HT'GQG#=TK&+B1>;VOQ)*E 4,V:N0W2KSX\
MV6Z%[YY/3^&*;!=&:YI8FSM06TR.RR#[:7>E"DKK<3K7C?I(B>(A!LA)ZK)M
M#4IR4@U-BWG."%2$H I:A28;RXIB2V\^F2XTCC2/<GWJYQ/Q9[>'NX6\6\EX
M]B<B?O\ I'6*OH5\'C_(\-LQO++@;R.I4^ *RVY48=)JDEZ!&Y+1$FK6^Q,[
M\SKKVAF+&*Q_O*KKD+, >6SX-IF>-,G4-1JMKE5[+XVA4T[G3T0C6:Y);GR^
MA&FX+IN;!%QH\/O772&I5>"+RS,WD7@II?V)I%EM3_D_<KD%I@T/:;9ELD "
MH.7GJB_6G)$@H,[(GSW/EQT]3%=?Y\:7!KM!Q2S5BT[9Y97T=22UGLM/JQ4O
MY-@J2JH;T::KX&1R/K6(DA)42EOL65(<'$7)XPC#G>QKGCO0W;E$MEPR&^^-
M]GMM\M/U[!"Y-9'8*P1O!M*FN%Y:+%<(X:0ZA#KJD+?D>UU[V]4OXHEWA:B]
M*,TXKY#E*A=+>'K*[=A*]@Q(KFM;B8P[4:G6I3L*KV:5&**67GOE%=8YZ3N^
MU">98;MD//,PIV>/@GIF>YY:+!;Q1/2Z?B=YSH?Y-1H]OK?*\0TXO9[/"EHB
M%A\MKK0B,0).D"J4=9\;[5-N?W_&9#2MKK-Y-WQ J#<+U-T<%4A0@@_"I=6
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M1+^1%@M(B]3EMFV@WM(LU4?++Q]MFATG,J1<JZ1J[T<YJ8#3!_UTVH,B=/\
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M0O=V*10M+G>-H6XF4&I3LINH1(N"6$5K=@"FEYII-=W'E\<B#,W-@F)[\RV
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M\EV.93F\[K]4A,.F2=Z:MHV4.?'MM]<C2(<CKW6VF'G$?JLH-=*_J]%X7^M
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MOKE-KH:P"*Q3H#(E)%P?V"RW-GREO2'Y<APCF5R);Z/):AG1"(0NPOC,BI9
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M(T84+&YU6Z37[\1'<H [K)"-#?G?*<>5(>?4][^-:L?W&7!T7ELK-%SLC7M
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M^XXOXQ.QU+1M$LAB7H^],YW2*M=A5CQJGZL4RIA6T2;+##1/K1Y\E70+LE,
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M!PL</05G2BA1,*#&BI)$YW$<FD9Z6&F^3)TSC:>.O.>YQSB>>[O?3XA6%NN
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MD%40E]87FNZ/J3"WM=$V0FN^S@V4[C3_ !UF:L%=L^65V]W#4[4E5\8IW)D
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MDZ)"&2+\5=0/'J_Y*:T+U 12S/CUXTVZHFBP.S#!0TU&4+L\190B244AOS!
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M*[3(P2JC\LE56N$7HEZ:C9IL=AJQO%0=_@;2%S8U8'[;] 7T8H[7EB&8$D=
MB17Y*RJY#?(J[616%H=LT3.3.SUPO;*D)NUCQO.!"K%A<87::_8*L<<B;!4Z
M/0[?+.6QB5&'V,1-%O#WXXQ"5RGK,1"R<BT2KX]9]29LUEJU O3/ZWPM&\C\
MZQL0'K[R+(3%U(P]4+:0(3I\;A>*^0B1WH;/V<XOUT:@9,.I]<*3CE"&+OEI
MJM^NL9(6'XV>06O/=2 C6X)75D%VO.1@E+D5<-"(9&1U[DB9R)SGAWY U]M$
M1 WQ,\A_)2?C#E;N)D*8U(;D.:EJY#(R1%@ 39$FM1KJ6C#H<F#)D.J=>4TS
MV5QKK,(GF%N+S<^J>F62B5FQYE+N#%>N@1IWP,MCIJ:3&/?9%H5$,Z$>'L3H
MO50OHTR&4=ZI,SJO),<**4*O2<9[2@]1R>QU0X8N-DI5R9SA^R^6A&>&._:5
M@Q[)F+68?("P V2\EFN2D3YT!YSO(NOV<([D5JJ&&8QN-ZB:=VDWE=5W8C2-
M(#T:E6RO("V!UL/1(4:81X9:&/%WRY 0M8A_D5[B47T%"M^/%*WGHS4K'G^X
M?<*QO4[RMMU(32'!7C5FX6!=U_9^BI)6N2*F$!LPVLA(BH<%P9"HQ5B*WH1@
M-7QV@VF[;K8:)E:J1(A#86=X';%TV?DMTNEBO8Z07V>T35(<::K, H1GJ2^L
M6(?AQ)$KXLF>##^>:(;F>2/DE'%$=057L@!#1U6U_. >:>+3!<M8H?MLA#(K
MV_:1I9E@J8*#V8G8PV6VJ6^U::"%$UGHVG%<:%U'(YE<L4W3/(T#IT I+O6A
M9U96I<0,&"XWT=(^KY]'/AM?8T[A*5"^K@*1X>6Z\:1BF<VCR2)MNZ#I9_.;
M>K/,O'%\#T'9A@P+4I=Z'EW9$(U6(0?LLT3C-R&7'EK0Q*=CL<;8J^?#QMV=
M\=[!8[-0;O1[!#CYML@C.LTOP8BMD=8W-$M^76-^_J@IER!0&,\XSR/"F29T
M>8US9LA :WG)FSF-WIH00HSB,R*/S*@/^&=AV,I<(5>KUUA3K6S?-3I3@MN6
M2)*88>^M90^X^VTPC2;)6<XRL3(K6(URY#J+:9LI-JF3+1C&;WH!JT&JP3+>
MDW7/>:/>)0"1#AC8S44:+>>=)-$4.0."L.1>ZGRZTGR3\:7@MBH "RSZ8U0S
M+-C%6N;JK%9MR20N\&BBI"UT<R[ '\@,P"$0@2C]F\B5$Z4G91AY?3R%.KMW
MU&^5K1CM5&3@'CWY%WN;,&U>=;P(^%TS<,=ALQV$.1_IQQ1<5UR:25 ==S4J
M%I-$JLDYX973RGU.AZ10[-<.2[%2&<FG]Q*.VV7!M &+!]\B<61*G1Y).&J,
MPXB$I2)+7+)F>2" 3=:)67/Z-5"5RSB>-)Y).?\ (NG89<8]DHM>NLDZMA%5
M-3C(%-A357Y_T;,MN(L0[\Y,(E< ^?\ '+IVN>RW0:H4K%?Q:N1_).UX%9[S
M;?OS:A8([%(@P,$RAN<4 PQA(HEAV2[ 2B4KPEU@R6H&96\]BODQ:;F%C$;;
MIN-VVY \XH]JJ-$"&JE, A"Q31"$!35;D27Y$GGU3K UHC*6E+NYA=)H[%<8
M\7LWE6':QM?JMJ+6;[Z7,='UG+:[1A#4J7(MO(>$26>E8\5*IKUE?^E;0PI'
M6>WZW7*'3.UZOUS>IM!N4X+*8B:+;ZKA^-[;EE#C,T:VW6M.6^6W?38J:'%%
MB<Z<\&4Q'4W/C3(Z3I9G2(MFM>3:GYPV%P"8HEF@U4/G5:\;<CT[.,LGU&JV
M&#T_]J$BJW 1XE+??Y$E/.1VI;J?3NF%*8!H,\X*?O06M8$4J]R(7>H5<%DX
M:^4[R1O-A$SXJR^76*Q&HT1^)%'PTR8I&/''SG2D:6PH7CHR[9V(OY3=R8VS
MQK)3"<(3I6>52C85.M5W!=L>FQTU>V6LY:_N94P8M^:Q//S8\A2%M02JE4T[
M;96'Y+7]!M#[)O1B[JKC&P<K R6P: 5PG4J;6[;&(5^\O6\:Q7!DLM,%%9KS
M<QO[';GJ'L2/%!4:>!KKQ7P@@;F_:=5!7*T3=OUBM5>@.C?&NKIEF -I#W^_
M]L+\A#LULE9'$];XP+DOLSDMVZ^66U$K(-%Z;^)'J)*@F*O>&8LHAG6#44/D
M=*,6&LWM7'1N5"3DH.,4,;3&E.]F2XC?U[J)C)T_#(YS6#:-M!XW8,K/"F(-
MA\5*,AZV,B]@V ];[V"'V,;IR 0MD1*DN@JXEVQ0TH)REMK^?;!^V/912(K<
M+-JO0Z%2UE3LZQ7V9AM"V353 S19Q-(B[5<,NZ_3C/LL<TVF"SQV0^MY74)_
M]/\ \1/_ '[Z7^\V7]GK']^_R<_?T;\JE<3SBE>GN5SG.=5Z<].>[O[??3GY
M.*]O/=SG4\5Z<]W.=[SO><[^WSG>\Y_\3X4KB><4KT]RN<YSJO;_ -'W=_;[
MZ>OYOCB4)XE//VDIYQ/.?_"YSTYSX7^X3_"?F<_<\_=_N?;^[_-^Z_<_F_/_
M */CVJ2E2>^G[GO.=3^;]K\W?S?F]/CGN2E7HKBN>[G.^BD]]4JYZ_M*YW]K
MOPKGM3Z+]??SV\]%^O.)[[N>G[KU3ST_/_H^.<YSG.<YZ<YS\W.<Y^USG/\
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M<EP %IG5\F?&-)2[R/U@G/JH]Q?5(4OBHJ?;WG.JYW@EVDUYH=^L.!K+D2#
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0@1FFU./O]?DO_P#W''__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g778708g02g02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g778708g02g02.jpg
M_]C_X0XY17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    ?    <@$R  (    4
M    D8=I  0    !    J    -0 +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P(#(R+C @*%=I;F1O=W,I #(P,C0Z,#0Z,38@,#(Z,S$Z,38
M  .@ 0 #     0 !  "@ @ $     0   S2@ P $     0  !"4
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   ,_P        !(     0   $@
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M96'U]++J36X,_1FSU7_H_5=^DL]=GI>G_-_X50MK>YS;K\)F2<BOUGEW2R7
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MAI.VRMQ'C'\]^?\ G*S]J_R?]LV:>CZOIS_)]39NA%O_ )BS^J?R*G_W@?\
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MYZ5;]1#W65BD$RX-C%W>XO&]I]3W>G^C?]+_ +^EOQW$.8U@8V""T89#-O\
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M.ZL5N;9N_-<7M<US/Z[DW^5O#'^]Z2FXDJ?^5O#'^]Z7^5O#'^]Z2FXDJ?\
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M_^T6*E!H;W1O<VAO<" S+C  .$))300$       '' (   (    X0DE-!"4
M     !#H\5SS+\$8H:)[9ZW%9-6Z.$))300Z      #E    $     $
M  MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN
M=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P
M4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L
M     BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O
M;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M         $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M        0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M           *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',
M    4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B-2
M;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5VAE
M;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG          QC
M<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M   +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !+     $  0$L
M     0 !.$))300F       .             #^    X0DE-! T       0
M  !:.$))3009       $    'CA"24T#\P      "0           0 X0DE-
M)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M   ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    !
M "T    &       !.$))30/X      !P  #_________________________
M____ ^@     _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M #A"24T$"       $     $   )    "0      X0DE-!!X       0
M.$))300:      -K    !@             $)0   S0    ; $$ 3 !! %4
M3@!/ %, ( !4 $@ 10!2 $$ 4 !% %4 5 !) $, 4P @ %\ 4 !# #, +0 R
M     0                         !              ,T   $)0
M               !                         !     !        ;G5L
M;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   $)0    !2
M9VAT;&]N9P   S0    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L
M:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M    !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T
M960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD
M<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE
M9G1L;VYG          !"=&]M;&]N9P  !"4     4F=H=&QO;F<   ,T
M W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M   !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O
M;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M
M#T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M   /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E
M;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T
M;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E
M=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M     C_P        .$))3004       $     CA"24T$#      -&P    $
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M<"]NT=VQ_60/^\#_ -!/_1:'C89H-[S4:]]1]WITLU(#MA=C'U-S?^VT3_O
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M?L@^P?8]VGI>COC^3Z>[:DI__]D .$))300A      !7     0$    / $$
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M<U)'0@               0  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[@ A061O8F4 9$
M   ! P 0 P(#!@               /_; (0  0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,#
M P$! 0$! 0$! 0$! @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,#_\( $0@$)0,T P$1  (1 0,1 ?_$ .X
M 0 !!0$! 0$!           '!08("0H$ P(!"P$! 0$!
M  $" Q    0% @,( 00! P,$ P   08'"  1 @4)$@0A PH0(& Q(Q08.5 P
M0$$B&; R%Q,S%G" D!5#-!H1  $% 0$   4! @P$ P4!$04" P0&!P$( !$2
M$PD4%18@(;*4U#47E]=X.0H08"(C4#$8,$!!43(DF&$SL)%"&8!Q4G,ELW2T
M92<2  (! @0#!@4$ 00# 0     !$2$Q\$&1 A!1X2!@87&QP4!0@:$2,-'Q
M(D* L#(#<%)B<O_:  P# 0$"$0,1    [^
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MDM%?"5I*>4]?X?4\Y_2FE\):JW>GY+=6II"2R4>\$3$M'L2S5N4\I<R?(N\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M            &HE90)!,6C86FO::S)LQS/B9+F&,NP:S7O+D]999$)G>8#2Y
M_P!F <3;5P&-AL$-?TN:MF*96R=C$4V &OXRL(H+$,S$P:FM@5FOLR#/X8^F
MP9-?<UG1<X8K?I*IBD;!$U^368%D"%(,J#"F78/9KU,F"V2%%S[3 "7/NYP-
M68"\C&*7819KYES.LQE/29#F'<NP*S7X92$<D:&;9@E+L LU_$\E0,=#8,:_
M)<W[,0B[293$LV"IKZ7+4S30
M        " 5CU;@3S%_D-KY"7$N<E9
M                !@NN*#7U)7292!%AQ<A&<JTR%0   #EL;_*@
M                                     "EFW1G9JR  .8UOIR8
M                                          YC6^G)@  <RDWTUW
M                                             ',I-]-=P  .92;Z
M:[@               #1NWELE.(X*L0ZMJE 2\3;$FF6;RUN<+EDF6=;F'%M
M,M5<H&;W,*9N1KB[R\3;LSSJ.F0+-N+N%8D@                YE)OIKN
M !S*3?37<               #&9>*EUV+L^TQ9+E6;Y=<AL?N(W.LIC3<UJ.
M:QM7*HN-,1EST2(R9DG(F]=)DO0I<:8FNGQCCOG7(A,@[G?4SFF@
M       ',I-]-=P  .92;Z:[@               6*7T  1&M1/07TGI!$!+
MX ,5%FD^))""(U$C)2RRP2\                 <RDWTUW   YE)OIKN
M            !_G;NW04YXGM9C)BR?99U3'F:U*&V*OZ8QQM*LPOCTV='K/.
M.W(4F9=FEJ;VM)BU5G1;9E;929<)VKA3+@BFYW!IMH9               ',
MI-]-=P  .92;Z:[@              #SF)"XK+=)D FMYJ14R[2\C$ NE?L>
MI/8OR300WUFL:JFM@3-J$ E":]Z5PL@RG3$!;Z*,78782&F;"
M    #F4F^FNX  ',I-]-=P                 !J(:R62"EN(G)-036^=G'
MTT&-YAI5R!(S*L@Q87+O-H;.HUJ9"%3H.9G=                  .92;Z:
M[@  <RDWTUW                  '/8WARN5Z:^)=OUSA*U/3,@RX@VU9+"
M6K&SAG"!886[39TSI,:R(3!]KK2<\@4                  YE)OIKN  !S
M*3?37<            :06LWDE,R-0  #'-<C$ Q&6ZS]DF)?YCRM1/ZDZ%*,
M-ES>08-+?YE,@&)*Y;);QAFN.ZY4IF8@_A8A?@             .92;Z:[@
M <RDWTUW            '/6WA%+:%LG,Y!+J0FL\KC&:66*G=,VDURM9I)KZ
M7"MO(]C)<CQ<4HA!.M.SE"ER9MZ &.:R=)03-^RH)IX:VB,X7K9\L_5M:8U>
M-[9V,-%U*3>;]Q\FKW37+-;#;F@IMT3<^R           !S*3?37<  #F4F^
MFNX            B\^"V0608X+D<DJI&2_4@-<Z4@,K9]2H%VF/I+9%Q^C*\
MQ1,4EV_LXBK-!"!(QZ2QBSS( A R-(E)P3&!9Z/48X%=/:4HN<D4EY
M      .92;Z:[@  <RDWTUW
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M2B%PI8BWV?<M\N0M@_12"_R7T       YE)OIKN  !S*3?37<
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MZ22ECEFYURV9K)@%-7/<V@U;TE=NKJ9M-:Y)#5U%B9>,_5:DNU%G86R
M        !S*3?37<  #F4F^FNX&C5K8^F.:WP?-)2+5/>5$APS,2"UL@M-?X
MF5Q&2R:F*JT%*NN4:8F+]S(9,=ERW2-S[EAF3!CX7^44AE:XE-7(=(07VI.I
M&2_=*H0TMQ)025%DM*H8Y+8:?99J2E%2(^+C(J6XB\TL$EPLU<]60
M      .92;Z:[@  <RDWTUW
M          ',I-]-=P  .92;Z:[@
M              #F4F^FNX  ',I-]-=P
M                  !S*3?37<  #F4F^FNX
M                       YE)OIKN  !S*3?37<
M                           <RDWTUW   YE)OIKN
M                               .92;Z:[@  <RDWTUW
M                                   ',I-]-=P  .92;Z:[@
M                                       #F4F^FNX  ',I-]-=P
M                                           !S*3?37<  #F4F^FN
MX                                               YE)OIKN  !S*
M3?37<                                               <RDWTUW
M  YE)OIKN                                               .92;
MZ:[@  <RDWTUW
M',I-]-=P  .92;Z:[@
M    #F4F^FNX  ',I-]-=P
M        !S*3?37<  #F4F^FNX
M             YE)OIKN  !S*3?37<
M                 <RDWTUW   YE)OIKN
M                     .92;Z:[@  <RDWTUW
M                         ',I-]-=P  .92;Z:[@
M                             #F4F^FNX  ',I-]-=P
M                                 !S*3?37<  #F4F^FNX
M                                      YE)OIKN  !S*3?37<
M                                          <RDWTUW   YE)OIKN
M                                              .92;Z:[@  <RDW
MTUW                                               ',I-]-=P
M.92;Z:[@                                              #F4F^F
MNX  ',I-]-=P              -"[5^$?%56)S,5,=%NXE0@TK*13+/=>-*4
MMN&=S.NUJ]$_2UDPIEW9W&$$N;]F :EKQ;B2HOJ2^3#<QJ:W_N>5@
M       .92;Z:[@  <RDWTUW               U*M1$L@LWHMMI##5F$LF5
MS.O%<ED_*SBF'+66J8*+M;35NNMMK<XQ:*Q(;$DQ?,TDP_7Y+8Q-212LDGY2
M$"S5W$,Y"(              .92;Z:[@  <PS?3RP
M                           !S#-]/+   YIVZ9
M                             H%;AV=@:
M
M
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M&F00' 94R  & X5U2&--(P(<--.JGS_K R$:@X4CPK$!J&FF5$" #4%( /\
M4!I !@)2@9  AJJ  &H. U#_ 'X"/")!.FG4-(@%<PF$A@)2J"F7"! --4AJ
MY8@%<@D,I4#_ %$:1"5.F@.(A3J *:AX#&D)#+52,H 0"JD*1#2$J9#']0
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M@0"H0 *HH#C1_N"0AI *0 )2  $ J&5,PXB(4@ @ 0/_ '1D$:?[2"!"F!
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M0%(0$IA3$@$*@ !H !CR  "0R"D/]M0 -504@ 2@0 1TA&FF50!$@BN)!,
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M+4,3& $0C4,Q$1B8R$1&-0QJJ@1$8F(Q.<:AB8P(B,3&-0P(B,3&-0@(B(P
MB$:AB8SU"(S&-0R&H1CC+4,"(C&H1"8C$QB8AV3&-0C "(0%0A$QE,8"H:8F
M,3&>H9S&-0Q,8GQU#*<3&-0C&H1C75'\S&)C U#5W*O+O5^?9H 1TA 4@(#2
M 5"$@"@!@*)0/E3+1I"!  J&@0@ IB050-( %8>II#3_ #H"04@-.D(  &
M-.@!C2 CHF-0  ARP&!  @0 !J"0#+0-(#%0 $ /]  !@* G()" :  )3 *:
M:A )<-(3T3"G3I$ "!I !'A  $AHE$@$::0J'2$@H 8D$](0%(# @&D  *I
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MY=ZOS\/U>7>K\_#]7EWJ_/P_5Y=ZOS\/U>7>K\_#]7EWJ_/P_5Y=ZOS_ 'W
M D QIC2&F0"(TRC0,PIBL "H:)0-,H&F5(4TZ1IBD &D*!&)<=/'3PT\- Z0
MI@ G&GB(2C3 T2@*!&-,:.%5.F-/]93'3,1X?OZO+O5^?[X*@C4$",XU0(QJ
MF.OCK"!&8C4 Q.!J 0 9!JX4U2@*Y"(SJ&N)@%.H1C7PU!(!E CQ$9QJXC5Q
M"L9C5.-<@&J8:@TA4$PKD(C,?WU7EWJ_/P_5Y=X*@E.B)T1.B)T1.B)T1.B)
MT1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)
MT1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)
MT1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)
MT1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.B)T1.D($1$?_9Q__]H " $!  $%
M /\ 55Q$*03U1T]5LG]NZW6UV7([/=;7W6X65(=HJA&4I.U.V6YW6UV7(*JS
MI.>5%@RF4N$PNHNZ=L;D![3*8[(3RZE[O&S+1<^SF;K;<GG(8O2/N736%%4E
M.T?)-HN]I,%I@[N"1--SJD2M)RO*8[!>$BN:X*B[ULR+;\@.)0Q5#5R>=RMQ
MRHNETMMDMK?G:-P=0DZ+.H;$Y&KM,QG+9*+FU<HW7>HR23P2U+*7,W6UY//@
M^K(E:77OF\WE\CE(8NB1N72A4513I$T\1=9DQ<.E<<[<[;;U(ZO"0N!LL&$P
MV HV A* 0U5)O:N*\) VM.5:6A'D#)JC.-;XCQ4[%?7)'4 3_P#";W_]/&>>
MW"&IM[9'OOOW>V9:_P"=Q:*V9/A<1>C0K.U<LY+ [E3R"*DA%R>XZQ]!3N[7
M"5R]EU"N2%-E%ON:9E3SKZ>D\=NK2P.B8.YM^SE4,61Z:^.93!;U74-<54Z>
M9OAZ5YJYXNS_ /)VWIIY'R%\]N3AE.R3OC0-%G4K.X4A+JC+KEU1QI%F>$_5
MK=]8 [53C*_U[Z<[:G/SC)4IQS>4>8J^/)$X9QV>)5=@JRNM7? X!O;!^0]I
M>E%;RV)^KE'*$DL.Y-9$QWT.*-"RNL6QZ3BG/M!<TH2IK,VE57LJ]C$(#RUF
M=OCHPI+VIJL\KDL()59&P;,M;&XY.L<?)6)X&YO9ERDOIM#4E$R/JXQ%'G(%
M-=$VZ?%/"N7MR4DM=;?BICA152E"=&^5@+V<D*\7)M#A7F;=O2$Y)5:4E^Z#
M.'<.W;%%U'UGV)ZPXN#7%?B^XAD[A7K/8?1ES3D+ME-;BICCV[VL@/0R3*R]
MGJ#UOO&T;R57LJFSS&F]UV3X64$UT[EGRM'LB\Y7M@G3H7(N27\X-7Z@@CDU
M3V@O(NQE6YGKW'EY&KT^PX/CR1J&]-0#*?6;D5^+G'Q%93LC60]P=CW#<K];
MKXOOX$0 0L*((N5>8=6R(X:$U9'CY;NQU+;<@+/F\7[F+?C1-2.W=G;2#!<[
MHC2-W:WA;VA'O?<LED[DF\V(.S??D/FM\03G(Y\=F_?^)7%CC++PD&R31.;:
MGUIM;>[NIN]1YBA.WS)\6]I;6H!29ZTDA%)2VWMX6@R*AR64HE9M^FY#N?)9
M[BTOC>W"J&BZ.JYO-JC:0[+9\IJ#6^2M7*(I)Y!SN*/HQ?=RH+<6]*T6+:B*
M+V:L_HLR(30X,I8Q[#R[LBZ.& =FER9V_<J]BQ3Y4E14,U)X2R7R4\8$R0B;
M:RDZQ$[8<]M.U(BH-U;^MR>V%%4;*N_<IC-+#BSN8"_8398N4E"6[>\+*F##
M2Q8^:W]LQ\+R5(4QL\'!,;&VU3$T+K5FPE \F%F;-3'=#<32@H!>5MKS:5^O
M&U)),V)M4]&4@6ZSU(TD%>POS4&N&I8]\0R/=#>:$41H[W4Q(PCQPW>[3-.-
M_>20TII:8%HJM+:N12F:B433UL;@B2,7?D*NU!KB\&HZ-0:XHZIWYM+<C4=;
MPCR2&'D/:Q4GQ[JF%]-4[*E^_"\[D\K<<H[<@.:P5R#A7$-H,S0K@X*MO"9;
M>U-Q9?:W"J]O;*WDUGUL*77I?%-)3"F07I=[8E/.>XL6YMSAEH7YI%\9!R-D
M7WX$=!5.<4X="%6< HY..3WG&EHJ[!95PJ=H^@IBERGV]94M31PQY,RFJA8+
M MSQ#^\I&3<Y%5PNCGG9G?9FU2G=&6S,VL>WY^1AQKNS3LG;I2J*_63;H HE
M[4!?%DY"T[O+JIKEEIVUJOIZ<?R2:25'<23;QF/("?G?'2L&]3"WY-&0'YQ-
MN93ASYQ:*?)RFNA,*9\M870N7LUC87O''4;?GNU6]<%QV[[+ZLR?79W"UJ"W
M!0G3G0N+2UU3#BFA92I:'/<](7BK;2DC?"4;CBXKE/R<8?VB'&U*H\Z^ETTY
M!5=OEZNKH'(IY>C4YE3>1C.<6XA=T.J5I0%)(UU3UQKCE:= 67H+L;[ 2E37
M=:521I0E!4Q9\;ZY.-.W.))[."R.S)SF5=MJ2)>+F3]=6D*[O5G;=^*K3A/.
M9:KZG">&C;D]/R$GA:WR7II<R]RT>23E*):DI2ZQ7W9-[0.V\\C)Z04P+]D0
M-"BUM[B2"7>-ZGZ2I6DVQM9?L-CY]Y1Q(C&1]FD23V_:)HV6VD=?#VA2(JE?
M+\ER9FHQ;)O:!VTB;A#D5W9QMR>D&T4&M"40/9=_X\('_0H3P@<LW[I'$BWI
M[Y9!(G*V=D1)&"T< +); R7!'$BNQ_\ _ "'[3_CT@C08"]8#995$21*E?MO
M/VVVW.VYB;)WSML<4B2A1+MRB*2>3R$]2]-$DL)>1I("D9M\C*/W0B\M'TDY
M5OJ11&JSG:461RPG6_M]04UV\XDLG*(6]XB"+7$I&0HE0Y;:W$\I6@Q;!($E
MM5DW"<I[O-ZN;44R6%'K(A*(%FU&Y'4C4 P7!*2#SK8@#7RLCB-G1'TD4@KW
M),$UO.[Y3:VY\CD&)'DD.!RMJ((O9C+LR*2;?SR\GQ"*6_\ ]-<O3!\@=RO:
M!,\>8EBLNJ;.Y]<375CZR(C2<4K5DP-R_P ?60^&G("X5"MNJ;)'S'A2DS9
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M"H"VI">'+FQLC46;D8-QN.1M.1M=UM=]M8M)F+E_WO?W^_V-JV)"/Q)5(G;
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M8GEUB_IR53>M>00EHP2S-8SJ3F\O7=6>;_=\C+BTZV"N).NFS>%8W'N8->,
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M&0UR%N$IR*,ELJZ#?Y_82YE7"Z2-+=1*2CE$S43>ZI_;="'#E"<GY+?3(6/
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MDX)8*[8!L(R".AB<9R&2$&!!%F2/)C"$-Y;3\=]M;3K:^I6GJ>]Y\#;"QFM
M9/AJ.K,A!QJG5ULP*S9;C+R\^&DT#DS8-'6]';7T2TM,#JFT]^U\T\^6;1=U
MROR_# X+6;OI.-";]FV;2XV35;+ 4(K?K7E ,F!DKJ(^E5Y49Z>\%99_2L=9
M^KY<^CXQUV5AV)6FL9*3#:%@C<_+Z03%9:<;0T1 W#*HLP$XQ0S4=*T/1IHM
M$20UWY*2KG><^#7J_(,*\UE]&ODR^5NQ^@*KD.?1]#MLR =,4'1Q1S0V*U'M
MAA3AP!,&%4R)*^2E15-N_<2GGQB]MRFIY/9<JJD:!9L!(5RG5SE7I;# V=7Q
MIG+XJ!+$:GKCAY<F$RZ.;BK;BNN-)[QM:D].Z?5/.6$UG2;1;N7^RZ#7\CH
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M3M3"GF+4&JYD@5%2Y92O"+/&;)183ZUQH\]M,AM"74\7RU3[;E&:VB=>A-<
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MK>K=Z9L66Z'XX\0>7?0,;/,E=H!#*(?HEW!M4U#6D6*<1KIB7HF07,Q4HP]
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M@L[+TW/*#E6C'"0"$/+Q)U->!;!5;A5V!Q:40CR5RFHJ9C;D%M*'.-K=0O\
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M^N!ZG_\ N5_"'^ ?PQE-Y])W;7=;;KMO$N^E+#1\RKEU?,6":<DUZS=H]/K
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MQPF5 D242G(JICKDUQ*W.MH:0B?*C?FU]0CHTJ=-DQ1T;RWX8=8'Q9$IUZ-
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M[@U+QK^["[&JU=S7*L)TQ6AI+H#<#I+]VNAW;@7]UU#I'6/V=R/^H_7N??\
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MG\NC?^!6_P#'(UBQP5GXBW7G$Z?ZSE7%A5)O/J#+<\KFEZ3@L.K*K+#< Y6
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MBG9TJ;=3 Q@:8,<F2(8Z',C FI0ROS7XW[1=B=EMQE]9XY\O@EHFSZ70<DH
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M[0J>IWWR;6M5  ,L\P^>IC06CBZT%T4TY!'Z'=<AHP3A I-9=>=-%9TER/\
MK'$<[*_+A2_)7FH'Z*RO\Q-(I4.LZMW6*!G<+RMI$C.B&,ZK)V0)<R,>PV*I
M.UP[+L Q^NP2;ZW66X:F_O.]^G"M[\;>?(7M^N1/Q291^-V[44%HU$R:VU+4
ML":B2,QV9^;J)H($)9E:Y3"(99B,[))CT_<D=96GB$KQOSM98HW0]KH=2O\
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M%=->5:KY.P87YRLIB+8;1C7<WK<ZAVNP0B(LM"/6L(2@S&+.;AD0D)UJ7/\
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MK6#@YV$D#6=9SCA+F?:!!BD6)C0VS4CAF7^R9,?C2A_ZIW['T?<5\Z#ZHNN
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M,,-1BS)ZBP K%;,\*,,H3([)C.J>XA/U][]//E= WFGR_BN,P-'95%OR*31
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M7&.GQX^ 7G@VY\5PQ!%%9$^(,)S!B7>S8P\C*%2FF'EH2V\Y&=2A7>MKYS^
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M2.HG_+]?UM7)?/\ Z>*^/,6\WW88N@5C<O6'IKS\<PP7F5)KH>+1:C,]/KR
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M,U;32(2M*&Y35K\0S7'?8^<><S-!CT+'7<G?QOE.R^P[1J]^TBP7D-M O1&
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M;=],M$S\<6+Y':\ZS;+K%Z&.W#0A>W&0.<%:4X*K6&_OQ*$Q#$]HI.'A D(
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MG;]Z)26,\BH+.3,[-7<33'HO%HC1BU?)IZCK_P!S[?F_UP9UNOMUOT%[F_\
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M17BEC-@ZK/(?3]^0#%%[>4DL1U=ZVV]/?5SGS<5\\M9'YE2XC.)5PG4,C:9
M0$M9U5C5?AU0O7ZFWUKJ XDE6AS$%YAKG$.16DMJYU//E\61C#LMJN8Q;9)A
M23D&J0W( ][@SDS@J#"']?<A!@PGA%_D2!";CPHO'E\::1Q7?AW=3.&YP2UI
MTM6;&Y>IU=B2"Z;13%P5U>X-_=XJ&S<PC(N,PR90TDFF)';C]?ZPA+?*83&U
MG+8>79C83&XT4O&0!;I-,L4]-N.'=0!ED.?L87(D-W4W+D$T.I1]!&2XI?TN
M+[\0-TRW%,B@V\N[8+77='JP,3)>;9TR!]VU$*66B]D0@P30(TO]60;%=8@E
M7GNRG4.O+Z[VXU.HX'G *J7XK6#-JJ\,$U^[<^;2K(FX5!$4"\MT2%'5BU(X
M0@0X+,:'%E\^ZVTE7\?Q$] &<LJI78QXU H??"$1V67@1VQ<\&U(@M/OK'0R
MS(,K*@HGML)G(A276$N\:<6A5*H%-K?FBA9?7\;?PE@Z8Q@C9]<S?.I<20"E
MUW*)C=N%Y^X&C59Q#02">$$(5<,-H*L-2'FVV4Z]01%0S@Z]:*K4,LWD E0P
M\9.U@304!*94=59<D3"LMOF<FDHB,D_^X\-E\7SZFW>*4!WB?D%*<U^MQQ,8
M7?F1GZ,[]%?@S!E=<).0G(\<[*K8XB_'&O3FY+P]EY:(ZFTJ[SLG;X&#YI%U
MF5;7;]^_3=9A?MN%>98PD&*W(.XI"F 5IL(PO)9*D(3<>662\KLQQ_OR[RPZ
M.>JU6_>0IGW<\M%Q)PH3<Z5F<"<7/+JQ<M(XGO:M$GF9LI3+BN,H7(=7WY?5
MWOQBE]BY%E5FBYA3*8+Q"V5Z'!='BLW \'',^"UXL D-PCV?B51HT\1"=7+%
MLN?3(CM\6KZ^Z-FAO)J&4H.N64Q=-,J4VNCY 2ZW$^0@ERML.PEL];EV628%
MQ9B9W\4IJ9&9?;6AUI"TU3,36#T M3J(]9)=)B$1CLTQ4"-P>^_:S-9MDB2Y
M;@1^QK[WDTA&G-39*%*0MU2%=3WR=$@"\OJ?FGR$97J&<9$ HB89AC:A%.M^
M;9Z3$EHTZ*#J='H5.OI1]J'"@]F32KK*G'T1VELO@PNPY[7;\/K)Z/9ZWPW%
M6J97S\9A^)PF%)Q'8Q,7(DP)3T61]AY"94-]V.]QQEQ;:JYJ,*L8;>?. 7ST
M0P6DY%4JE7GZ,$(Q=I)7>UEJL>JA)H*.#$2##X8T$B1T1YO6GH\WKK7W(WQ?
M-:UF@YSH]:,47 Z9GU!-4F)^CS]C%9FG3'XB'DRNP#-1LB[Q [T$[$2,;<$-
MK<:?5]OK-=TK4<6S^]7JJM#(XBR6(!%GSE1 991\! ,)7SD:R#:Y8%J(#8Q%
MN6P.(*5)C(:?[USO+MS/ZK^]W+XO4.6/]D1/VOS1',WYCR[IR;]'WOWB5EO.
M .R?G]S]E?\ V?Y_;_B^'Z]8,?H\\1(V-CT(Y&X(;AK3N$<@@HG5&)<%46;&
MN[DM/?NSVW$//M..-.=4TZXA1XI>\V"W\86U$UL8VI6Z,V4JM:OMNB5Q-^GC
M!'4ML3A=^-52&7*C2/ZT>^7XY*XREQQ7SUJ2&+I+:+K%M1K&@R"Y$;+MCT67
M C4RG1NQV&V)\2D5H!4$"0S:T=90F&_\EK?5(6I>B9;Y[S&FW;A"R%8%C&5R
M,X1KT^Y3RA.W2*@N;V6W2^V@@;F.D$B4PDS%RG>N\7]:OG#VNRYCC0#5KI?P
M$@+<[%" P"QK6^CI8X$5JR"SK</FK% S#T7]<.:2;(0VNLN..LM_0G)*U<<4
MR.*.SR7(K6.#GQT"O.!EE9#MIGTRK+A2!LN:+,2@JB,D*E3T26N%]]V.OK'%
M(.4>_P!5KMWI=G'O";)4K:%'6*MGQ<CY??'F0A>-+&DH3OT\^IIYM:.]YSOR
M_B^-$S2G8E1AM UJ+V!I52F#G3P2ZCNCGQ*!9^'89!5$T4P-DN,-1>__ &=E
MM?>(0GY_#;=8PW,:U!$V2E:&^3<"1')RK?EG[2D46\'+$57)*E;)2FR4G]$3
MG27I45I?4\<XA*><7KYG/<XTF;HF3PL^?O"6(!\=?\<*F!M]"@Y<Z&^^'M]2
M69CQR@UQW]2VRM?78JT<>7U=VV6EYA5@.IZ*J=VX7N/$<?L)1LJ0:+EXS,V:
M])4)@FB\=J7-CPN1V)LIIMY]#CC:%)U%_P#<6L_>VWK/==<_947Z]&['IPW/
M6/WN5]'S-?:HP>**3][ZOE!CH:_^E/.?&=#;UY_S"S#LGK(RD9_ )5B"N%7Z
M('2/2-H*8K:6V"=!C=$15<!S$R!*G(S2U1^K0E7#@229\PPP0D%F=?U J*SV
M0<]8U"M03J+I!J\<]V].TX#RX0H#K=?,EJZZ0KD.:0=%H<>D??:D;%=,+SBS
MZ9,;K')MN,UR'-(S9=)GPB5,-36W4]A3+-49(UC@PJZTHE 9:2RP^VSS[?Q:
M]*J=3IN=>CM$JUP7_:+5V!D"_==)BQM7.Z)"!/J<$%+% 1(&L2B[T!]YWB8K
M$EU;?4-]I7D&XUMW3L:J%$I=#E";[/FEIMRA4ID9^G)W*>R_%?-E#A$9R82Z
MOOVIK[KO'$*;<4CMI E\JI$@+=LL#XA:1C(&% AE\@KW[?X S9]D>W%2U3@G
M+41Y$@M?;8C<FN\;2GBN_#6>:Q0Z_>:?&(B# \.:C+7^QS0!S[@0X!(1G(Y0
M =$]ZKD>;"?8E-(6M*7.)6OG:M-HF44"FRJ1'O,:HNUBKB0?[NLZ<2"&M&X)
M0.BQVXCEZ,UR#,++3SBY\J,AY[JW.=5VB5"R^?\ ,"M8S(C925$!OUB$V.K;
MMU)O&KI"A1XZ64N [F6D*DF!SOW!Y1[B52F7>H1]+6-V;/Z%S"JR!KL!J@%1
M(N/GH&LY[(&&:S&X*?0V)&AJA(KT21&Y\D,Q/T;:D_3QOGRTK5++7<8F5[TO
M0:+G>IZ,335/V+M.;DF2E8S:J6>W.N)@7&L%&M-E0 T=R0\S)_;?6H_%=DI2
MJM;@0QVDN:S48H6&"O3 O]$;9CUF++@UA,]R"Y&CG'*O#(/M"USFY+@YM]Q,
M;K7%J^9(*O#\U4),4N[9T5'*JPSL0A1-)N;^BWZI2F?L_0\"M]ZDN%B$?O/M
MR9Z^NKYU??G\7R^:W2<U(0BN3E,\TJTWX6"<%2L6@R"5G,UBXDCR/V=^X<*1
M*ESI+4M7(C75..K^7/GWXLE'!>?\M[2-'33"EH["$MR9EPETE4F;G]H)6],A
MVR%;#5/V@M8@QV<HA"2I/V'T)2CY&<UHN9TBI4"QN&W[%3P%<%C:_8)5GC<B
M6:<<&QH[<<P0LK/S_:,B1QQ^<M2EOK<6I2NG:!7?.M'%TRPQZ7&G5UAT^L;$
M1G,F1+H#M>:?-.JJ<NF.RG.#'Q78;\)M7VVEI;^2?B!DIO <O<SL3:)UW"U@
M=5H **!NI3DQ)>XU^4"0-(@;6:02E)G$8;S$R:F7(X^XYQ][BRN>0*-E9,K1
M[WE6MFJW X)DV>G:13@ $1D&BDFXLE=BKMN'U:A08HDFXIF4^/'_ &D..,\<
M3W2=OQ3+,NI_HJ[!K2XU>2(0B@(1N%ACQG9!RUAJ^0&?J56 L,AN')</D8H3
M0Q_W9"E_)7*?E4JS I$U5GL]BM]O<'B*5 O&R;=HQV_7<L/#,NIC0'+?I5WE
MI&0/O29*&G6(WW9#B?K7.] A<8S\9LI*25(2K_# 1637[9/#4A;!9(R4\_0P
M;98@B.02)=AELG/A<_3R'W&?^CXC58"&JN>Y30:S)CL!X[$ '3:K41,1^3,0
MIES[(T:#@04.+=^OZ66VN*ZKY)^?P[$@89AU:KV@3*]6VU2Z^$;C'>$;F"N5
M-I(J82^XXV!3>P@Z<&!1%MCX\]AE42,A?RYW::MF7,YHE[]%TL1CFLZ3:*9+
MM1"?D'8UG %XC \<9K_3%FK]6O9SE<Y/D.#(9"?UR2Q(8Z['='X#07:S*K&+
MTZGY1)H48@+,/U&L#:8*A52LV@.VMYT>F;2N17&F);+?ZF$ZAQ*5-KYWNB4^
MC8'FE<K&LU]VH:*$A5R*J#::6[$(0$4:>U)^_P!:HD*$6EM1 C/6A4)$I[C$
M=OCB_J-T"U5P-8J19:]/J=@JAD?&(@#59*CW11("3&2FW(DP7.&O+8=96GJ%
MM*ZGO/EWXL5%#974(U4N&8UO%[<(?'<((M>54^O&:G6*)9I1)R7./UX'6;%.
M@QV9;KWT1I3C?S^E7>?%3VB=C='5J5'A A];NL<5R 9B0ZK'E1*HQ,7 <C,&
MDU2--?0*[.1)4-2\YR-UKZU?.E1PV<U$8QG%NN%^H34,+#814;KH'[W_ +[V
M@"E#?.#C=I_?\W^ND-_)<C]J2?J[W[JOGGFT!VIE=>S6'N\P)1:[U@+2B&A^
MC+'7;#INL60</:8>L5Z)*"266GY;CK+/#$]WC?WWN.(AZ1J&(YS?;K##1:]P
MY::W!+N3@PZ>X5#P#4*6AP;8&J\5><E"^SF9"Q<EUQV)UEQQ:E7+:ZAE]5":
MOH'ZU-KOK$-Q^PD6RDN,0+QX\R8])_8\4V1A,2)[,+D9J=(8:=?2XXVA2=1W
MS1J=1=*T>U;XWM>>V8K4VVC&>I@9EF-%KPAV0]-FQ[(3JABARRHDA(:2L4^2
M[V&AAU"GG-!S,QE%$)Y_JUC/7'1JA.K@Z2!N-NLQ6.>.6DY =94S+L4X]$9G
M?K>\Y);FLMOMK2ZVA::$BB8_2:TK,;%;KC1Y4$4E1 '<[\#E5BZW3]I25OD"
M5RM-<G/P)Q:6[((R(;[C*WNH6I/;/G\?!LM31KG5>T:T5%5/#NUTU3>7"WZ"
MS5Y8AZ,Y"_84&\7\T6BQ4H2U$GDGWF4MK7\_BI9H8P>DF*)2+":M5>K)=LF4
M'MG;*I"K),+?KR4A^RMV+C:4SV":Y<>8VA*'D+0GB>;A;H%ALEE.[KIS6C'I
M%ADQEQJY$%4>H9W5*'48$&-$A!Z94JQ3(Z(L=*.N+DOR'W5N.O*5\7S<*'G.
M4$=%L1*YU#1[;6&Q9%)&R/*8KNC"[2.&R7P'[Y2U"&X!Y<B-PF_^GXQ,4KZ/
MHY9 E"\_Y77Q=QJ9&@6J&BH"B"+%GI1Z0]*SHPHLQ/=GYVCLQY$<"XI0B(RZ
MMIB.VVI2.@%9;DM3J#M5DVR56),*/)ES:ZJ]0:P,MK .<4E3I@J <&TH1'>C
M,+;C<8'1T)0E+:><:H=(J0"K4MAX_(:JX8;&A T/6HR3L5D<X.:1R-U1PX:E
MRY7S3_WGY+BE?/JN_&'UZN8QG(4'YI?D2?/PH?514>#CLB55C-(DOY]'1'XB
MM//U*PSAZE1N(ZJ-*<1W^)7QT*:R*DRAW]L\;T4AIL2W">8W6(327:U>--@*
MBS8MY5.3WKL]MQ#SS;CC3G5-.N(54PC>;4YL11-%*:[3!C8*"W!J^G&RMJ.E
M[T$C(:2T/LQ Q>#$EV4WQ+BGB4A7>_-Q7SS>ZWNB@+-;\@-EK#F=E(Q.]-4P
MH?#/5\^X%(LK:DLQ#X5_L>=%4I468VEO[S:^M-]3E[4+,Z7&:Q6KDZ5DK+8&
M!QK/*B:KX^J%JW5&NL];$AB5:$QH+T=OG&W(K"&^\ZGG.?&ATWSS4<XH9CDB
MMS-%I]%F1$S "9<,A*ID,G66)\E=."K'2)3@B"VQ#@I84YV,UQ'U?%TV2TU&
MB7S9#V][CL]:TAVGLCSU7CZY:2Q4:,^IZ:0:(V2HU@GT*R<4E,WD#KC+'8\=
MYQGMEWND9=E?]LK9RP0[)>Z^/%238FXF1T.)<);R(CCL.O7VP!W6&3,UMF.7
M(1%H;ENNM*XGMUS^7A^9R:1H^MJWJ^U5^I"7 =NVE=S"Z(O4#P]<?L<C=EWJ
MN0"W2#G.R.SHC;O5?4GG?BI;;<,IJ)O6J/\ LKE;O[T!4>QQ&P!%XQ7H\V="
M=C=-Q*Z7DNRQS,_DEJ!)><=CI;<<6I1:!3:X(K,([:;1=C,4-"9@L$[==CDV
MRVZQS6V$I2^7L=@(OS)CZOFMZ0\I:N][WOQLR#.,4,E']#3:V6VJ%+"LNCM%
M.T]IEJKV4^-[W] NU ^Q6'(Y5IMHBA^+'=^]]V.RMLIG.#!:+6ZW4+04A6:O
MT=\>^L7>R<8?8CO[YNQ9$HD[>BD0U$GSG2CBR<EN6R^\I7'4*5_P_P!Q/_GO
MI?\ (V7^'K'^>_TY_+HW_&FE<WL.IZQY^NNW^D<+Z")97D=9SFQV/",%UN]%
M /G:VQ['%W?1+L U3"B@&01D"Y]5+.2)C$9QA<..^]#]/'_8Y8?-W@%Y5TZ!
M7,<HN9UND9IW3=UR0I%I],M,@2?OQH;5!-C0)FOE3$E\O+A+=<3&CR'AO,:U
M$?:QBJ#2-KR@'Z8/7&*!BHFXC=G9.96:[RY<6"-AUV;4+G:@MEF2(#<:,U '
M2T=:3&4KB*=C]J*5R'H?I;?*!M&)HD5\&-(TWP+;1=NT6S 7QO6G(UFM-"K&
M2R@,RP26_J40N8U76$.I9XO#-&-:-,!TVQ?@Z]/W.XX%1ZM1ZGD9V?'@Y&)+
M<& H(!<VKQB,NU1)+783Z7!O1B8T1QF',FQY%$/6NZUW;0L7\15J]/U[/D4$
M94!=&T[SG4L2ALU^LF0,EFQ$,GLH?4VEE$F7BAB%^Q79<>6EI_L)F1 D>H*'
MO!;0O&][]"C+NSE-#%P<NN&0Z'A L[9JW#JLR,-*^>=/KVSO0A/[;24*#2 ^
M*KI>:F4[]CW#B5+V&?GHG,?+?D35&I=%; LW.N6W1_3.IU@]&+FYD:=.A"K?
M4:./2RPC]*^C]*MQIW[;SR'#D.M;;>:/9PE\\U0R6B 85-B66R_K-]RRMREE
M$?NZV&'<(RR:9K[0V/ 9><:Y&4CL)U^*[^5#T!FNKBAH_#+KY"L1"FEZ)6#/
M]MY$=YXQ6+?8VF&UCHDNO0+#3Y344;VK\#/#B2>RW%R(_.0.VS^SBCWFQ9'0
M/<5B\M7"B1Z)EL?)Z_BE$A1@=ZV,[K1.W0M89UB'8";%@ACVH?!$D&IL<P/E
M2'?VJG+O(F8:6O 1!GSWI_H:R:E#I=2NUON<FJ7.F9N$S>@0] AEZ<-C5XA=
M4'+-*=&DIBHJAT6/^CY+<EIR'7-!V]V>*3X4_(+5] SS,X58;QG69^ >F*E@
MQ'3*LT1&%;&(!:RN##L<)7"4F6+2RF'%F_HI,ODKS';+'>*YL-;L/XH--W$#
ME+=#$5<#G=U\Q85D-TI JGG [D>Y6&HGJU:U#SK!N=+E]?A\GQ),)KJX7Q>6
MY!4_%=L%D\/5S)M]WC&,FJ4)>A[OZ%KF0[E3P6=Y1?3\:V9R)I1EFS58A(6S
M+A_K>0)I$HZW^HX/7==ENQ#2R3V?9!4M&KF84NUZEI>R7DT,JU9BU+*(<,%G
MDZZW0Q(5QJ(IF&$@_4N0_P#:B1W>IS7S:G69&;.1_5'L3&]'OA[.L3-;?+S[
M',0R+7*%'EP*>0O&#@=4'E]8:@RYT*'*$R1<7CK@MF8ZIMCRIALO8*WEUH-U
M7VM9M5V2NYA6Y<[8RGD#T4+\VUZLT:JW66?J]45<5'&K;;F8[$R7%C-)AC71
M[;_ZIFZ$PFAQZG:N^>?9!]>C9/R#P:\5'7K<2Y<W2W#C1M(T+9Y$9Y4=U+CD
MR%%E<7'E)D-MR>4'S/4?5;>1?V-_C^PC="^HV[.<TN6@[)==;>O8$2=*"CT*
M%5^8IDK.:<;/]&1QIDG-,1VE%H2FE/R\N]87>26Q^][1GN:PZ]$SND?VEGR&
MN:N;$4BCB\<S\_(7RZJT6WF(RZO'(/*87!GQY$U[].A][E Q&3L#>9'R7Y&K
MSY3L%\U.A8D[K+N8M^')WJ\$">#YV>M6(Q]UBG)C \8]$;<@RAL=+\T1]_KL
M9>.>3WO0M-JDUCT3[YPJ_P"W!L]HSU[V %YFJ61W&@F*'6#PTOG5;TL8C27A
MMI2T-G"?U(,DXS 8^;;,/*_.\;=*CEUD 99ZNMNA;[FV<5&Q.[R8\_>K+1Y)
MJ1G-*I?5VZGUBG37J^Q:[5QIL@[V07@#X#T".Y^H<TW;J?*Q +L\7RAYOA!;
MR/S^.>JAR^3_ ,@6^>8SNA1)KLQNT&\=NX6JHL($ X1<9'-DW%,2ENOKDK]L
MX%8/35G>?R*S?C[T>C[#7J;GU+T-03>-M34[+G%D9" &*I+  [105$QLJ'"@
MD'HDU(X@].9;?7,\. JS:(D>[<]_>7H ^]V<%!,=ARV8UR:.6B171:00B8=?
M"HF+BL-IBP4$'6U*;_3H4RJEY==K13M5LV;_ ).IWGT)H=NS:IPS%BIIKQ1=
M-YH4XQ%"0(P*I7X$=N$0(0/UP<,7)$0WNLQ6E37V^ZCF/HZX7>3Z?RMO-IVQ
MYC<J+FU7$4-^^5XE(''L<LV6MO@M'P2]G:X9_=@E.FRK#'8&.Q#"(I%F1'1Y
M>]>'-1JSM'],>S4^=IODN32JT.9HU'M^LV_%@ VLW^/%_M%,;MD4VG.6"V]G
MO.")<>(9B-#!W(K,EMK;_26HC=&M.V9=/O[8*ITFO4NJ9V (526PQ5*QV%&Z
M9/*DQF.3)<TM(DN*(/N\82Q$XTPCQ66N-R";)2K]^,O1M9@Y&-I@:GC,\/\
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M9]IQ 0VB5 .X #8!HN#M;'1J@[7HSCY/*MSQ?1BT:JRB:YA^"=!_<;)RTO\
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MC.M$&20_3#EZHS"BZH-5MI,V\1+V$,)2=EMP&9;[J8#+W6HWVFTI2E_SK8Z
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M/57[@6&^V#RP^FLH-T""P^VXRBJED4T4F1#ZGK+J8#/%<[Q'.?"O,P[*ZGW
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ME1)1U)"2W):#/0([K$I]KK?VGW4+1DN4Q:/7 F40@M8[G='X$@0\\A/BHQ,
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M<?:7 K<:\P0V-GLK_'Q8O46LX@W1*\8N>I[&&O6P4*FU3A+IFW1,]I5\'TZ
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M#0>N7*2Y"8?::ZY$G<7\EH4COQ:Y.98;1JTNZ59ZA'FNP9)N'_9W)ES)\C-
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MQ@NU1&(%LK[)ZM$PQIRK6V%$9:+"G)"QI-##7)3#O&F_I!W:IC\J VX!0!>
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MTKG512(V5%FL<4M*'>)6OBJ_FL?$J:*I=5UF)N]>$ &B%;=$[+$F/SUZ9$+
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M_P!O_N)_\]]+_D;+_#UC_/?Z<_ET;_F#_<3_ .>^E_R-E_AZQ_GO].?RZ-_
M=+5"R@+4*CDR@5\G6S(XX/9, Y[XHV)=F#),J,V3#DXKL:4QU7'8[[:FW$I6
MGO.2%C2$(@B',DCI:X,IB6F*0AK^W+@R%,..<8F17/\ I<:5\EH[_$KG._\
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M@I#@2"LP;78$R2S*-SX@N([)<9C(=<;CM+<5SB$][S_A7J^8L8$4>MSY"+5
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M>E.2#QU,J=)%"EID1XJW&OLR?P%P:_E^&E35LSG\Y]V$7^UTF1:[ODA^C']
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MK'GT78\M]%V*-;=OB:)=-+U"YZ391;T%^M';)J^BW.T:O(,4EX9&77Y2#:)
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MV.';X]8U++:-H%:SK6*['M Z/.3#L@PHQ]YE/.IZW\T=O>S[+YS%76ZZ@,I
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M[DK+&]=.UV=IV=TK0%VX;92=F\LW>;V'79!4B56*<[UN4W)2KZ/C\FNV/53
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MQBD>DLFCFAE;MDNT@2E9LO1"K)3+K0K28I%YIYQVOE#@"9+ 6@#*9;EP)LN
M0C<:E17G8[[2U?\ OW^XG_SWTO\ D;+_  ]8_P ]_IS^71O_ '_4/7OAOV9;
MO$NR>@:W4JYZ+$KQR@>A<;V"5GP=ZOT*^D,RO$^N/5S3ZP"=3#06'E6FI,9E
M")$5SZY/9&[GLK]_:7A\7V[E.<YK^0."#Q;,K+*WTQ1\Z8R@WK.2S24J#"\Q
MZ9H5![)'E'A,,N+2E]#[$)N7'9DI]IT&F:7=:G0/7GA;"_ XZKH&B2S>,99@
M&27O'Z:4K1&:XF;9BS@"\+>>205SG7V/_K[Q?_1XL]!YGZ*L]#L?EKS._P".
MM#$$<^JMS%[_ .>9C54F30$CLR8*<S"YOV>G1"'#8[DSZ$\['_2];_C^/ )H
M#M%WMO? OGO?//E6BF:]78*=$#;S9:W9"!VQNP._4)F5IVMMM1F8O%)>3WBG
M%_-*ON>'QOG'VEH.0ZMXGG>LA 37".1YWHCN@YA[*TTAINK4TU1S4H=6PUB#
M%7XW*\;C]=3!=B<<E09R5]9YY.I&3>A$(U+R4+]!TH#IOHGSED/IVIZKEWH[
M9"FWVVHZWCEL_=H&2/ ;I-:D"; %(@R3+R'^O??:E.,<\^;1B7NVY^>?1V:^
M;)ODG:]8S[SKA40!O&*%[@YH!",+QH4+KV9XU> URFRIP N*AS$"5/<2Y%F?
M)?78OXVXND:+8\X:Q[7,5?TUJ4.JFHJKFNS+R\4-#R@**F )MP:/>74Q)S3/
M>_J([;ZT=7U7.V&G7KUF0M;$_P#';Z#_ !K5F)0?-V/XG5:KCFY-55I%[77*
M<[+FV77ABZLW),$YY)R*>G.=>;BCN=<;=ZC1=-O4ZOR?QC6/\99$/!&U^'*<
MJ9RX9]>H6T#ROV'OT.B +)FX^3&BK8D"E.(^3C*V_K;<IOL3T5[KTKUUK]%\
MQV#R;7V3N29KDU+@9>0NE3N0B<P!IBIY!=W;EU?YF"DB?(4:D2..=;C-L,L)
M\\>SZ9MI/,K+E.;7K M:H$S/Z[H=/WCSKHMB 6VT9L^HR0%$,Z.2SU=86D_
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M?2AK?,WV"F5W-4YEG@P1XL\^X?J;4&)/$MB[7KFZY]&>N>LW:#4PS0AV0RT
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M^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\
MX&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X
M2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^
M.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'
M^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\
MX&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X
M2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^
M.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'
M^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\
MX&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X
M2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^
M.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'
M^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\
MX&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X
M2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^
M.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'
M^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\
MX&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X
M2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^
M.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'
M^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\
MX&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X
M2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^.[^X2?\ X&?'^I%^
M.[^X2?\ X&?!+/;G^5KQUF]1MD=0:R7;&\/(0-/!!IG_ &B$FF3V\MJ4H>:_
M3*5QI^,6&2VE?)3,IA?R<X)\[8N^8LDJ8;(7G5=4MGV%W;7M..,Q63EULBH_
>5,1$=C06(D""TI;<&!&:;4X^_P!?DO\ _P"IQ__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
